Nitrogen-containing heterocyclic compound and method for controlling plant diseases

Abstract

The present invention provides an effective method for controlling plant diseases. A compound represented by formula (I), an N-oxide thereof, or a salt of the compound or a salt of the N-oxide can be used for controlling plant diseases. (In formula (I), A represents a 5- to 6-membered non-aromatic nitrogen-containing heterocyclic group or the like (in the 5- to 6-membered non-aromatic nitrogen-containing heterocyclic group or the like, at least one of the atoms constituting the 5- to 6-membered non-aromatic nitrogen-containing heterocyclic group or the like and adjacent to the atom bound to D is a nitrogen atom); D represents CR1R2 or the like; X represents a halogen atom; X1, X2, and X3 are the same or different from each other and each represent a halogen atom or the like; Z1 represents a methyl group or the like; and R1 and R2 are the same or different from each other and each represent a C1-C4 chain hydrocarbon group or the like, and R1 and R2, together with the carbon atom bound thereto, may form a C3-C8 alicyclic hydrocarbon or the like.)

Description

Nitrogen-containing heterocyclic compound and plant disease control method

[0001] This application claims priority to and the benefit of Japanese Patent Application No. 2024-127793, filed on August 2, 2024, the entire contents of which are incorporated herein by reference. The present invention relates to a method for controlling plant diseases.

[0002] Patent Document 1 describes a nitrogen-containing heterocyclic compound.

[0003] International Publication No. 2022 / 262821

[0004] An object of the present invention is to provide an excellent method for controlling plant diseases.

[0005] The present inventors have conducted studies to find an excellent method for controlling plant diseases and have found that a compound represented by the following formula (I) has excellent control activity against plant diseases.

[0006] [1] Formula (I) [wherein A represents a 5- to 6-membered non-aromatic nitrogen-containing heterocyclic group or a 5- to 6-membered aromatic nitrogen-containing heterocyclic group (provided that in the 5- to 6-membered non-aromatic nitrogen-containing heterocyclic group and the 5- to 6-membered aromatic nitrogen-containing heterocyclic group, at least one of the atoms adjacent to the atom bonding to D and constituting the 5- to 6-membered non-aromatic nitrogen-containing heterocyclic group and the 5- to 6-membered aromatic nitrogen-containing heterocyclic group is a nitrogen atom) {the 5- to 6-membered non-aromatic nitrogen-containing heterocyclic group and the 5- to 6-membered aromatic nitrogen-containing heterocyclic group may be substituted with one or more substituents selected from group J}, D represents CR 1 R 2 , C=O, C=S, or C=N-OR 10 X represents a halogen atom; 1 , X 2 , and X 3 are the same or different and represent a halogen atom or a hydrogen atom; Z 1represents a methyl group substituted with one or more substituents selected from Group D, a C2-C6 chain hydrocarbon group {the C2-C6 chain hydrocarbon group may be substituted with one or more substituents selected from Group C}, a 5- to 7-membered aromatic heterocyclic group {the 5- to 7-membered aromatic heterocyclic group may be substituted with one or more substituents selected from Group A, and any two adjacent atoms not bonded to the benzene ring substituted with X among the atoms constituting the 5- to 7-membered aromatic heterocyclic group are replaced by another C4-C7 alicyclic hydrocarbon containing the two adjacent atoms, a 4- to 7-membered non-aromatic heterocyclic ring {the C4-C7 alicyclic hydrocarbon and the 4- to 7-membered non-aromatic heterocycle may be substituted with one or more substituents selected from Group B}, a benzene ring or a 5- to 6-membered aromatic heterocycle {the benzene ring and the 5- to 6-membered aromatic heterocycle may be substituted with one or more substituents selected from Group A} (excluding a 5-trifluoromethyl-1,2,4-oxadiazol-3-yl group), a C3-C8 alicyclic hydrocarbon group {the C3-C8 alicyclic hydrocarbon group may be substituted with one or more substituents selected from Group B, and among the atoms constituting the C3-C8 alicyclic hydrocarbon group, X may be Any atom not bonded to the substituted benzene ring may form a C3-C7 alicyclic hydrocarbon or a 3- to 7-membered non-aromatic heterocycle as a spiro atom, and any two adjacent atoms not bonded to the benzene ring substituted with X among the atoms constituting the C3-C8 alicyclic hydrocarbon group may form another C4-C7 alicyclic hydrocarbon containing the two adjacent atoms, a 4- to 7-membered non-aromatic heterocycle (the C4-C7 alicyclic hydrocarbon and the 4- to 7-membered non-aromatic heterocycle may be substituted with one or more substituents selected from Group B), a benzene ring, or a 5- to 6-membered aromatic heterocycle (the benzene ring and the 5- or 6-membered aromatic heterocycle may be substituted with one or more substituents selected from Group A}, and among the atoms constituting the C3-C8 alicyclic hydrocarbon group, any two atoms that are not adjacent to each other (provided that neither of the any two atoms is bonded to the benzene ring substituted with X) may be bridged by —CH2— or —(CH2)2—}, a 3- to 8-membered non-aromatic heterocyclic group {the 3- to 8-membered non-aromatic heterocyclic group may be substituted with one or more substituents selected from Group B, and among the atoms constituting the 3- to 8-membered non-aromatic heterocyclic group,Any atom not bonded to the benzene ring substituted with X may form a C3-C7 alicyclic hydrocarbon or a 3- to 7-membered non-aromatic heterocycle as a spiro atom, and any two adjacent atoms not bonded to the benzene ring substituted with X among the atoms constituting the 3- to 8-membered non-aromatic heterocyclic group may be another C4-C7 alicyclic hydrocarbon containing the two adjacent atoms, a 4- to 7-membered non-aromatic heterocycle {the C4-C7 alicyclic hydrocarbon and the 4- to 7-membered non-aromatic heterocycle may be substituted with one or more substituents selected from group B}, a benzene ring, or a 5- to 6-membered aromatic heterocycle. a 3- to 8-membered non-aromatic heterocyclic group (the benzene ring and the 5- or 6-membered aromatic heterocyclic ring may be substituted with one or more substituents selected from Group A), and any two atoms that are not adjacent to each other among the atoms constituting the 3- to 8-membered non-aromatic heterocyclic group (provided that neither of the two atoms is bonded to the benzene ring substituted with X) may be bridged by —CH— or —(CH)—) (excluding a 5-trifluoromethyl-4,5-dihydro-1,2,4-oxadiazol-3-yl group), a cyano group, OR, 5 , S.R. 6 , S(O)R 7 , S(O)R 8 , C(O)R 9 , N.R. 11 R 12 , or C(R 35 ) = NOR 36 represents R 1 and R 2 are the same or different and each represent a C1-C4 chain hydrocarbon group optionally substituted with one or more substituents selected from Group E, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group (the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group may be substituted with one or more substituents selected from Group B), a phenyl group, a 5- to 6-membered aromatic heterocyclic group (the phenyl group and the 5- to 6-membered aromatic heterocyclic group may be substituted with one or more substituents selected from Group G), OR 13 , S.R. 14 , S(O)R 15 , S(O)R 16 , N.R. 17 R 18 , C(O)R 19 , C(R20 ) = NOR 21 , a cyano group, a nitro group, a halogen atom, or a hydrogen atom, or R 1 and R 2 may form, together with the carbon atom to which they are attached, a C3-C8 alicyclic hydrocarbon or a 3- to 8-membered non-aromatic heterocycle (the C3-C8 alicyclic hydrocarbon and the 3- to 8-membered non-aromatic heterocycle may be substituted with one or more substituents selected from Group B); R 5 is a methyl group, a C2-C6 chain hydrocarbon group, a C1-C6 alkylsulfonyl group, a (C1-C6 alkyl)carbonyl group, a (C1-C6 alkoxy)carbonyl group, a (C1-C6 alkylamino)carbonyl group, or a (C2-C8 dialkylamino)carbonyl group substituted by one or more substituents selected from Group C {the C2-C6 chain hydrocarbon group, the C1-C6 alkylsulfonyl group, the (C1-C6 alkyl)carbonyl group, the (C1-C6 alkoxy)carbonyl group, the (C1-C6 alkylamino)carbonyl group, a (C2-C8 dialkylamino)carbonyl group, and the (C2-C8 dialkylamino)carbonyl group may be substituted with one or more substituents selected from Group C}, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group may be substituted with one or more substituents selected from Group B}, a phenyl group, or a 5- to 6-membered aromatic heterocyclic group {the phenyl group and the 5- to 6-membered aromatic heterocyclic group may be substituted with one or more substituents selected from Group A}, R 6means a C1-C6 chain hydrocarbon group, a (C1-C6 alkyl)carbonyl group, a (C1-C6 alkoxy)carbonyl group, a (C1-C6 alkylamino)carbonyl group, a (C2-C8 dialkylamino)carbonyl group {the C1-C6 chain hydrocarbon group, the (C1-C6 alkyl)carbonyl group, the (C1-C6 alkoxy)carbonyl group, the (C1-C6 alkylamino)carbonyl group, and the (C2-C8 dialkylamino)carbonyl group a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group may be substituted with one or more substituents selected from Group C}, a phenyl group, or a 5- to 6-membered aromatic heterocyclic group {the phenyl group and the 5- to 6-membered aromatic heterocyclic group may be substituted with one or more substituents selected from Group A}, R 7 and R 8 are the same or different and represent a C1-C6 chain hydrocarbon group, a C1-C6 alkylamino group, a C2-C8 dialkylamino group (the C1-C6 chain hydrocarbon group, the C1-C6 alkylamino group, and the C2-C8 dialkylamino group are optionally substituted with one or more substituents selected from Group C), a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group (the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group are optionally substituted with one or more substituents selected from Group B), a phenyl group, or a 5- to 6-membered aromatic heterocyclic group (the phenyl group and the 5- to 6-membered aromatic heterocyclic group are optionally substituted with one or more substituents selected from Group A), R 9means a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group, a C1-C6 alkylamino group, a C2-C8 dialkylamino group, a (C1-C6 alkyl)(C3-C6 cycloalkyl)amino group, a C3-C6 cycloalkylamino group {the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, the C1-C6 alkylamino group, the C2-C8 dialkylamino group, the (C1-C6 alkyl)(C3-C6 cycloalkyl)amino group, and the C3-C6 cycloalkylamino group. R represents a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group may be substituted with one or more substituents selected from Group C}, a phenyl group, a 5- to 6-membered aromatic heterocyclic group {the phenyl group and the 5- to 6-membered aromatic heterocyclic group may be substituted with one or more substituents selected from Group A}, an amino group, or a hydrogen atom; 10 and R 36 are the same or different and represent a C1-C6 chain hydrocarbon group optionally substituted with one or more substituents selected from Group C, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group (the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group may be substituted with one or more substituents selected from Group B), or a hydrogen atom; R 11means a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group, a C1-C6 alkylsulfonyl group, a (C1-C6 alkyl)carbonyl group, a (C1-C6 alkoxy)carbonyl group, a (C1-C6 alkylamino)carbonyl group, a (C2-C8 dialkylamino)carbonyl group {the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, the C1-C6 alkylsulfonyl group, the (C1-C6 alkyl)carbonyl group, the (C1-C6 alkoxy)carbonyl group, the (C1-C6 alkylamino)carbonyl group, a (C2-C8 dialkylamino)carbonyl group, and the (C2-C8 dialkylamino)carbonyl group may be substituted with one or more substituents selected from Group C}, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group may be substituted with one or more substituents selected from Group B}, a phenyl group, a 5- to 6-membered aromatic heterocyclic group {the phenyl group and the 5- to 6-membered aromatic heterocyclic group may be substituted with one or more substituents selected from Group A}, or a hydrogen atom; 12 means a C1-C6 chain hydrocarbon group, a C1-C6 alkylsulfonyl group, a (C1-C6 alkyl)carbonyl group, a (C3-C6 cycloalkyl)carbonyl group, a (C1-C6 alkoxy)carbonyl group, a (C1-C6 alkylamino)carbonyl group, a (C2-C8 dialkylamino)carbonyl group {the C1-C6 chain hydrocarbon group, the C1-C6 alkylsulfonyl group, the (C1-C6 alkyl)carbonyl group, the (C3-C6 cycloalkyl)carbonyl group, the (C1-C6 alkoxy)carbonyl group, the (C1-C a (C2-C8 dialkylamino)carbonyl group, and the (C2-C8 dialkylamino)carbonyl group may be substituted with one or more substituents selected from Group C}, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group may be substituted with one or more substituents selected from Group B}, a phenyl group, or a 5- to 6-membered aromatic heterocyclic group {the phenyl group and the 5- to 6-membered aromatic heterocyclic group may be substituted with one or more substituents selected from Group A}, R 13 and R 14are the same or different and represent a C1-C6 chain hydrocarbon group optionally substituted with one or more substituents selected from Group E, a C1-C6 alkylsulfonyl group, a (C1-C6 alkyl)carbonyl group, a (C1-C6 alkoxy)carbonyl group, a (C1-C6 alkylamino)carbonyl group, a (C2-C8 dialkylamino)carbonyl group {the C1-C6 alkylsulfonyl group, the (C1-C6 alkyl)carbonyl group, the (C1-C6 alkoxy)carbonyl group, the (C1-C6 alkylamino)carbonyl group, and the (C2-C8 dialkylamino)carbonyl group are optionally substituted with one or more halogen atoms}, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group are optionally substituted with one or more substituents selected from Group B}, or a hydrogen atom; R 15 and R 16 are the same or different and represent a C1-C6 chain hydrocarbon group optionally substituted with one or more substituents selected from Group E, a C1-C6 alkoxy group, a C1-C6 alkylamino group, a C2-C8 dialkylamino group (the C1-C6 alkoxy group, the C1-C6 alkylamino group, and the C2-C8 dialkylamino group are optionally substituted with one or more halogen atoms), a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group (the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group are optionally substituted with one or more substituents selected from Group B), a phenyl group, a 5- to 6-membered aromatic heterocyclic group (the phenyl group and the 5- to 6-membered aromatic heterocyclic group are optionally substituted with one or more substituents selected from Group G), or an amino group, R 17 and R 23are the same or different and each represents a C1-C6 chain hydrocarbon group optionally substituted by one or more substituents selected from Group E, a C1-C6 alkoxy group, a C1-C6 alkylsulfonyl group, a (C1-C6 alkyl)carbonyl group, a (C1-C6 alkoxy)carbonyl group, a (C1-C6 alkylamino)carbonyl group, a (C2-C8 dialkylamino)carbonyl group {the C1-C6 alkoxy group, the C1-C6 alkylsulfonyl group, the (C1-C6 alkyl)carbonyl group, the (C1-C6 alkoxy)carbonyl group, the (C1- a (C6 alkylamino)carbonyl group, and the (C2-C8 dialkylamino)carbonyl group may be substituted with one or more halogen atoms}, a C3-C8 alicyclic hydrocarbon group, a 3-8 membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3-8 membered non-aromatic heterocyclic group may be substituted with one or more substituents selected from Group B}, a phenyl group, a 5-6 membered aromatic heterocyclic group {the phenyl group and the 5-6 membered aromatic heterocyclic group may be substituted with one or more substituents selected from Group G}, or a hydrogen atom; 18 and R 24 are the same or different and are each a C1-C6 chain hydrocarbon group optionally substituted by one or more substituents selected from Group E, a C1-C6 alkylsulfonyl group, a (C1-C6 alkyl)carbonyl group, a (C1-C6 alkoxy)carbonyl group, a (C1-C6 alkylamino)carbonyl group, a (C2-C8 dialkylamino)carbonyl group {the C1-C6 alkylsulfonyl group, the (C1-C6 alkyl)carbonyl group, the (C1-C6 alkoxy)carbonyl group, the (C1-C6 alkylamino)carbonyl group, a (C2-C8 dialkylamino)carbonyl group, and the (C2-C8 dialkylamino)carbonyl group may be substituted with one or more halogen atoms}, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group may be substituted with one or more substituents selected from Group B}, a phenyl group, a 5- to 6-membered aromatic heterocyclic group {the phenyl group and the 5- to 6-membered aromatic heterocyclic group may be substituted with one or more substituents selected from Group G}, or a hydrogen atom; 19represents a C1-C6 chain hydrocarbon group optionally substituted with one or more substituents selected from Group E, a C1-C6 alkoxy group, a C1-C6 alkylamino group, a C2-C8 dialkylamino group {the C1-C6 alkoxy group, the C1-C6 alkylamino group, and the C2-C8 dialkylamino group are optionally substituted with one or more halogen atoms}, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group are optionally substituted with one or more substituents selected from Group B}, a phenyl group, a 5- to 6-membered aromatic heterocyclic group {the phenyl group and the 5- to 6-membered aromatic heterocyclic group are optionally substituted with one or more substituents selected from Group G}, a hydroxy group, an amino group, or a hydrogen atom; R 20 , R 26 , and R 35 are the same or different and represent a C1-C6 chain hydrocarbon group optionally substituted with one or more substituents selected from group C, or a hydrogen atom; R 21 and R 27 are the same or different and represent a C1-C6 chain hydrocarbon group optionally substituted with one or more substituents selected from Group E, a C3-C8 alicyclic hydrocarbon group, a 3-8 membered non-aromatic heterocyclic group (the C3-C8 alicyclic hydrocarbon group and the 3-8 membered non-aromatic heterocyclic group may be substituted with one or more substituents selected from Group B), a phenyl group, a 5-6 membered aromatic heterocyclic group (the phenyl group and the 5-6 membered aromatic heterocyclic group may be substituted with one or more substituents selected from Group G), or a hydrogen atom, R 22is a C1-C6 chain hydrocarbon group optionally substituted by one or more substituents selected from Group E, a C1-C6 alkylsulfonyl group, a (C1-C6 alkyl)carbonyl group, a (C1-C6 alkoxy)carbonyl group, a (C1-C6 alkylamino)carbonyl group, a (C2-C8 dialkylamino)carbonyl group {the C1-C6 alkylsulfonyl group, the (C1-C6 alkyl)carbonyl group, the (C1-C6 alkoxy)carbonyl group, the (C1-C6 alkylamino)carbonyl group, a (C2-C8 dialkylamino)carbonyl group, and the (C2-C8 dialkylamino)carbonyl group may be substituted with one or more halogen atoms}, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group may be substituted with one or more substituents selected from Group B}, a phenyl group, or a 5- to 6-membered aromatic heterocyclic group {the phenyl group and the 5- to 6-membered aromatic heterocyclic group may be substituted with one or more substituents selected from Group G}, R 25represents a C1-C6 chain hydrocarbon group which may be substituted with one or more substituents selected from Group E, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group may be substituted with one or more substituents selected from Group B}, an amino group, a hydroxy group, or a hydrogen atom. Group A: a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group, a C1-C6 alkylamino group, a C2-C8 dialkylamino group, a (C1-C6 alkyl)carbonyl group, a (C1-C6 alkoxy)carbonyl group, a (C1-C6 alkylamino)carbonyl group, a (C2-C8 dialkylamino)carbonyl group, a (C1-C6 alkyl)carbonylamino group, a (C1-C6 alkoxy)carbonylamino group {the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, the C1-C6 alkylamino group, the C2-C8 dialkylamino group, the (C1-C6 alkyl)carbonyl group, the ( the (C1-C6 alkoxy)carbonyl group, the (C1-C6 alkylamino)carbonyl group, the (C2-C8 dialkylamino)carbonyl group, the (C1-C6 alkyl)carbonylamino group, and the (C1-C6 alkoxy)carbonylamino group are optionally substituted with one or more halogen atoms}, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group are optionally substituted with one or more substituents selected from group F}, a halogen atom, a cyano group, a nitro group, a hydroxy group, and a sulfanyl group.Group B: oxo group, thioxo group, C1-C6 chain hydrocarbon group, C1-C6 alkoxy group, C1-C6 alkylamino group, C2-C8 dialkylamino group, (C1-C6 alkyl)carbonyl group, (C1-C6 alkoxy)carbonyl group, (C1-C6 alkylamino)carbonyl group, (C2-C8 dialkylamino)carbonyl group, (C1-C6 alkyl)carbonylamino group, (C1-C6 alkoxy)carbonylamino group {the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, the C1-C6 alkylamino group, the C2-C8 dialkylamino group, the (C1-C6 alkyl)carbonyl the (C1-C6 alkoxy)carbonyl group, the (C1-C6 alkylamino)carbonyl group, the (C2-C8 dialkylamino)carbonyl group, the (C1-C6 alkyl)carbonylamino group, and the (C1-C6 alkoxy)carbonylamino group are optionally substituted with one or more halogen atoms}, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group are optionally substituted with one or more substituents selected from group F}, a halogen atom, a cyano group, a nitro group, a hydroxy group, and a sulfanyl group. Group C: the group consisting of a C1-C6 alkoxy group, a C1-C6 alkylamino group, a C2-C8 dialkylamino group, a C1-C6 alkylsulfanyl group, a C1-C6 alkylsulfinyl group, a C1-C6 alkylsulfonyl group {the C1-C6 alkoxy group, the C1-C6 alkylamino group, the C2-C8 dialkylamino group, the C1-C6 alkylsulfanyl group, the C1-C6 alkylsulfinyl group and the C1-C6 alkylsulfonyl group are optionally substituted with one or more halogen atoms}, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group are optionally substituted with one or more substituents selected from Group F}, a halogen atom, a cyano group, a nitro group, a hydroxy group, and a sulfanyl group.Group D: a C1-C6 alkoxy group, a C1-C6 alkylamino group, a C2-C8 dialkylamino group, a C1-C6 alkylsulfanyl group, a C1-C6 alkylsulfinyl group, a C1-C6 alkylsulfonyl group, a (C1-C6 alkyl)carbonyl group, a (C1-C6 alkoxy)carbonyl group, a (C1-C6 alkylamino)carbonyl group, a (C2-C8 dialkylamino)carbonyl group, a (C1-C6 alkyl)carbonylamino group, a (C1-C6 alkoxy)carbonylamino group {the C1-C6 alkoxy group, the C1-C6 alkylamino group, the C2-C8 dialkylamino group, the C1-C6 alkylsulfanyl group, the C1-C6 alkylsulfinyl group, the C1-C6 alkylsulfonyl group, the (C the (C1-C6 alkyl)carbonyl group, the (C1-C6 alkoxy)carbonyl group, the (C1-C6 alkylamino)carbonyl group, the (C2-C8 dialkylamino)carbonyl group, the (C1-C6 alkyl)carbonylamino group and the (C1-C6 alkoxy)carbonylamino group are optionally substituted with one or more halogen atoms}, a C3-C8 alicyclic hydrocarbon group, a 3-8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3-8-membered non-aromatic heterocyclic group are optionally substituted with one or more substituents selected from group F}, a phenyl group, a 5- or 6-membered aromatic heterocycle {the phenyl group and the 5- or 6-membered aromatic heterocycle are optionally substituted with one or more substituents selected from group A}, and a cyano group.Group E: a C1-C6 alkoxy group, a C1-C6 alkylamino group, a C2-C8 dialkylamino group, a C1-C6 alkylsulfanyl group, a C1-C6 alkylsulfinyl group, a C1-C6 alkylsulfonyl group {the C1-C6 alkoxy group, the C1-C6 alkylamino group, the C2-C8 dialkylamino group, the C1-C6 alkylsulfanyl group, the C1-C6 alkylsulfinyl group, and the C1-C6 alkylsulfonyl group are substituted with one or more halogen atoms; the group consisting of a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group may be substituted with one or more substituents selected from group F}, a phenyl group, a 5- to 6-membered aromatic heterocyclic group {the phenyl group and the 5- to 6-membered aromatic heterocyclic group may be substituted with one or more substituents selected from group G}, a halogen atom, a cyano group, a nitro group, a hydroxy group, and a sulfanyl group. Group F: a group consisting of an oxo group, a thioxo group, a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group, a C1-C6 alkylsulfanyl group, a C1-C6 alkylsulfinyl group, a C1-C6 alkylsulfonyl group (the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, the C1-C6 alkylsulfanyl group, the C1-C6 alkylsulfinyl group, and the C1-C6 alkylsulfonyl group are optionally substituted with one or more halogen atoms), a hydroxy group, a sulfanyl group, a halogen atom, and a cyano group.Group G: C1-C6 chain hydrocarbon group, C1-C6 alkoxy group, C1-C6 alkylsulfanyl group, C1-C6 alkylsulfinyl group, C1-C6 alkylsulfonyl group, C1-C6 alkylamino group, C2-C8 dialkylamino group, (C1-C6 alkyl)carbonyl group, (C1-C6 alkoxy)carbonyl group, (C1-C6 alkylamino)carbonyl group, (C2-C8 dialkylamino)carbonyl group, (C1-C6 alkyl)carbonylamino group, (C1-C6 alkoxy)carbonylamino group {the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, the C1-C6 alkylsulfanyl group, the C1-C6 alkylsulfinyl group, the C1-C6 alkylsulfonyl group, the C1 the group consisting of a -C6 alkylamino group, the C2-C8 dialkylamino group, the (C1-C6 alkyl)carbonyl group, the (C1-C6 alkoxy)carbonyl group, the (C1-C6 alkylamino)carbonyl group, the (C2-C8 dialkylamino)carbonyl group, the (C1-C6 alkyl)carbonylamino group and the (C1-C6 alkoxy)carbonylamino group are optionally substituted with one or more halogen atoms}, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group are optionally substituted with one or more substituents selected from group F}, an amino group, a nitro group, a cyano group, a hydroxy group, a sulfanyl group, and a halogen atom. Group H: a group consisting of a C1-C6 alkylsulfanyl group, a C1-C6 alkylsulfinyl group, a C1-C6 alkylsulfonyl group, a C1-C6 alkylamino group, a C2-C8 dialkylamino group (the C1-C6 alkylsulfanyl group, the C1-C6 alkylsulfinyl group, the C1-C6 alkylsulfonyl group, the C1-C6 alkylamino group and the C2-C8 dialkylamino group are optionally substituted with one or more halogen atoms), a C3-C8 alicyclic hydrocarbon group, a 3-8-membered non-aromatic heterocyclic group (the C3-C8 alicyclic hydrocarbon group and the 3-8-membered non-aromatic heterocyclic group are optionally substituted with one or more substituents selected from Group F), a phenyl group, a 5-6-membered aromatic heterocyclic group (the phenyl group and the 5-6-membered aromatic heterocyclic group are optionally substituted with one or more substituents selected from Group G}, a hydroxy group, and a halogen atom.Group J: a methyl group optionally substituted with one or more substituents selected from Group H, a C2-C6 chain hydrocarbon group {the C2-C6 chain hydrocarbon group may be substituted with one or more substituents selected from Group E}, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group may be substituted with one or more substituents selected from Group B}, OR. 22 , N.R. 23 R 24 , C(O)R 25 , C(R 26 ) = NOR 27 [2] A method for controlling plant diseases, comprising treating a plant or soil in which the plant is grown with a compound represented by formula (II) (hereinafter referred to as the present compound A) or an N-oxide thereof, or a salt thereof (hereinafter the present compound A or the N-oxide or the salt thereof will be referred to as the present compound). [In the formula, A a is a compound of formula H1, H2, H3, or H4 [Wherein, # is D a represents a bonding site with 1 is a nitrogen atom or CR 1b represents 2 is a nitrogen atom or CR 2b represents 3 is a nitrogen atom or CR 3b represents 4 is a nitrogen atom or CR 4b represents 5 is a nitrogen atom or CR 5b (where G 2 , G 3 , G 4 , and G 5 The number of nitrogen atoms is 0 or 1. 1 and Q 2 are the same or different and represent an oxygen atom or a sulfur atom; R 1a , R 2a , R 3a , R 1b , R 2b , R 4b , and R 5bare the same or different, and are in the group H1 a a methyl group which may be substituted by one or more substituents selected from the group consisting of a C2-C6 chain hydrocarbon group (the C2-C6 chain hydrocarbon group is selected from the group consisting of a a a C3-C8 alicyclic hydrocarbon group {which may be substituted with one or more substituents selected from the group F a may be substituted with one or more substituents selected from the group consisting of OR 24a , N.R. 25a R 26a , C(O)R 27a , C(R 28a ) = NOR 29a , an amino group, a cyano group, a nitro group, a hydrogen atom, or a halogen atom; R 4a and R 3b are the same or different, and are in the group H2 a a methyl group which may be substituted by one or more substituents selected from the group consisting of a C2-C6 chain hydrocarbon group (the C2-C6 chain hydrocarbon group is selected from the group consisting of a a a C3-C8 alicyclic hydrocarbon group {which may be substituted with one or more substituents selected from the group F a may be substituted with one or more substituents selected from the group consisting of OR 32a , N.R. 33a R 34a , C(O)R 35a , C(R 36a ) = NOR 37a , an amino group, a cyano group, a nitro group, a hydrogen atom, or a halogen atom; D a is CR 5a R 6a , C=O, C=S, or C=N-OR 7a represents X a represents a halogen atom; X 1a , X 2a , and X 3a are the same or different and represent a hydrogen atom or a halogen atom; Z a is group D a a C2 chain hydrocarbon group (the C2 chain hydrocarbon group is selected from the group C2 aa C3-C6 chain hydrocarbon group {which may be substituted with one or more substituents selected from the group C1 a a 5- to 7-membered aromatic heterocyclic group {which may be substituted with one or more substituents selected from the following}, a 5- to 7-membered aromatic heterocyclic group {which may be substituted with one or more substituents selected from the following group A a and optionally substituted with one or more substituents selected from the following} (excluding a 5-trifluoromethyl-1,2,4-oxadiazol-3-yl group and a 1,2,4-triazine-3,5(2H,4H)-dione-2-yl group), a C3-C8 alicyclic hydrocarbon group {the C3-C8 alicyclic hydrocarbon group is a group selected from the group B a Among the atoms constituting the C3-C8 alicyclic hydrocarbon group, X a Any atom not bonded to the benzene ring substituted with X may form a C3-C7 alicyclic hydrocarbon or a 3- to 7-membered non-aromatic heterocycle as a spiro atom, and among the atoms constituting the C3-C8 alicyclic hydrocarbon group, X a any two adjacent atoms not bonded to a benzene ring substituted with another C4-C7 alicyclic hydrocarbon, a 4- to 7-membered non-aromatic heterocycle containing the two adjacent atoms {the C4-C7 alicyclic hydrocarbon and the 4- to 7-membered non-aromatic heterocycle are included in group B a a benzene ring, or a 5- or 6-membered aromatic heterocycle {the benzene ring and the 5- or 6-membered aromatic heterocycle are each selected from the group A a and any two atoms that are not adjacent to each other among the atoms constituting the C3-C8 alicyclic hydrocarbon group (provided that both of the any two atoms are substituted with one or more substituents selected from the following) may form a ring structure. a a 3- to 8-membered non-aromatic heterocyclic group {which is not bonded to a benzene ring substituted with -CH2- or -(CH2)2-, and which may be bridged by -CH2- or -(CH2)2-}, a 3- to 8-membered non-aromatic heterocyclic group {which is a 3- to 8-membered non-aromatic heterocyclic group selected from the group B a Among the atoms constituting the 3- to 8-membered non-aromatic heterocyclic group, X aAny atom not bonded to the benzene ring substituted with X may form a C3-C7 alicyclic hydrocarbon or a 3- to 7-membered non-aromatic heterocyclic ring as a spiro atom, and among the atoms constituting the 3- to 8-membered non-aromatic heterocyclic group, X a any two adjacent atoms not bonded to a benzene ring substituted with another C4-C7 alicyclic hydrocarbon, a 4- to 7-membered non-aromatic heterocycle containing the two adjacent atoms {the C4-C7 alicyclic hydrocarbon and the 4- to 7-membered non-aromatic heterocycle are included in group B a a benzene ring, or a 5- or 6-membered aromatic heterocycle {the benzene ring and the 5- or 6-membered aromatic heterocycle are each selected from the group A a and any two atoms that are not adjacent to each other among the atoms constituting the 3- to 8-membered non-aromatic heterocyclic group (provided that both of the any two atoms are not X a (not bonded to a benzene ring substituted with -CH2- or -(CH2)2-) may be bridged by -CH2- or -(CH2)2- (excluding 5-trifluoromethyl-4,5-dihydro-1,2,4-oxadiazol-3-yl group and 4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl group), a cyano group, OR 8a , S.R. 9a , S(O)R 10a , S(O)R 11a , C(O)R 12a , N.R. 13a R 14a , or C(R 30a ) = NOR 31a represents R 5a and R 6a are the same or different, and are group E a a C1-C4 chain hydrocarbon group, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group, each of which may be substituted by one or more substituents selected from the group consisting of a a phenyl group, a 5- or 6-membered aromatic heterocyclic group {the phenyl group and the 5- or 6-membered aromatic heterocyclic group may be selected from the group G a may be substituted with one or more substituents selected from the group consisting of OR15a , S.R. 16a , S(O)R 17a , S(O)R 18a , N.R. 19a R 20a , C(O)R 21a , C(R 22a ) = NOR 23a , a cyano group, a nitro group, a halogen atom, or a hydrogen atom, or R 5a and R 6a together with the carbon atom to which they are attached, form a C3-C8 alicyclic hydrocarbon or a 3- to 8-membered non-aromatic heterocycle {the C3-C8 alicyclic hydrocarbon and the 3- to 8-membered non-aromatic heterocycle are selected from the group B a may be substituted with one or more substituents selected from the following; 7a and R 31a are the same or different, and are in the group C1 a a C1-C6 chain hydrocarbon group, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group, each of which may be substituted by one or more substituents selected from the group consisting of a or a hydrogen atom, R 8a and R 9a are the same or different, and are members of Group I a a C1-C2 chain hydrocarbon group substituted with one or more substituents selected from the group C1 a and optionally substituted with one or more substituents selected from the group consisting of a (C2-C8 dialkylamino)carbonyl group {the (C2-C8 dialkylamino)carbonyl group is optionally substituted with one or more halogen atoms}, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group are selected from the group consisting of a (C2-C8 dialkylamino)carbonyl group and ... and a (C2-C8 dialkylamino)carbonyl group {the (C2-C8 dialkylamino)carbonyl group is optionally substituted with one or more halogen atoms}, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group selected from the group consisting of a (C2-C8 dialkylamino)carbonyl group and a (C2-C8 dialkylamino)carbonyl group {the (C2-C8 dialkylamino)carbonyl group is optionally substituted with one or more halogen atoms}, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group selected from the group consisting of a (C2-C8 dialkylamino)carbonyl group and a (C2-C8 dialkylamino)carbonyl group a a phenyl group, or a 5- or 6-membered aromatic heterocyclic group {the phenyl group and the 5- or 6-membered aromatic heterocyclic group may be selected from the group G a R may be substituted with one or more substituents selected from the following 10a and R 11aare the same or different, and are in the group C1 a a C1-C6 chain hydrocarbon group, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group, each of which may be substituted by one or more substituents selected from the group consisting of the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group, each of which may be substituted by one or more substituents selected from the group consisting of the C1-C6 chain hydrocarbon group, the C3-C8 alicyclic hydrocarbon group, and the 3- to 8-membered non-aromatic heterocyclic group a a phenyl group, or a 5- or 6-membered aromatic heterocyclic group {which may be substituted with one or more substituents selected from the following}, a phenyl group, or a 5- or 6-membered aromatic heterocyclic group {the phenyl group and the 5- or 6-membered aromatic heterocyclic group are selected from the following group A a R may be substituted with one or more substituents selected from the following 12a is the group C1 a a C3-C6 chain hydrocarbon group, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group, each of which may be substituted by one or more substituents selected from the group consisting of a a phenyl group, or a 5- or 6-membered aromatic heterocyclic group {the phenyl group and the 5- or 6-membered aromatic heterocyclic group may be selected from the group G a R may be substituted with one or more substituents selected from the following 13a represents a C3-C6 chain hydrocarbon group, a (C3-C6 cycloalkyl)carbonyl group, a C1-C6 alkylsulfonyl group (the C3-C6 chain hydrocarbon group, the (C3-C6 cycloalkyl)carbonyl group, and the C1-C6 alkylsulfonyl group are optionally substituted with one or more halogen atoms), a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group (the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group are each selected from group F a and a 5- or 6-membered aromatic heterocyclic group {which may be substituted with one or more substituents selected from the group G a R may be substituted with one or more substituents selected from the following 14arepresents a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group, a (C1-C6 alkoxy)carbonyl group, a (C1-C6 alkylamino)carbonyl group, a (C2-C8 dialkylamino)carbonyl group (the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, the (C1-C6 alkoxy)carbonyl group, the (C1-C6 alkylamino)carbonyl group, and the (C2-C8 dialkylamino)carbonyl group are optionally substituted with one or more halogen atoms), a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group (the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group are each selected from group F a a 5- or 6-membered aromatic heterocyclic group {which may be substituted with one or more substituents selected from the group G a or a hydrogen atom, R 15a and R 16a are the same or different, and are group E a a C1-C6 chain hydrocarbon group optionally substituted by one or more substituents selected from the group consisting of a C1-C6 alkylsulfonyl group, a (C1-C6 alkyl)carbonyl group, a (C1-C6 alkoxy)carbonyl group, a (C1-C6 alkylamino)carbonyl group, a (C2-C8 dialkylamino)carbonyl group {the C1-C6 alkylsulfonyl group, the (C1-C6 alkyl)carbonyl group, the (C1-C6 alkoxy)carbonyl group, the (C1-C6 alkylamino)carbonyl group, and the (C2-C8 dialkylamino)carbonyl group are optionally substituted by one or more halogen atoms}, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group are selected from the group consisting of a C1-C6 alkylsulfonyl group, a C1-C6 alkyl)carbonyl group, a (C1-C6 alkoxy)carbonyl group, a (C1-C6 alkylamino)carbonyl group, and a ... a or a hydrogen atom, R 17a and R 18a are the same or different, and are group E aa C1-C6 chain hydrocarbon group optionally substituted by one or more substituents selected from the group consisting of a C1-C6 alkoxy group, a C1-C6 alkylamino group, a C2-C8 dialkylamino group (the C1-C6 alkoxy group, the C1-C6 alkylamino group, and the C2-C8 dialkylamino group are optionally substituted by one or more halogen atoms), a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group (the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group are selected from the group consisting of ... chain hydrocarbon group, a C1-C6 alkoxy group, a C1-C6 alkylamino group, a C2-C8 dialkylamino group (the C1-C6 alkoxy group, the C1-C6 alkylamino group, and the C2-C8 dialkylamino group are optionally substituted by one or more halogen atoms), a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group (the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group are selected from the group consisting of a a phenyl group, a 5- or 6-membered aromatic heterocyclic group {the phenyl group and the 5- or 6-membered aromatic heterocyclic group may be selected from the group G a or an amino group, R 19a and R 20a are the same or different, and are group E a a C1-C6 chain hydrocarbon group optionally substituted by one or more substituents selected from the group consisting of a C1-C6 alkylsulfonyl group, a (C1-C6 alkyl)carbonyl group, a (C1-C6 alkoxy)carbonyl group, a (C1-C6 alkylamino)carbonyl group, a (C2-C8 dialkylamino)carbonyl group {the C1-C6 alkylsulfonyl group, the (C1-C6 alkyl)carbonyl group, the (C1-C6 alkoxy)carbonyl group, the (C1-C6 alkylamino)carbonyl group, and the (C2-C8 dialkylamino)carbonyl group are optionally substituted by one or more halogen atoms}, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group are selected from the group consisting of a C1-C6 alkylsulfonyl group, a C1-C6 alkyl)carbonyl group, a (C1-C6 alkoxy)carbonyl group, a (C1-C6 alkylamino)carbonyl group, and a ... a a phenyl group, a 5- or 6-membered aromatic heterocyclic group {the phenyl group and the 5- or 6-membered aromatic heterocyclic group may be selected from the group G a or a hydrogen atom, R 21a is Group E aa C1-C6 chain hydrocarbon group optionally substituted by one or more substituents selected from the group consisting of a C1-C6 alkoxy group, a C1-C6 alkylamino group, a C2-C8 dialkylamino group (the C1-C6 alkoxy group, the C1-C6 alkylamino group, and the C2-C8 dialkylamino group are optionally substituted by one or more halogen atoms), a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group (the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group are selected from the group consisting of ... chain hydrocarbon group, a C1-C6 alkoxy group, a C1-C6 alkylamino group, a C2-C8 dialkylamino group (the C1-C6 alkoxy group, the C1-C6 alkylamino group, and the C2-C8 dialkylamino group are optionally substituted by one or more halogen atoms), a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group (the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group are selected from the group consisting of a a phenyl group, a 5- or 6-membered aromatic heterocyclic group {the phenyl group and the 5- or 6-membered aromatic heterocyclic group may be selected from the group G a R represents a hydroxy group, an amino group, or a hydrogen atom, and R 22a , R 28a , R 30a , and R 36a are the same or different, and are in the group C1 a R represents a C1-C6 chain hydrocarbon group optionally substituted with one or more substituents selected from the group consisting of: 23a , R 29a , and R 37a are the same or different, and are group E a a C1-C6 chain hydrocarbon group, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group, each of which may be substituted by one or more substituents selected from the group consisting of a a phenyl group, a 5- or 6-membered aromatic heterocyclic group {the phenyl group and the 5- or 6-membered aromatic heterocyclic group may be selected from the group G a or a hydrogen atom, R 25a , R 26a , R 33a , and R 34a are the same or different, and are group E aa C1-C6 chain hydrocarbon group optionally substituted by one or more substituents selected from the group consisting of a C1-C6 alkylsulfonyl group, a (C1-C6 alkyl)carbonyl group, a (C1-C6 alkoxy)carbonyl group, a (C1-C6 alkylamino)carbonyl group, a (C2-C8 dialkylamino)carbonyl group {the C1-C6 alkylsulfonyl group, the (C1-C6 alkyl)carbonyl group, the (C1-C6 alkoxy)carbonyl group, the (C1-C6 alkylamino)carbonyl group, and the (C2-C8 dialkylamino)carbonyl group are optionally substituted by one or more halogen atoms}, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group are selected from the group consisting of a C1-C6 alkylsulfonyl group, a C1-C6 alkyl)carbonyl group, a (C1-C6 alkoxy)carbonyl group, a (C1-C6 alkylamino)carbonyl group, and a ... a a phenyl group, a 5- or 6-membered aromatic heterocyclic group {the phenyl group and the 5- or 6-membered aromatic heterocyclic group may be selected from the group G a or a hydrogen atom, R 24a and R 32a are the same or different, and are group E a a C1-C6 chain hydrocarbon group optionally substituted by one or more substituents selected from the group consisting of a C1-C6 alkylsulfonyl group, a (C1-C6 alkyl)carbonyl group, a (C1-C6 alkoxy)carbonyl group, a (C1-C6 alkylamino)carbonyl group, a (C2-C8 dialkylamino)carbonyl group {the C1-C6 alkylsulfonyl group, the (C1-C6 alkyl)carbonyl group, the (C1-C6 alkoxy)carbonyl group, the (C1-C6 alkylamino)carbonyl group, and the (C2-C8 dialkylamino)carbonyl group are optionally substituted by one or more halogen atoms}, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group are selected from the group consisting of a C1-C6 alkylsulfonyl group, a C1-C6 alkyl)carbonyl group, a (C1-C6 alkoxy)carbonyl group, a (C1-C6 alkylamino)carbonyl group, and a ... a a phenyl group, or a 5- or 6-membered aromatic heterocyclic group {the phenyl group and the 5- or 6-membered aromatic heterocyclic group may be selected from the group G a R may be substituted with one or more substituents selected from the following 27a and R 35aare the same or different, and are in the group C1 a a C1-C6 chain hydrocarbon group, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group, each of which may be substituted by one or more substituents selected from the group consisting of a Group A represents an amino group, a hydroxy group, or a hydrogen atom, and may be substituted with one or more substituents selected from the group consisting of: a C1-C6 chain hydrocarbon group, C1-C6 alkoxy group, C1-C6 alkylamino group, C2-C8 dialkylamino group, (C1-C6 alkyl)carbonyl group, (C1-C6 alkoxy)carbonyl group, (C1-C6 alkylamino)carbonyl group, (C2-C8 dialkylamino)carbonyl group, (C1-C6 alkyl)carbonylamino group, (C1-C6 alkoxy)carbonylamino group {the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, the C1-C6 alkylamino group, the C2-C8 a dialkylamino group, the (C1-C6 alkyl)carbonyl group, the (C1-C6 alkoxy)carbonyl group, the (C1-C6 alkylamino)carbonyl group, the (C2-C8 dialkylamino)carbonyl group, the (C1-C6 alkyl)carbonylamino group, and the (C1-C6 alkoxy)carbonylamino group are optionally substituted with one or more halogen atoms}, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group are selected from group F a and a group consisting of a halogen atom, a cyano group, a nitro group, a hydroxy group, and a sulfanyl group, each of which may be substituted with one or more substituents selected from the group consisting of: aoxo group, thioxo group, C1-C6 chain hydrocarbon group, C1-C6 alkoxy group, C1-C6 alkylamino group, C2-C8 dialkylamino group, (C1-C6 alkyl)carbonyl group, (C1-C6 alkoxy)carbonyl group, (C1-C6 alkylamino)carbonyl group, (C2-C8 dialkylamino)carbonyl group, (C1-C6 alkyl)carbonylamino group, (C1-C6 alkoxy)carbonylamino group {the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, the C1-C6 alkylamino group, the C2-C8 dialkylamino group, the (C1-C6 alkyl)carbonyl group, the (C1-C6 alkoxy)carbonyl group, the (C1-C6 alkylamino)carbonyl group, the (C2-C8 dialkylamino)carbonyl group, the (C1-C6 alkyl)carbonylamino group, and the (C1-C6 alkoxy)carbonylamino group are optionally substituted with one or more halogen atoms}, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group are selected from group F a and a group consisting of a halogen atom, a cyano group, a nitro group, a hydroxy group, and a sulfanyl group, each of which may be substituted with one or more substituents selected from the group consisting of: a a C1-C6 alkoxy group, a C1-C6 alkylamino group, a C2-C8 dialkylamino group, a C1-C6 alkylsulfanyl group, a C1-C6 alkylsulfinyl group, a C1-C6 alkylsulfonyl group {the C1-C6 alkoxy group, the C1-C6 alkylamino group, the C2-C8 dialkylamino group, the C1-C6 alkylsulfanyl group, the C1-C6 alkylsulfinyl group, and the C1-C6 alkylsulfonyl group are optionally substituted with one or more halogen atoms}, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group are selected from group F a and a group consisting of a halogen atom, a cyano group, a nitro group, a hydroxy group, and a sulfanyl group, each of which may be substituted with one or more substituents selected from the group consisting of a halogen atom, a cyano group, a nitro group, a hydroxy group, and a sulfanyl group. aa C1-C6 alkoxy group, a C1-C6 alkylamino group, a C2-C8 dialkylamino group, a C1-C6 alkylsulfanyl group, a C1-C6 alkylsulfinyl group, a C1-C6 alkylsulfonyl group {the C1-C6 alkoxy group, the C1-C6 alkylamino group, the C2-C8 dialkylamino group, the C1-C6 alkylsulfanyl group, the C1-C6 alkylsulfinyl group, and the C1-C6 alkylsulfonyl group are optionally substituted with one or more halogen atoms}, a C3-C8 alicyclic hydrocarbon group {the C3-C8 alicyclic hydrocarbon group is selected from group F a and a group consisting of a halogen atom, a cyano group, a nitro group, a hydroxy group, and a sulfanyl group, each of which may be substituted with one or more substituents selected from the group consisting of: a a C1-C6 alkoxy group, a C1-C6 alkylsulfanyl group, a C1-C6 alkylsulfinyl group, a (C1-C6 alkyl)carbonyl group, a (C1-C6 alkoxy)carbonyl group, a (C1-C6 alkylamino)carbonyl group, a (C2-C8 dialkylamino)carbonyl group {the C1-C6 alkoxy group, the C1-C6 alkylsulfanyl group, the C1-C6 alkylsulfinyl group, the (C1-C6 alkyl)carbonyl group, the (C1-C6 alkoxy)carbonyl group, the (C1-C6 alkylamino)carbonyl group, and the (C2-C8 dialkylamino)carbonyl group are optionally substituted with one or more halogen atoms}, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group are selected from group F a a phenyl group, a 5- or 6-membered aromatic heterocycle {the phenyl group and the 5- or 6-membered aromatic heterocycle are each selected from the group A a and a cyano group. aa C1-C6 alkoxy group, a C1-C6 alkylamino group, a C2-C8 dialkylamino group, a C1-C6 alkylsulfanyl group, a C1-C6 alkylsulfinyl group, a C1-C6 alkylsulfonyl group {the C1-C6 alkoxy group, the C1-C6 alkylamino group, the C2-C8 dialkylamino group, the C1-C6 alkylsulfanyl group, the C1-C6 alkylsulfinyl group, and the C1-C6 alkylsulfonyl group are optionally substituted with one or more halogen atoms}, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group are selected from group F a a phenyl group, a 5- or 6-membered aromatic heterocyclic group {the phenyl group and the 5- or 6-membered aromatic heterocyclic group may be selected from the group G a and a group consisting of a halogen atom, a cyano group, a nitro group, a hydroxy group, and a sulfanyl group, each of which may be substituted with one or more substituents selected from the group consisting of: a Group G: a group consisting of an oxo group, a thioxo group, a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group, a C1-C6 alkylsulfanyl group, a C1-C6 alkylsulfinyl group, a C1-C6 alkylsulfonyl group (the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, the C1-C6 alkylsulfanyl group, the C1-C6 alkylsulfinyl group, and the C1-C6 alkylsulfonyl group are optionally substituted with one or more halogen atoms), a hydroxy group, a sulfanyl group, a halogen atom, and a cyano group. aC1-C6 chain hydrocarbon group, C1-C6 alkoxy group, C1-C6 alkylsulfanyl group, C1-C6 alkylsulfinyl group, C1-C6 alkylsulfonyl group, C1-C6 alkylamino group, C2-C8 dialkylamino group, (C1-C6 alkyl)carbonyl group, (C1-C6 alkoxy)carbonyl group, (C1-C6 alkylamino)carbonyl group, (C2-C8 dialkylamino)carbonyl group, (C1-C6 alkyl)carbonylamino group, (C1-C6 alkoxy)carbonylamino group {the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, the C1-C6 alkylsulfanyl group, the C1- a C6 alkylsulfinyl group, the C1-C6 alkylsulfonyl group, the C1-C6 alkylamino group, the C2-C8 dialkylamino group, the (C1-C6 alkyl)carbonyl group, the (C1-C6 alkoxy)carbonyl group, the (C1-C6 alkylamino)carbonyl group, the (C2-C8 dialkylamino)carbonyl group, the (C1-C6 alkyl)carbonylamino group, and the (C1-C6 alkoxy)carbonylamino group are optionally substituted with one or more halogen atoms}, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group are selected from group F a Group H1 is a group consisting of an amino group, a nitro group, a cyano group, a hydroxy group, a sulfanyl group, and a halogen atom, and may be substituted with one or more substituents selected from the group consisting of: a a C1-C6 alkylsulfanyl group, a C1-C6 alkylsulfinyl group, a C1-C6 alkylsulfonyl group, a C1-C6 alkylamino group, a C2-C8 dialkylamino group (the C1-C6 alkylsulfanyl group, the C1-C6 alkylsulfinyl group, the C1-C6 alkylsulfonyl group, the C1-C6 alkylamino group, and the C2-C8 dialkylamino group are optionally substituted with one or more halogen atoms), a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group (the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group are selected from Group E a Group H2 is a group consisting of a hydroxy group and a halogen atom, each of which may be substituted with one or more substituents selected from the group consisting of: aa C1-C6 alkylsulfanyl group, a C1-C6 alkylsulfinyl group, a C1-C6 alkylsulfonyl group, a C1-C6 alkylamino group, a C2-C8 dialkylamino group (the C1-C6 alkylsulfanyl group, the C1-C6 alkylsulfinyl group, the C1-C6 alkylsulfonyl group, the C1-C6 alkylamino group, and the C2-C8 dialkylamino group are optionally substituted with one or more halogen atoms), a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group (the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group are selected from Group E a and a hydroxy group. a a C1-C6 alkoxy group, a C1-C6 alkylsulfanyl group, a C1-C6 alkylsulfinyl group, a C1-C6 alkylsulfonyl group {the C1-C6 alkoxy group, the C1-C6 alkylsulfanyl group, the C1-C6 alkylsulfinyl group, and the C1-C6 alkylsulfonyl group are optionally substituted with one or more halogen atoms}, a C3-C8 alicyclic hydrocarbon group, and a 3- to 8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group are selected from group F a

[0023]

[0024]

[0025]

[0026]

[0027]

[0028]

[0029]

[0030]

[0031]

[0032]

[0033]

[0034]

[0035]

[0036]

[0037]

[0038]

[0039]

[0040]

[0041]

[0042]

[0050]

[0051]

[0052]

[0053]

[0054]

[0055]

[0056]

[0057]

[0068]

[0069]

[0070]

[0071]

[0072]

[0082]

[0083]

[0084]

[0090]

[0091]

[0092]

[0093]

[0094]

[0095]

[0096]

[0097]

[0098]

[0099]

[0100]

[0099]

[0110]

[0099]

[0099]

[0120]

[0099]

[0099]

[0131]

[0099]

[0099]

[0142]

[0099]

[0099]

[0150]

[0099]

[0161]

[0099]

[0099]

[0170]

[0099]

[0180]

[0099]

[0190]

[0191]

[0099]

[0199]

[0200]

[0099]

[0210]

[0099]

[0199]

[0220]

[0099]

[0231]

[0099]

[0199]

[0242]

[0099] [ [6] Use of the compound according to [2], its N-oxide, or a salt thereof, or the composition according to [4] for controlling plant diseases. [7] Seeds or vegetative reproductive organs carrying an effective amount of the compound according to [2], its N-oxide, or a salt thereof, or an effective amount of the composition according to [4].

[0007] According to the present invention, plant diseases can be controlled.

[0008] Substituents in the present invention will be explained. A halogen atom means a fluorine atom, a chlorine atom, a bromine atom, or an iodine atom. When a substituent is substituted with two or more halogen atoms or substituents, these halogen atoms or substituents may be the same or different. In the present specification, the term "optionally substituted with one or more substituents selected from group X" (X is A, B, C, D, E, F, G, H, J, A a , B a , C1 a , C2 a , D a , E a , F a , G a , H1 a , H2 a , I a , A 2, B 2 , B 3 , C 2 , D 2 , A 2a , A 3a , B 2a , B 3a , C a , I 2a , I 3a , and I a2In the notation "CX-CY," when two or more substituents selected from group X are present, the substituents may be the same or different. In this specification, the notation "CX-CY" means that the number of carbon atoms is X to Y. For example, the notation "C1-C6" means that the number of carbon atoms is 1 to 6. The chain hydrocarbon group represents an alkyl group, an alkenyl group, or an alkynyl group. Examples of the alkyl group include a methyl group, an ethyl group, a propyl group, an isopropyl group, a 1,1-dimethylpropyl group, a 1,2-dimethylpropyl group, a butyl group, a sec-butyl group, a tert-butyl group, a pentyl group, and a hexyl group. Examples of the alkenyl group include a vinyl group, a 1-propenyl group, a 2-propenyl group, a 1-methyl-1-propenyl group, a 1-methyl-2-propenyl group, a 1,2-dimethyl-1-propenyl group, a 3-butenyl group, a 4-pentenyl group, and a 5-hexenyl group. Examples of alkynyl groups include ethynyl, 1-propynyl, 2-propynyl, 1-methyl-2-propynyl, 1,1-dimethyl-2-propynyl, 2-butynyl, 4-pentynyl, and 5-hexynyl groups. Examples of alkoxy groups include methoxy, ethoxy, propoxy, isopropoxy, butoxy, tert-butoxy, pentyloxy, and hexyloxy groups. Examples of alkylsulfanyl groups include methylsulfanyl, ethylsulfanyl, isopropylsulfanyl, and hexylsulfanyl groups. Examples of alkylsulfinyl groups include methylsulfinyl, ethylsulfinyl, isopropylsulfinyl, and hexylsulfinyl groups. Examples of alkylsulfonyl groups include methanesulfonyl, ethanesulfonyl, isopropanesulfonyl, and hexanesulfonyl groups. Examples of alkylcarbonyl groups include acetyl, propanoyl, 2-methylpropanoyl, and hexanoyl groups. Examples of alkoxycarbonyl groups include methoxycarbonyl, ethoxycarbonyl, isopropoxycarbonyl, and pentyloxycarbonyl groups.Examples of alkylamino groups include methylamino groups, ethylamino groups, propylamino groups, isopropylamino groups, and butylamino groups. Examples of alkylaminocarbonyl groups include methylaminocarbonyl groups, ethylaminocarbonyl groups, isopropylaminocarbonyl groups, and hexylaminocarbonyl groups. Examples of alkylcarbonylamino groups include acetylamino groups, propanoylamino groups, 2-methylpropanoylamino groups, and hexanoylamino groups. Examples of alkoxycarbonylamino groups include methoxycarbonylamino groups, ethoxycarbonylamino groups, isopropoxycarbonylamino groups, and pentyloxycarbonylamino groups. Examples of C2-C8 dialkylamino groups include dimethylamino, diethylamino, dipropylamino, diisopropylamino, dibutylamino, ethylmethylamino, methylpropylamino, isopropylmethylamino, butylmethylamino, ethylpropylamino, ethylisopropylamino, butylethylamino, isopropylpropylamino, butylpropylamino, and butylisopropylamino. Examples of (C2-C8 dialkylamino)carbonyl groups include dimethylaminocarbonyl, diethylaminocarbonyl, dipropylaminocarbonyl, diisopropylaminocarbonyl, dibutylaminocarbonyl, ethylmethylaminocarbonyl, methylpropylaminocarbonyl, isopropylmethylaminocarbonyl, butylmethylaminocarbonyl, ethylpropylaminocarbonyl, ethylisopropylaminocarbonyl, butylethylaminocarbonyl, isopropylpropylaminocarbonyl, butylpropylaminocarbonyl, and butylisopropylaminocarbonyl.Examples of (C1-C6 alkyl)(C3-C6 cycloalkyl)amino groups include cyclopropylmethylamino groups, cyclopropylethylamino groups, cyclopropylpropylamino groups, cyclopropylisopropylamino groups, butylcyclopropylamino groups, cyclopropylisobutylamino groups, cyclopropylpentylamino groups, cyclopropylhexylamino groups, cyclobutylmethylamino groups, cyclobutylethylamino groups, cyclobutylpropylamino groups, cyclobutylisopropylamino groups, cyclopentylmethylamino groups, cyclopentylethylamino groups, cyclopentylpropylamino groups, cyclopentylisopropylamino groups, cyclohexylmethylamino groups, cyclohexylethylamino groups, cyclohexylpropylamino groups, and cyclohexylisopropylamino groups. Examples of alicyclic hydrocarbon groups include cyclobutene rings, cyclopentene rings, cyclopentadiene rings, cyclohexene rings, cyclohexadiene rings, and cycloheptene rings. Examples of alicyclic hydrocarbon groups include cycloalkyl groups and cycloalkenyl groups. Examples of cycloalkyl groups include cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, and cyclooctyl groups. Examples of cycloalkenyl groups include cyclopentenyl, cyclohexenyl, cycloheptenyl, and cyclooctenyl groups. Examples of cycloalkylamino groups include cyclopropylamino, cyclobutylamino, cyclopentylamino, cyclohexylamino, cycloheptylamino, and cyclooctylamino groups.Examples of non-aromatic heterocycles include an aziridine ring, an oxirane ring, a thiirane ring, an azetidine ring, an oxetane ring, a thietane ring, a dihydrofuran ring, a dihydrothiophene ring, a dihydropyrrole ring, an oxazoline ring, a thiazoline ring, an isoxazoline ring, a dihydroisoxazoline ring, an isothiazolinone ring, a dihydroisothiazoline ring, a 1,3-dioxole ring, a pyran ring, a dihydropyran ring, a piperidine ring, a piperazine ring, a tetrahydropyridazine ring, a hexahydropyridazine ring, a tetrahydropyrimidine ring, a hexahydropyrimidine ring, an azepane ring, an oxepane ring, a thiepane ring, an azocane ring, an oxocane ring, and a thiocane ring. Examples of aromatic heterocyclic groups include furan rings, thiophene rings, pyrrole rings, pyrazole rings, imidazole rings, oxazole rings, isoxazole rings, thiazole rings, isothiazole rings, triazole rings, oxadiazole rings, thiadiazole rings, pyridine rings, pyridazine rings, pyrimidine rings, and pyrazine rings. Examples of aromatic heterocyclic groups include 5-membered aromatic heterocyclic groups such as pyrrolyl group, furanyl group, thienyl group, pyrazolyl group, imidazolyl group, triazolyl group, tetrazolyl group, oxazolyl group, isoxazolyl group, thiazolyl group, isothiazolyl group, oxadiazolyl group, and thiadiazolyl group; 6-membered aromatic heterocyclic groups such as pyridyl group, pyridazinyl group, pyrimidinyl group, pyrazinyl group, triazinyl group, and tetrazinyl group; and 7-membered aromatic heterocyclic groups such as azepyr group and diazepyr group. Examples of the aromatic nitrogen-containing heterocyclic group include the above-mentioned aromatic heterocyclic groups having at least one ring nitrogen atom.Examples of non-aromatic heterocyclic groups include an aziridinyl group, an oxiranyl group, a thiiranyl group, an azetidinyl group, an oxetanyl group, a thietanyl group, a pyrrolidinyl group, a tetrahydrofuranyl group, a tetrahydrothienyl group, a pyrazolinyl group, a pyrazolidinyl group, an imidazolinyl group, an imidazolidinyl group, an oxazolinyl group, a thiazolinyl group, an oxazolidinyl group, a thiazolidinyl group, and an isoxazolinyl group. , an isoxazolidinyl group, an isothiazolinyl group, an isothiazolidinyl group, a dioxolanyl group, a dioxanyl group, a piperidyl group, a piperazinyl group, a morpholinyl group, a thiomorpholinyl group, a pyranyl group, a dihydropyranyl group, a tetrahydropyranyl group, a tetrahydrothiopyranyl group, an azepanyl group, an oxepanyl group, a thiepanyl group, an azocanyl group, an oxocanyl group, and a thiocanyl group. Examples of the non-aromatic nitrogen-containing heterocyclic group include the above-mentioned non-aromatic heterocyclic groups having at least one ring nitrogen atom.

[0009] A in formula (I) is a group represented by the formula (A 5 -1) [wherein * represents the bonding site to D, ring A 5 represents a 5-membered non-aromatic nitrogen-containing heterocycle or a 5-membered aromatic nitrogen-containing heterocycle (provided that ring A 5 In the formula (I), the atom bonded to D is a carbon atom or a nitrogen atom, and ring A is adjacent to the atom bonded to D. 5 at least one of the atoms constituting R is a nitrogen atom; 50 represents a substituent selected from group J, m represents 0, 1, 2, 3, 4, 5, 6, 7 or 8, and when m is 2, 3, 4, 5, 6, 7 or 8, a plurality of R 50 may be the same or different.] or a group represented by the formula (A 6 -1) wherein * has the same meaning as above, and Ring A 6 represents a 6-membered non-aromatic nitrogen-containing heterocycle or a 6-membered aromatic nitrogen-containing heterocycle (provided that ring A 6 In the formula (I), the atom bonded to D is a carbon atom or a nitrogen atom, and ring A is adjacent to the atom bonded to D. 6 at least one of the atoms constituting R is a nitrogen atom;60 represents a substituent selected from group J, n represents 0, 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10, and when n is 2, 3, 4, 5, 6, 7, 8, 9 or 10, a plurality of R 60 may be the same or different. m and n each represent a group represented by the formula (A 5 -1) includes, for example, groups represented by the formulae T1, T2, T3 and T4 [wherein * represents the bonding site to D, L 1 is a nitrogen atom, or CR 40 represents L 2 is a nitrogen atom, or CR 41 represents L 3 is a nitrogen atom, or CR 42 (where L 1 , L 2 and L 3 wherein the number of nitrogen atoms is 0, 1 or 2), Q 1 represents an oxygen atom or a sulfur atom; 2 represents an oxygen atom or a sulfur atom; Y 1 is a nitrogen atom, or CR 46 represents Y 2 is a nitrogen atom, or CR 47 represents R 48 represents a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, or a hydrogen atom; R 40 , R 41 , R 42 , R 43 , R 44 , R 45 , R 46 , and R 47 are the same or different and each represent a methyl group optionally substituted with one or more substituents selected from Group H, a C2-C6 chain hydrocarbon group (the C2-C6 chain hydrocarbon group optionally substituted with one or more substituents selected from Group E), a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group (the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group optionally substituted with one or more substituents selected from Group B), OR 22 , N.R. 23 R 24 , C(O)R25 , C(R 26 ) = NOR 27 , an amino group, a cyano group, a nitro group, a halogen atom, or a hydrogen atom. 6 -1) includes, for example, the groups represented by the formulae T5, T6, T7, T8 and T9 [In the formula, na represents 0, 1, 2, 3, or 4, and when na is 2, 3, or 4, a plurality of R 60 may be the same or different, nb represents 0, 1, 2 or 3, and when nb is 2 or 3, a plurality of R 60 may be the same or different, and other symbols have the same meanings as above.

[0010] In the compound of formula (I), Z 1 is a 5-7-membered aromatic heterocyclic group, any two adjacent atoms not bonded to the benzene ring substituted with X among the atoms constituting the 5-7-membered aromatic heterocyclic group form another C4-C7 alicyclic hydrocarbon, a 4-7-membered non-aromatic heterocycle (the C4-C7 alicyclic hydrocarbon and the 4-7-membered non-aromatic heterocycle may be substituted with one or more substituents selected from Group B), a benzene ring, or a 5-6-membered aromatic heterocycle (the benzene ring and the 5-6-membered aromatic heterocycle may be substituted with one or more substituents selected from Group A) containing the adjacent two atoms. 1Specific examples of the aryl group include a 1,4,5,6-tetrahydrocyclopenta[c]pyrazol-1-yl group, a 1,4,5,6-tetrahydrocyclopenta[c]pyrazol-2-yl group, a 5,6-dihydro-4H-cyclopenta[b]thiophen-2-yl group, a 6H-thieno[2,3-b]pyrrol-6-yl group, a 1,4,5,6-tetrahydrocyclopenta[c]pyrazol-1-yl group, a 1,4,5,6-tetrahydrocyclopenta[c]pyrazol-2-yl group, a 4,5,6,7-tetrahydroindazol-1-yl group, a 4,5,6,7-tetrahydroindazol-1-yl group, a 4,5,6,7-tetrahydroindazol-1-yl group, a 4,5,6,7-tetrahydroindazol-1-yl group, a 4,5,6,7-tetrahydroindazol-2 ...2-yl group, a 4,5,6,7-tetrahydroindazol-2-yl group, a 4,5,6,7-tetrahydroindazol-2-yl group, a 4,5,6,7-tetrahydroindazol-2-yl group, a 4,5,6,7- , 5,6,7-tetrahydroindazol-2-yl group, indol-1-yl group, 1H-indol-2-yl group, 1H-indol-3-yl group, 1H-4-azaindol-2-yl group, 1H-4-azaindol-3-yl group, 5-azaindol-1-yl group, 1H-5-azaindol-2-yl group, 1H-5-azaindol-3-yl group, 6-azaindol-1-yl group, 1H-6-azaindol-2-yl group, 1H-6-azaindol-3-yl group, 7-azaindol-1-yl group, 1H-7-azaindol azaindol-2-yl group, 1H-7-azaindole-3-yl group, benzimidazol-1-yl group, 1H-benzimidazol-2-yl group, indazol-1-yl group, 1H-indazol-3-yl group, azaindazol-1-yl group, 1H-azaindazol-3-yl group, indolizin-8-yl group, benzofuran-2-yl group, benzofuran-3-yl group, benzo[d]isoxazolin-3-yl group, benzo[d]isothiazolin-3-yl group, benzo[d]oxazol-2-yl group, benzo[d]thiazol-2-yl group a quinolin-2-yl group, a quinolin-3-yl group, a quinolin-4-yl group, a 1H-quinolin-2-one-1-yl group, a 1H-quinolin-2-one-3-yl group, a 1H-quinolin-2-one-4-yl group, a quinolin-3-yl group, a quinolin-4-yl group, an isoquinolin-1-yl group, an isoquinolin-3-yl group, an isoquinolin-4-yl group, a quinoxalin-2-yl group, a phthalazin-1-yl group, a quinazolin-2-yl group, a quinazolin-4-yl group, a 1,8-naphthyridin-2-yl group, a 1,8-naphthyridin-3-yl group, a 1,Examples of the aryl group include an 8-naphthyridin-4-yl group, a 1H-4-azaindole-4-yl group, a 1H-4-azaindole-5-yl group, a 1H-4-azaindole-6-yl group, a 1,4,5,6,7,8-hexahydrocyclohepta[c]pyrazol-1-yl group, a 1,4,5,6,7,8-hexahydrocyclohepta[c]pyrazol-2-yl group, and a 4-azaindole-1-yl group. 1 is a C3-C8 alicyclic hydrocarbon group or a 3- to 8-membered non-aromatic heterocyclic group, the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group may be substituted with one or more substituents selected from group B, and among the atoms constituting the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group, any atom not bonded to the benzene ring substituted with X acts as a spiro atom to form a C3-C7 alicyclic hydrocarbon or a 3- to 7-membered non-aromatic heterocyclic ring. 1 Specific examples of the compounds include compounds represented by the formulae ZY1, ZY2, ZY3, ZY4, ZY5, ZY6, ZY7, ZY8, ZY9, ZY10, ZY11, ZY12, ZY13, ZY14, ZY15, ZY16, ZY17, ZY18, ZY19, ZY20, ZY21, ZY22, ZY23, ZY24, ZY25, ZY26, ZY27, ZY28, ZY29, ZY30, ZY31, ZY32, ZY33, ZY34, ZY35, ZY36, ZY37, ZY38, ZY39, ZY40, ZY41, ZY42, ZY43, ZY44, ZY45, ZY46, ZY47, ZY48, and ZY49. [In the formula, # a represents a bonding site to the benzene ring substituted by X. In the compound of formula (I), Z 1is a C3-C8 alicyclic hydrocarbon group or a 3- to 8-membered non-aromatic heterocyclic group, the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group are optionally substituted with one or more substituents selected from Group B, and any two adjacent atoms constituting the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group that are not bonded to the benzene ring substituted with X form another C4-C7 alicyclic hydrocarbon, a 4- to 7-membered non-aromatic heterocycle containing the two adjacent atoms (the C4-C7 alicyclic hydrocarbon and the 4- to 7-membered non-aromatic heterocycle are optionally substituted with one or more substituents selected from Group B), a benzene ring, or a 5- to 6-membered aromatic heterocycle (the benzene ring and the 5- to 6-membered aromatic heterocycle are optionally substituted with one or more substituents selected from Group A). 1 Specific examples of the compounds include those represented by the formulae ZZ1, ZZ2, ZZ3, ZZ4, ZZ5, ZZ6, ZZ7, ZZ8, ZZ9, ZZ10, ZZ11, ZZ12, ZZ13, ZZ14, ZZ15, ZZ16, ZZ17, ZZ18, ZZ19, ZZ20, ZZ21, ZZ22, ZZ23, ZZ24, ZZ25, ZZ26, ZZ27, ZZ28, ZZ29, ZZ30, ZZ31, ZZ32, ZZ33, ZZ34, ZZ35, ZZ36, ZZ37, and ZZ38. [In the formula, # a represents a bonding site to the benzene ring substituted by X. In the compound of formula (I), Z 1 is a C3-C8 alicyclic hydrocarbon group or a 3- to 8-membered non-aromatic heterocyclic group, the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group may be substituted with one or more substituents selected from Group B, and any two atoms that are not adjacent to each other among the atoms constituting the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group (provided that neither of the two atoms is bonded to the benzene ring substituted with X) are bridged by -CH2- or -(CH2)2-. 1Specific examples of the compounds include compounds represented by the formulae ZW1, ZW2, ZW3, ZW4, ZW5, ZW6, ZW7, ZW8, ZW9, ZW10, ZW11, ZW12, ZW13, and ZW14. [In the formula, # a represents a bonding site to the benzene ring substituted by X.]

[0011] The N-oxide of the compound represented by formula (I) or formula (II) means a structure in which at least one nitrogen atom contained in the compound represented by formula (I) or formula (II) is substituted with an oxo group.

[0012] The present compound or the compound of the present invention may exist in one or more stereoisomers. Stereoisomers include enantiomers, diastereomers, atropisomers, and geometric isomers. The present invention includes each stereoisomer and a mixture of stereoisomers in any ratio.

[0013] The compound represented by formula (I) or formula (II) or an N-oxide thereof may form an acid addition salt such as a hydrochloride, a sulfate, a nitrate, a phosphate, an acetate, or a benzoate when mixed with an acid such as hydrochloric acid, sulfuric acid, nitric acid, phosphoric acid, acetic acid, or benzoic acid.

[0014] The following compounds are examples of the present compound A.

[0015] [Aspect 1] In the present compound A, Z 1 is a 5- to 7-membered aromatic heterocycle {the 5- to 7-membered aromatic heterocyclic group may be substituted with one or more substituents selected from Group A, and any two adjacent atoms constituting the 5- to 7-membered aromatic heterocyclic group that are not bonded to the benzene ring substituted with X may form another C4-C7 alicyclic hydrocarbon, a 4- to 7-membered non-aromatic heterocycle {the C4-C7 alicyclic hydrocarbon and the 4- to 7-membered non-aromatic heterocycle may be substituted with one or more substituents selected from Group B}, a benzene ring, or a 5- to 6-membered aromatic heterocycle {the benzene ring and the 5- to 6-membered aromatic heterocycle may be substituted with one or more substituents selected from Group A}} (provided that a 5-trifluoromethyl-1,2,4-oxadiazol-3-yl group is excluded). [Aspect 2] A compound in which Z1 is a 5- to 7-membered aromatic heterocycle {the 5- to 7-membered aromatic heterocyclic group may be substituted with one or more substituents selected from Group A} (excluding 5-trifluoromethyl-1,2,4-oxadiazol-3-yl group). [Embodiment 3] A compound in which Z 1 is a 5- to 7-membered aromatic heterocyclic ring {the 5- to 7-membered aromatic heterocyclic group is a group A 2 and optionally substituted with one or more substituents selected from the following (provided that 5-trifluoromethyl-1,2,4-oxadiazol-3-yl group is excluded). 2 The group consisting of a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group (the C1-C6 chain hydrocarbon group and the C1-C6 alkoxy group may be substituted with one or more halogen atoms), and a halogen atom. 1 is a C3-C8 alicyclic hydrocarbon group {the C3-C8 alicyclic hydrocarbon group may be substituted with one or more substituents selected from Group B, and among the atoms constituting the C3-C8 alicyclic hydrocarbon group, any atoms not bonded to a benzene ring substituted with X may form a C3-C7 alicyclic hydrocarbon or a 3- to 7-membered non-aromatic heterocycle as spiro atoms, and among the atoms constituting the C3-C8 alicyclic hydrocarbon group, any two adjacent atoms not bonded to a benzene ring substituted with X may form another C4-C7 alicyclic hydrocarbon or 4- to 7-membered non-aromatic heterocycle containing the two adjacent atoms {the C4 A compound in which the compound A is a C3-C8 alicyclic hydrocarbon group, and the 4- to 7-membered non-aromatic heterocycle may be substituted with one or more substituents selected from Group B}, a benzene ring, or a 5- to 6-membered aromatic heterocycle {the benzene ring and the 5- to 6-membered aromatic heterocycle may be substituted with one or more substituents selected from Group A}, and any two atoms that are not adjacent to each other among the atoms constituting the C3-C8 alicyclic hydrocarbon group (provided that neither of the any two atoms is bonded to the benzene ring substituted with X) may be bridged by —CH2— or —(CH2)2—. [Aspect 5] A compound in which Z 1 is a C3-C8 alicyclic hydrocarbon group optionally substituted with one or more substituents selected from group B. [Embodiment 6] Compound A, wherein Z1 Group B 2 Group B: Compounds which are C3-C8 alicyclic hydrocarbon groups optionally substituted with one or more substituents selected from the following: 2 : a group consisting of a C1-C6 chain hydrocarbon group, a C3-C6 alicyclic hydrocarbon group (the C1-C6 chain hydrocarbon group and the C3-C6 alicyclic hydrocarbon group may be substituted with one or more halogen atoms), a cyano group, or a halogen atom. 1 is a 3- to 8-membered non-aromatic heterocyclic group {the 3- to 8-membered non-aromatic heterocyclic group is optionally substituted with one or more substituents selected from group B, and among the atoms constituting the 3- to 8-membered non-aromatic heterocyclic group, any atom not bonded to a benzene ring substituted with X may form a C3-C7 alicyclic hydrocarbon or a 3- to 7-membered non-aromatic heterocycle as a spiro atom, and among the atoms constituting the 3- to 8-membered non-aromatic heterocyclic group, any two adjacent atoms not bonded to a benzene ring substituted with X may form another C4-C7 alicyclic hydrocarbon containing the two adjacent atoms, a 4- to 7-membered non-aromatic heterocycle {the C4-C7 alicyclic hydrocarbon and the 4- to 7-membered non-aromatic heterocycle are A compound in which Z is a 3- to 8-membered non-aromatic heterocyclic group {which may be substituted with one or more substituents selected from Group B}, a benzene ring, or a 5- to 6-membered aromatic heterocyclic ring {which may be substituted with one or more substituents selected from Group A}, and any two atoms that are not adjacent to each other (with the proviso that neither of the any two atoms is bonded to the benzene ring substituted with X) among the atoms constituting the 3- to 8-membered non-aromatic heterocyclic group may be bridged by —CH— or —(CH)— (with the proviso that a 5-trifluoromethyl-4,5-dihydro-1,2,4-oxadiazol-3-yl group is excluded). [Aspect 8] A compound in which Z is a 3- to 8-membered non-aromatic heterocyclic group {which may be substituted with one or more substituents selected from Group B}, a benzene ring, or a 5- to 6-membered non-aromatic heterocyclic ring {which may be substituted with one or more substituents selected from Group A}, and any two atoms that are not adjacent to each other (with the proviso that neither of the any two atoms is bonded to the benzene ring substituted with X) among the atoms constituting the 3- to 8-membered non-aromatic heterocyclic group may be bridged by —CH— or —(CH)— (with the proviso that a 5-trifluoromethyl-4,5-dihydro-1,2,4-oxadiazol-3-yl group is excluded). 1 is a 3- to 8-membered non-aromatic heterocyclic group {the 3- to 8-membered non-aromatic heterocyclic group is a group B 3and among the atoms constituting the 3-8-membered non-aromatic heterocyclic group, any atom not bonded to the benzene ring substituted with X may form a C3-C5 alicyclic hydrocarbon as a spiro atom, and among the atoms constituting the 3-8-membered non-aromatic heterocyclic group, any two atoms that are not adjacent to each other (provided that neither of the two atoms is bonded to the benzene ring substituted with X) may be bridged by —CH— (excluding a 5-trifluoromethyl-4,5-dihydro-1,2,4-oxadiazol-3-yl group). 3 The group consisting of an oxo group, a thioxo group, a C1-C6 chain hydrocarbon group, and a C3-C6 alicyclic hydrocarbon group (the C1-C6 chain hydrocarbon group and the C3-C6 alicyclic hydrocarbon group may be substituted with one or more halogen atoms). 1 Group B 3 A compound in which Z is a 3- to 8-membered non-aromatic heterocyclic group (excluding 5-trifluoromethyl-4,5-dihydro-1,2,4-oxadiazol-3-yl group) optionally substituted with one or more substituents selected from the following: 1 is a methyl group substituted with one or more substituents selected from group D. [Embodiment 11] In the compound A, Z 1 Group D 2 Group D: Compounds each of which is a methyl group substituted with one or more substituents selected from the following: 2 [Aspect 12] In Compound A, Z is a C1-C6 alkoxy group, a C1-C6 alkylamino group, a C2-C8 dialkylamino group, a C1-C6 alkylsulfanyl group, a C1-C6 alkylsulfinyl group, a C1-C6 alkylsulfonyl group, a C3-C8 alicyclic hydrocarbon group, a phenyl group, and a 5- or 6-membered aromatic heterocycle {the C1-C6 alkoxy group, the C1-C6 alkylamino group, the C2-C8 dialkylamino group, the C1-C6 alkylsulfanyl group, the C1-C6 alkylsulfinyl group, the C1-C6 alkylsulfonyl group, the C3-C8 alicyclic hydrocarbon group, the phenyl group, and the 5- or 6-membered aromatic heterocycle are optionally substituted with one or more halogen atoms}. 1is a C2-C6 chain hydrocarbon group optionally substituted with one or more substituents selected from Group C. [Embodiment 13] In the compound A, Z 1 Group C 2 Compounds which are C2-C6 chain hydrocarbon groups optionally substituted with one or more substituents selected from the following: 2 The group consisting of a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group (the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group may be substituted with one or more halogen atoms), a halogen atom, and a cyano group. 1 is OR 5 [Aspect 15] In the compound A, Z 1 is OR 5 and R 5 But group C 2 A compound which is a methyl group, a C2-C6 chain hydrocarbon group, a (C1-C4 alkylamino)carbonyl group, a (C2-C4 dialkylamino)carbonyl group, a C3-C6 alicyclic hydrocarbon group, a 3- to 6-membered non-aromatic heterocyclic group, or a phenyl group, each of which is substituted by one or more substituents selected from the group consisting of (the C2-C6 chain hydrocarbon group, the (C1-C4 alkylamino)carbonyl group, the (C2-C4 dialkylamino)carbonyl group, the C3-C6 alicyclic hydrocarbon group, the 3- to 6-membered non-aromatic heterocyclic group, and the phenyl group are optionally substituted by one or more halogen atoms). [Aspect 16] A compound which is a compound A in which Z 1 is SR 6 , S(O)R 7 , S(O)R 8 , C(O)R 9 , N.R. 11 R 12 , or C(R 35 ) = NOR 36 [Aspect 17] In the compound A, Z 1 is SR 6 , S(O)R 7 , S(O)R 8 , C(O)R 9 , N.R. 11 R 12 , or C(R 35 ) = NOR 36 and R 6, R 7 , and R 8 are the same or different and are a C1-C6 chain hydrocarbon group or a C3-C8 alicyclic hydrocarbon group (the C1-C6 chain hydrocarbon group and the C3-C8 alicyclic hydrocarbon group may be substituted with one or more halogen atoms), and R 9 is a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group, a C1-C6 alkylamino group, a C2-C8 dialkylamino group, a (C1-C6 alkyl)(C3-C6 cycloalkyl)amino group, a C3-C6 cycloalkylamino group, or a 3- to 8-membered non-aromatic heterocyclic group {the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, the C1-C6 alkylamino group, the C2-C8 dialkylamino group, the (C1-C6 alkyl)(C3-C6 cycloalkyl)amino group, the C3-C6 cycloalkylamino group, and the 3- to 8-membered non-aromatic heterocyclic group are optionally substituted with one or more halogen atoms}, R 11 is a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, or a hydrogen atom, and R 12 is a C1-C6 chain hydrocarbon group, a C1-C6 alkylsulfonyl group, a (C3-C6 cycloalkyl)carbonyl group, or a (C1-C6 alkyl)carbonyl group {the C1-C6 chain hydrocarbon group, the C1-C6 alkylsulfonyl group, the (C3-C6 cycloalkyl)carbonyl group, and the (C1-C6 alkyl)carbonyl group may be substituted with one or more halogen atoms}, and R 35 is a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, or a hydrogen atom, and R 36 is a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, or a hydrogen atom. 1 a 5- to 7-membered aromatic heterocyclic ring (excluding a 5-trifluoromethyl-1,2,4-oxadiazol-3-yl group) optionally substituted with one or more substituents selected from group A, a C3-C8 alicyclic hydrocarbon group (the C3-C8 alicyclic hydrocarbon group may be substituted with one or more substituents selected from group B), or a 3- to 8-membered non-aromatic heterocyclic group (the 3- to 8-membered non-aromatic heterocyclic group is a group selected from group B) 3Among the atoms constituting the 3-8-membered non-aromatic heterocyclic group, any atom not bonded to the benzene ring substituted with X may form a C3-C5 alicyclic hydrocarbon as a spiro atom, and among the atoms constituting the 3-8-membered non-aromatic heterocyclic group, any two atoms that are not adjacent to each other (provided that neither of the two atoms is bonded to the benzene ring substituted with X) may be bridged by —CH— (provided that a 5-trifluoromethyl-4,5-dihydro-1,2,4-oxadiazol-3-yl group is excluded). [Aspect 19] A compound in which Z 1 Group A 2 a 5- to 7-membered aromatic heterocycle (excluding a 5-trifluoromethyl-1,2,4-oxadiazol-3-yl group) optionally substituted by one or more substituents selected from the group consisting of a C3-C8 alicyclic hydrocarbon group (the C3-C8 alicyclic hydrocarbon group is selected from the group consisting of a C3-C8 alicyclic hydrocarbon group ... 2 and a 3- to 8-membered non-aromatic heterocyclic group {which may be substituted with one or more substituents selected from the following}, or a 3- to 8-membered non-aromatic heterocyclic group {which may be substituted with one or more substituents selected from the following group B 3 and optionally substituted with one or more substituents selected from the following (provided that 5-trifluoromethyl-4,5-dihydro-1,2,4-oxadiazol-3-yl group is excluded). [Embodiment 20] A compound of the present invention, wherein Z 1 Group D 2 a methyl group substituted with one or more substituents selected from the group C 2 A compound in which Z is a C2-C6 chain hydrocarbon group optionally substituted with one or more substituents selected from the following. 1 is OR 5 , S.R. 6 , S(O)R 7 , or S(O)R 8 and R 6 , R 7 , and R 8 are the same or different and are a C1-C6 chain hydrocarbon group or a C3-C8 alicyclic hydrocarbon group (the C1-C6 chain hydrocarbon group and the C3-C8 alicyclic hydrocarbon group may be substituted with one or more halogen atoms), and R 5 But group C 2A compound which is a methyl group, a C2-C6 chain hydrocarbon group, a (C1-C4 alkylamino)carbonyl group, a (C2-C4 dialkylamino)carbonyl group, a C3-C6 alicyclic hydrocarbon group, a 3- to 6-membered non-aromatic heterocyclic group, or a phenyl group, each of which is substituted by one or more substituents selected from the group consisting of (the C2-C6 chain hydrocarbon group, the (C1-C4 alkylamino)carbonyl group, the (C2-C4 dialkylamino)carbonyl group, the C3-C6 alicyclic hydrocarbon group, the 3- to 6-membered non-aromatic heterocyclic group, and the phenyl group are optionally substituted by one or more halogen atoms). [Aspect 22] A compound which is a compound of the present invention, 1 Group A 2 a 5- to 7-membered aromatic heterocycle (excluding a 5-trifluoromethyl-1,2,4-oxadiazol-3-yl group) optionally substituted by one or more substituents selected from the group consisting of a C3-C8 alicyclic hydrocarbon group (the C3-C8 alicyclic hydrocarbon group is selected from the group consisting of a C3-C8 alicyclic hydrocarbon group ... 2 a 3- to 8-membered non-aromatic heterocyclic group {which may be substituted with one or more substituents selected from the group B 3 and optionally substituted with one or more substituents selected from the following (provided that 5-trifluoromethyl-4,5-dihydro-1,2,4-oxadiazol-3-yl group is excluded), or OR 5 and R 5 But group C 2 A compound which is a methyl group, a C2-C6 chain hydrocarbon group, a (C1-C4 alkylamino)carbonyl group, a (C2-C4 dialkylamino)carbonyl group, a C3-C6 alicyclic hydrocarbon group, a 3- to 6-membered non-aromatic heterocyclic group, or a phenyl group, each of which is substituted by one or more substituents selected from the group consisting of (the C2-C6 chain hydrocarbon group, the (C1-C4 alkylamino)carbonyl group, the (C2-C4 dialkylamino)carbonyl group, the C3-C6 alicyclic hydrocarbon group, the 3- to 6-membered non-aromatic heterocyclic group, and the phenyl group are optionally substituted by one or more halogen atoms). [Aspect 23] A compound which is a compound of the present invention, 1 Group A 2a 5- to 7-membered aromatic heterocycle (excluding a 5-trifluoromethyl-1,2,4-oxadiazol-3-yl group) optionally substituted by one or more substituents selected from the group consisting of a C3-C8 alicyclic hydrocarbon group (the C3-C8 alicyclic hydrocarbon group is selected from the group consisting of a C3-C8 alicyclic hydrocarbon group ... 2 a 3- to 8-membered non-aromatic heterocyclic group {which may be substituted with one or more substituents selected from the group B 3 or a C2-C6 chain hydrocarbon group {which may be substituted with one or more substituents selected from the group C 2 and optionally substituted with one or more substituents selected from the following (provided that 5-trifluoromethyl-4,5-dihydro-1,2,4-oxadiazol-3-yl group is excluded). [Embodiment 24] A compound of the present invention, wherein Z 1 Group A 2 a 5- to 7-membered aromatic heterocycle (excluding a 5-trifluoromethyl-1,2,4-oxadiazol-3-yl group) optionally substituted by one or more substituents selected from the group consisting of a C3-C8 alicyclic hydrocarbon group (the C3-C8 alicyclic hydrocarbon group is selected from the group consisting of a C3-C8 alicyclic hydrocarbon group ... 2 a 3- to 8-membered non-aromatic heterocyclic group {which may be substituted with one or more substituents selected from the group B 3 and optionally substituted with one or more substituents selected from the following} (excluding 5-trifluoromethyl-4,5-dihydro-1,2,4-oxadiazol-3-yl group), a C2-C6 chain hydrocarbon group {the C2-C6 chain hydrocarbon group is a group selected from the group C 2 may be substituted with one or more substituents selected from the group consisting of: 5 and R 5 But group C 2A compound which is a methyl group, a C2-C6 chain hydrocarbon group, a (C1-C4 alkylamino)carbonyl group, a (C2-C4 dialkylamino)carbonyl group, a C3-C6 alicyclic hydrocarbon group, a 3- to 6-membered non-aromatic heterocyclic group, or a phenyl group, each of which is substituted by one or more substituents selected from the group consisting of (the C2-C6 chain hydrocarbon group, the (C1-C4 alkylamino)carbonyl group, the (C2-C4 dialkylamino)carbonyl group, the C3-C6 alicyclic hydrocarbon group, the 3- to 6-membered non-aromatic heterocyclic group, and the phenyl group are optionally substituted by one or more halogen atoms). [Aspect 25] A compound which is a compound of the present invention, 1 But group C 2 a C2-C6 chain hydrocarbon group optionally substituted with one or more substituents selected from the group consisting of OR 5 , S.R. 6 , S(O)R 7 , or S(O)R 8 and R 6 , R 7 , and R 8 are the same or different and are a C1-C6 chain hydrocarbon group or a C3-C8 alicyclic hydrocarbon group (the C1-C6 chain hydrocarbon group and the C3-C8 alicyclic hydrocarbon group may be substituted with one or more halogen atoms), and R 5 But group C 2 A compound which is a methyl group, a C2-C6 chain hydrocarbon group, a (C1-C4 alkylamino)carbonyl group, a (C2-C4 dialkylamino)carbonyl group, a C3-C6 alicyclic hydrocarbon group, a 3- to 6-membered non-aromatic heterocyclic group, or a phenyl group, each of which is substituted by one or more substituents selected from the group consisting of (the C2-C6 chain hydrocarbon group, the (C1-C4 alkylamino)carbonyl group, the (C2-C4 dialkylamino)carbonyl group, the C3-C6 alicyclic hydrocarbon group, the 3- to 6-membered non-aromatic heterocyclic group, and the phenyl group are optionally substituted by one or more halogen atoms). [Aspect 26] A compound which is a compound according to Aspect 1, wherein X 1 is a halogen atom, and X 2 and X 3 is a hydrogen atom. [Aspect 27] A compound according to aspect 2, 1 is a halogen atom, and X 2 and X 3 is a hydrogen atom. [Aspect 28] In aspect 3, X1 is a halogen atom, and X 2 and X 3 is a hydrogen atom. [Aspect 29] A compound according to aspect 4, wherein X 1 is a halogen atom, and X 2 and X 3 is a hydrogen atom. [Aspect 30] A compound according to aspect 5, wherein X 1 is a halogen atom, and X 2 and X 3 is a hydrogen atom. [Aspect 31] A compound according to aspect 6, wherein X 1 is a halogen atom, and X 2 and X 3 is a hydrogen atom. [Aspect 32] In aspect 7, X 1 is a halogen atom, and X 2 and X 3 is a hydrogen atom. [Aspect 33] In aspect 8, X 1 is a halogen atom, and X 2 and X 3 is a hydrogen atom. [Aspect 34] In aspect 9, X 1 is a halogen atom, and X 2 and X 3 is a hydrogen atom. [Aspect 35] A compound according to aspect 10, wherein X 1 is a halogen atom, and X 2 and X 3 is a hydrogen atom. [Aspect 36] A compound according to aspect 11, wherein X 1 is a halogen atom, and X 2 and X 3 is a hydrogen atom. [Aspect 37] A compound according to aspect 12, wherein X 1 is a halogen atom, and X 2 and X 3 is a hydrogen atom. [Aspect 38] In aspect 13, X 1 is a halogen atom, and X 2 and X 3 is a hydrogen atom. [Aspect 39] In aspect 14, X 1 is a halogen atom, and X 2 and X 3 is a hydrogen atom. [Aspect 40] In aspect 15, X1 is a halogen atom, and X 2 and X 3 is a hydrogen atom. [Aspect 41] In aspect 16, X 1 is a halogen atom, and X 2 and X 3 is a hydrogen atom. [Aspect 42] In aspect 17, X 1 is a halogen atom, and X 2 and X 3 is a hydrogen atom. [Aspect 43] In aspect 18, X 1 is a halogen atom, and X 2 and X 3 is a hydrogen atom. [Aspect 44] In aspect 19, X 1 is a halogen atom, and X 2 and X 3 is a hydrogen atom. [Aspect 45] In aspect 20, X 1 is a halogen atom, and X 2 and X 3 is a hydrogen atom. [Aspect 46] In aspect 21, X 1 is a halogen atom, and X 2 and X 3 is a hydrogen atom. [Aspect 47] In aspect 22, X 1 is a halogen atom, and X 2 and X 3 is a hydrogen atom. [Aspect 48] In aspect 23, X 1 is a halogen atom, and X 2 and X 3 is a hydrogen atom. [Aspect 49] In aspect 24, X 1 is a halogen atom, and X 2 and X 3 is a hydrogen atom. [Aspect 50] In aspect 25, X 1 is a halogen atom, and X 2 and X 3 is a hydrogen atom. 1 is a halogen atom or a hydrogen atom, and X 2 and X 3is a hydrogen atom. 1 is a halogen atom or a hydrogen atom, and X 2 and X 3 is a hydrogen atom. [Aspect 53] A compound according to aspect 3, wherein X 1 is a halogen atom or a hydrogen atom, and X 2 and X 3 is a hydrogen atom. 1 is a halogen atom or a hydrogen atom, and X 2 and X 3 is a hydrogen atom. [Aspect 55] A compound according to aspect 5, 1 is a halogen atom or a hydrogen atom, and X 2 and X 3 is a hydrogen atom. 1 is a halogen atom or a hydrogen atom, and X 2 and X 3 is a hydrogen atom. 1 is a halogen atom or a hydrogen atom, and X 2 and X 3 is a hydrogen atom. [Aspect 58] In aspect 8, X 1 is a halogen atom or a hydrogen atom, and X 2 and X 3 is a hydrogen atom. 1 is a halogen atom or a hydrogen atom, and X 2 and X 3 is a hydrogen atom. [Aspect 60] In aspect 10, X 1 is a halogen atom or a hydrogen atom, and X 2 and X 3 is a hydrogen atom. 1 is a halogen atom or a hydrogen atom, and X 2 and X 3 is a hydrogen atom. 1 is a halogen atom or a hydrogen atom, and X 2 and X 3is a hydrogen atom. 1 is a halogen atom or a hydrogen atom, and X 2 and X 3 is a hydrogen atom. [Aspect 64] In aspect 14, X 1 is a halogen atom or a hydrogen atom, and X 2 and X 3 is a hydrogen atom. [Aspect 65] In aspect 15, X 1 is a halogen atom or a hydrogen atom, and X 2 and X 3 is a hydrogen atom. 1 is a halogen atom or a hydrogen atom, and X 2 and X 3 is a hydrogen atom. 1 is a halogen atom or a hydrogen atom, and X 2 and X 3 is a hydrogen atom. [Aspect 68] In aspect 18, X 1 is a halogen atom or a hydrogen atom, and X 2 and X 3 is a hydrogen atom. [Aspect 69] In aspect 19, X 1 is a halogen atom or a hydrogen atom, and X 2 and X 3 is a hydrogen atom. [Aspect 70] In aspect 20, X 1 is a halogen atom or a hydrogen atom, and X 2 and X 3 is a hydrogen atom. [Aspect 71] In aspect 21, X 1 is a halogen atom or a hydrogen atom, and X 2 and X 3 is a hydrogen atom. 1 is a halogen atom or a hydrogen atom, and X 2 and X 3 is a hydrogen atom. [Aspect 73] In aspect 23, X 1 is a halogen atom or a hydrogen atom, and X 2 and X 3is a hydrogen atom. [Aspect 74] In aspect 24, X 1 is a halogen atom or a hydrogen atom, and X 2 and X 3 is a hydrogen atom. [Aspect 75] In aspect 25, X 1 is a halogen atom or a hydrogen atom, and X 2 and X 3 is a hydrogen atom. 1 , X 2 and X 3 is a hydrogen atom. [Aspect 77] In aspect 2, X 1 , X 2 and X 3 is a hydrogen atom. 1 , X 2 and X 3 is a hydrogen atom. 1 , X 2 and X 3 is a hydrogen atom. [Aspect 80] In aspect 5, X 1 , X 2 and X 3 is a hydrogen atom. [Aspect 81] A compound according to aspect 6, wherein X 1 , X 2 and X 3 is a hydrogen atom. 1 , X 2 and X 3 is a hydrogen atom. 1 , X 2 and X 3 is a hydrogen atom. 1 , X 2 and X 3 is a hydrogen atom. [Aspect 85] In aspect 10, X 1 , X 2 and X 3 is a hydrogen atom. 1 , X 2 and X 3is a hydrogen atom. [Aspect 87] In aspect 12, X 1 , X 2 and X 3 is a hydrogen atom. 1 , X 2 and X 3 is a hydrogen atom. 1 , X 2 and X 3 is a hydrogen atom. [Aspect 90] In aspect 15, X 1 , X 2 and X 3 is a hydrogen atom. 1 , X 2 and X 3 is a hydrogen atom. 1 , X 2 and X 3 is a hydrogen atom. 1 , X 2 and X 3 is a hydrogen atom. 1 , X 2 and X 3 is a hydrogen atom. [Aspect 95] In aspect 20, X 1 , X 2 and X 3 is a hydrogen atom. 1 , X 2 and X 3 is a hydrogen atom. 1 , X 2 and X 3 is a hydrogen atom. 1 , X 2 and X 3 is a hydrogen atom. 1 , X 2 and X 3 is a hydrogen atom.1 , X 2 and X 3 is a hydrogen atom. 1 , X 2 and X 3 is a halogen atom. 1 , X 2 and X 3 is a halogen atom. 1 , X 2 and X 3 is a halogen atom. 1 , X 2 and X 3 is a halogen atom. 1 , X 2 and X 3 is a halogen atom. 1 , X 2 and X 3 is a halogen atom. 1 , X 2 and X 3 is a halogen atom. 1 , X 2 and X 3 is a halogen atom. 1 , X 2 and X 3 is a halogen atom. 1 , X 2 and X 3 is a halogen atom. 1 , X 2 and X 3 is a halogen atom. 1 , X 2 and X 3 is a halogen atom. 1, X 2 and X 3 is a halogen atom. 1 , X 2 and X 3 is a halogen atom. 1 , X 2 and X 3 is a halogen atom. 1 , X 2 and X 3 is a halogen atom. 1 , X 2 and X 3 is a halogen atom. 1 , X 2 and X 3 is a halogen atom. 1 , X 2 and X 3 is a halogen atom. 1 , X 2 and X 3 is a halogen atom. 1 , X 2 and X 3 is a halogen atom. 1 , X 2 and X 3 is a halogen atom. 1 , X 2 and X 3 is a halogen atom. 1 , X 2 and X 3 is a halogen atom. 1 , X 2 and X 3 is a halogen atom. 1is a halogen atom, and X 2 and X 3 is a hydrogen atom. [Embodiment 127] In the compound A, X 1 is a halogen atom or a hydrogen atom, and X 2 and X 3 is a hydrogen atom. [Embodiment 128] In the compound A, X 1 , X 2 and X 3 is a hydrogen atom. [Embodiment 129] In the compound A, X 1 , X 2 and X 3is a halogen atom. [Aspect 130] A compound of the present compound A or any of Aspects 1 to 129, wherein A is a 5- to 6-membered aromatic nitrogen-containing heterocyclic group optionally substituted with one or more substituents selected from Group J (provided that, in the 5- to 6-membered aromatic nitrogen-containing heterocyclic group, at least one of the atoms constituting the 5- to 6-membered aromatic nitrogen-containing heterocyclic group adjacent to the atom bonded to D is a nitrogen atom). [Aspect 131] A compound of the present compound A or any of Aspects 1 to 129, wherein A is a 6-membered aromatic nitrogen-containing heterocyclic group optionally substituted with one or more substituents selected from Group J (provided that, in the 6-membered aromatic nitrogen-containing heterocyclic group, at least one of the atoms constituting the 6-membered aromatic nitrogen-containing heterocyclic group adjacent to the atom bonded to D is a nitrogen atom). [Aspect 132] Compound A or a compound in any one of Aspects 1 to 129, wherein A is a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, or a pyridazinyl group (provided that, in the pyridinyl group, the pyrazinyl group, the pyrimidinyl group, and the pyridazinyl group, at least one of the atoms constituting the pyridinyl group, the pyrazinyl group, the pyrimidinyl group, and the pyridazinyl group adjacent to the atom bonding to D is a nitrogen atom) {the pyridinyl group, the pyrazinyl group, the pyrimidinyl group, and the pyridazinyl group are optionally substituted with one or more substituents selected from Group J}. [Aspect 133] A compound of the present compound A or any of Aspects 1 to 129, wherein A is a pyridinyl group or a pyrimidinyl group (provided that, in the pyridinyl group and the pyrimidinyl group, at least one of the atoms constituting the pyridinyl group and the pyrimidinyl group adjacent to the atom bonded to D is a nitrogen atom) {the pyridinyl group and the pyrimidinyl group may be substituted with one or more C1-C6 chain hydrocarbon groups}. [Aspect 134] A compound of the present compound A or any of Aspects 1 to 129, wherein A is a pyridinyl group or a pyrimidinyl group (provided that, in the pyridinyl group and the pyrimidinyl group, at least one of the atoms constituting the pyridinyl group and the pyrimidinyl group adjacent to the atom bonded to D is a nitrogen atom).[Aspect 135] A compound of the present compound A or any of Aspects 1 to 129, wherein A is a pyridinyl group (provided that in the pyridinyl group, the atom constituting the pyridinyl group adjacent to the atom bonded to D is a nitrogen atom). [Aspect 136] A compound of the present compound A or any of Aspects 1 to 129, wherein A is a pyrazinyl group (provided that in the pyrazinyl group, the atom constituting the pyrazinyl group adjacent to the atom bonded to D is a nitrogen atom). [Aspect 137] A compound of the present compound A or any of Aspects 1 to 129, wherein A is a pyrimidinyl group (provided that in the pyrimidinyl group, at least one of the atoms constituting the pyrimidinyl group adjacent to the atom bonded to D is a nitrogen atom). [Aspect 138] A compound of the present compound A or any of Aspects 1 to 129, wherein A is a pyridazinyl group (provided that in the pyridazinyl group, the atom adjacent to the atom bonded to D and constituting the pyridazinyl group is a nitrogen atom). [Aspect 139] A compound of the present compound A or any of Aspects 1 to 129, wherein A is a 5-membered aromatic nitrogen-containing heterocyclic group optionally substituted with one or more substituents selected from Group J (provided that in the 5-membered aromatic nitrogen-containing heterocyclic group, at least one of the atoms adjacent to the atom bonded to D and constituting the 5-membered aromatic nitrogen-containing heterocyclic group is a nitrogen atom). [Aspect 140] A compound of the present compound A or any of Aspects 1 to 129, wherein A is represented by formula T1, T2, T3, or T4. [wherein the symbols have the same meanings as defined above.] [Embodiment 141] In the present compound A or any of embodiments 1 to 129, A is a group represented by formula T1, T2, T3, or T4, and L 1 is a nitrogen atom, or CR 40 and L 2 is a nitrogen atom, or CR 41 and L 3 is a nitrogen atom, or CR 42 (where L 1 , L 2 and L 3 wherein the number of nitrogen atoms is 0, 1 or 2), Q 1 is an oxygen atom or a sulfur atom, and Q 2 is an oxygen atom or a sulfur atom, and Y 1is a nitrogen atom, or CR 46 and Y 2 is a nitrogen atom, or CR 47 and R 40 , R 41 , R 42 , R 43 , R 44 , R 45 , R 46 , R 47 , and R 48 and are the same or different and are a C1-C6 chain hydrocarbon group or a hydrogen atom. [Aspect 142] In the present compound A or any of Aspects 1 to 129, A is a group represented by the formula T1, T2, or T3, and L 1 is a nitrogen atom, or CR 40 and L 2 is a nitrogen atom, or CR 41 and L 3 is CR 42 and Q 1 is an oxygen atom or a sulfur atom, and Q 2 is an oxygen atom or a sulfur atom, and R 40 , R 41 , R 42 , R 43 , R 44 , and R 45 and are the same or different and are a C1-C6 chain hydrocarbon group or a hydrogen atom. [Aspect 143] In the present compound A or any of Aspects 1 to 129, A is a group represented by formula T1, and L 1 is a nitrogen atom, or CR 40 and L 2 is a nitrogen atom, or CR 41 and L 3 is CR 42 and R 40 , R 41 , and R 42 and Q are the same or different and are a C1-C6 chain hydrocarbon group or a hydrogen atom. [Aspect 144] In the present compound A or any of Aspects 1 to 129, A is a group represented by formula T2, and Q 1 is an oxygen atom or a sulfur atom, and R 43 , and R 44and are the same or different and are a C1-C6 chain hydrocarbon group or a hydrogen atom. [Aspect 145] In the present compound A or any of Aspects 1 to 129, A is a group represented by formula T3, and Q 2 is an oxygen atom or a sulfur atom, and R 45 is a C1-C6 chain hydrocarbon group or a hydrogen atom. [Aspect 146] In the present compound A or any of Aspects 1 to 129, A is a group represented by formula T4, and Y 1 is a nitrogen atom, or CR 46 and Y 2 is a nitrogen atom, or CR 47 and R 46 , R 47 , and R 48 and are the same or different and are a C1-C6 chain hydrocarbon group or a hydrogen atom. [Aspect 147] In Compound A or any of Aspects 1 to 129, A is a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group (provided that in the pyridinyl group, the pyrazinyl group, the pyrimidinyl group, and the pyridazinyl group, at least one of the atoms constituting the pyridinyl group, the pyrazinyl group, the pyrimidinyl group, and the pyridazinyl group adjacent to the atom bonded to D is a nitrogen atom), or a group represented by formula T1, T2, T3, or T4, and L 1 is a nitrogen atom, or CR 40 and L 2 is a nitrogen atom, or CR 41 and L 3 is a nitrogen atom, or CR 42 (where L 1 , L 2 and L 3 wherein the number of nitrogen atoms is 0, 1 or 2), Q 1 is an oxygen atom or a sulfur atom, and Q 2 is an oxygen atom or a sulfur atom, and Y 1 is a nitrogen atom, or CR 46 and Y 2 is a nitrogen atom, or CR 47 and R 40 , R 41 , R 42 , R 43 , R 44 , R45 , R 46 , R 47 , and R 48 and are the same or different and are a C1-C6 chain hydrocarbon group or a hydrogen atom. [Aspect 148] In Compound A or any of Aspects 1 to 129, A is a pyridinyl group, a pyrimidinyl group (provided that in the pyridinyl group and the pyrimidinyl group, at least one of the atoms constituting the pyridinyl group and the pyrimidinyl group adjacent to the atom bonded to D is a nitrogen atom), or a group represented by formula T1, T2, or T3, and L 1 is a nitrogen atom, or CR 40 and L 2 is a nitrogen atom, or CR 41 and L 3 is CR 42 and Q 1 is an oxygen atom or a sulfur atom, and Q 2 is an oxygen atom or a sulfur atom, and R 40 , R 41 , R 42 , R 43 , R 44 , and R 45are the same or different and are a C1-C6 chain hydrocarbon group, or a hydrogen atom. [Aspect 149] A compound of the present compound A or any of Aspects 1 to 129, wherein A is a 5- to 6-membered non-aromatic nitrogen-containing heterocyclic group optionally substituted with one or more substituents selected from Group J (provided that, in the 5- to 6-membered non-aromatic nitrogen-containing heterocyclic group, at least one of the atoms constituting the 5- to 6-membered non-aromatic nitrogen-containing heterocyclic group adjacent to the atom bonded to D is a nitrogen atom). [Aspect 150] A compound of the present compound A or any of Aspects 1 to 129, wherein A is a 5-membered non-aromatic nitrogen-containing heterocyclic group optionally substituted with one or more substituents selected from Group J (provided that, in the 5-membered non-aromatic nitrogen-containing heterocyclic group, at least one of the atoms constituting the 5-membered non-aromatic nitrogen-containing heterocyclic group adjacent to the atom bonded to D is a nitrogen atom). [Aspect 151] The compound A or any one of Aspects 1 to 129, wherein A is a 6-membered non-aromatic nitrogen-containing heterocyclic group (provided that in the 6-membered non-aromatic nitrogen-containing heterocyclic group, at least one of the atoms constituting the 6-membered non-aromatic nitrogen-containing heterocyclic group adjacent to the atom bonding to D is a nitrogen atom). [Aspect 152] The compound in Aspect 130, wherein D is CR 1 R 2 [Embodiment 153] In embodiment 131, D is CR 1 R 2 [Embodiment 154] In embodiment 132, D is CR 1 R 2 [Embodiment 155] In embodiment 133, D is CR 1 R 2 [Embodiment 156] In embodiment 134, D is CR 1 R 2 [Embodiment 157] In embodiment 135, D is CR 1 R 2 [Embodiment 158] In embodiment 136, D is CR 1 R 2 [Embodiment 159] In embodiment 137, D is CR 1 R 2 [Embodiment 160] In embodiment 138, D is CR 1 R 2[Embodiment 161] In embodiment 139, D is CR 1 R 2 [Embodiment 162] In embodiment 140, D is CR 1 R 2 [Embodiment 163] In embodiment 141, D is CR 1 R 2 [Embodiment 164] In embodiment 142, D is CR 1 R 2 [Embodiment 165] In embodiment 143, D is CR 1 R 2 [Embodiment 166] In embodiment 144, D is CR 1 R 2 [Embodiment 167] In embodiment 145, D is CR 1 R 2 [Embodiment 168] In embodiment 146, D is CR 1 R 2 [Embodiment 169] In embodiment 147, D is CR 1 R 2 [Embodiment 170] In embodiment 148, D is CR 1 R 2 [Embodiment 171] In embodiment 149, D is CR 1 R 2 [Embodiment 172] In embodiment 150, D is CR 1 R 2 [Embodiment 173] In embodiment 151, D is CR 1 R 2 [Embodiment 174] The compound A, wherein D is CR 1 R 2 [Embodiment 175] In embodiment 130, D is CR 1 R 2 and R 1 and R 2 is a hydrogen atom. [Embodiment 176] In embodiment 131, D is CR 1 R 2 and R 1 and R 2is a hydrogen atom. [Embodiment 177] In embodiment 132, D is CR 1 R 2 and R 1 and R 2 is a hydrogen atom. [Embodiment 178] In embodiment 133, D is CR 1 R 2 and R 1 and R 2 is a hydrogen atom. [Embodiment 179] In embodiment 134, D is CR 1 R 2 and R 1 and R 2 is a hydrogen atom. [Embodiment 180] In embodiment 135, D is CR 1 R 2 and R 1 and R 2 is a hydrogen atom. [Embodiment 181] In embodiment 136, D is CR 1 R 2 and R 1 and R 2 is a hydrogen atom. [Embodiment 182] In embodiment 137, D is CR 1 R 2 and R 1 and R 2 is a hydrogen atom. [Embodiment 183] In embodiment 138, D is CR 1 R 2 and R 1 and R 2 is a hydrogen atom. [Embodiment 184] In embodiment 139, D is CR 1 R 2 and R 1 and R 2 is a hydrogen atom. [Embodiment 185] In embodiment 140, D is CR 1 R 2 and R 1 and R 2 is a hydrogen atom. [Embodiment 186] In embodiment 141, D is CR 1 R 2 and R 1 and R 2is a hydrogen atom. [Embodiment 187] In embodiment 142, D is CR 1 R 2 and R 1 and R 2 is a hydrogen atom. [Embodiment 188] In embodiment 143, D is CR 1 R 2 and R 1 and R 2 is a hydrogen atom. [Embodiment 189] In embodiment 144, D is CR 1 R 2 and R 1 and R 2 is a hydrogen atom. [Embodiment 190] In embodiment 145, D is CR 1 R 2 and R 1 and R 2 is a hydrogen atom. [Embodiment 191] In embodiment 146, D is CR 1 R 2 and R 1 and R 2 is a hydrogen atom. [Embodiment 192] In embodiment 147, D is CR 1 R 2 and R 1 and R 2 is a hydrogen atom. [Embodiment 193] In embodiment 148, D is CR 1 R 2 and R 1 and R 2 is a hydrogen atom. [Embodiment 194] In embodiment 149, D is CR 1 R 2 and R 1 and R 2 is a hydrogen atom. [Embodiment 195] In embodiment 150, D is CR 1 R 2 and R 1 and R 2 is a hydrogen atom. [Embodiment 196] In embodiment 151, D is CR 1 R 2 and R 1 and R 2is a hydrogen atom. [Embodiment 197] The compound A, wherein D is CR 1 R 2 and R 1 and R 2 is a hydrogen atom. 1 R 2 and R 1 and R 2 and are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. 1 R 2 and R 1 and R 2 and are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. 1 R 2 and R 1 and R 2 are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. 1 R 2 and R 1 and R 2 and are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. 1 R 2 and R 1 and R 2 and are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. 1 R 2 and R 1 and R 2 and are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. 1 R 2 and R 1 and R 2 and are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. 1 R2 and R 1 and R 2 and are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. 1 R 2 and R 1 and R 2 and are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. 1 R 2 and R 1 and R 2 and are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. 1 R 2 and R 1 and R 2 and are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. 1 R 2 and R 1 and R 2 are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. 1 R 2 and R 1 and R 2 are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. 1 R 2 and R 1 and R 2 and are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. 1 R 2 and R 1 and R 2 and are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. 1 R 2 and R1 and R 2 and are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. 1 R 2 and R 1 and R 2 are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. 1 R 2 and R 1 and R 2 and are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. 1 R 2 and R 1 and R 2 and are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. 1 R 2 and R 1 and R 2 and are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. 1 R 2 and R 1 and R 2 are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. 1 R 2 and R 1 and R 2 and are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. 1 R 2 and R 1 and R 2 and are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. 1 R 2 and R 1 and R 2and are the same or different and are a hydroxy group or a hydrogen atom. 1 R 2 and R 1 and R 2 and are the same or different and are a hydroxy group or a hydrogen atom. 1 R 2 and R 1 and R 2 and are the same or different and are a hydroxy group or a hydrogen atom. 1 R 2 and R 1 and R 2 and are the same or different and are a hydroxy group or a hydrogen atom. 1 R 2 and R 1 and R 2 and are the same or different and are a hydroxy group or a hydrogen atom. 1 R 2 and R 1 and R 2 and are the same or different and are a hydroxy group or a hydrogen atom. 1 R 2 and R 1 and R 2 and are the same or different and are a hydroxy group or a hydrogen atom. 1 R 2 and R 1 and R 2 and are the same or different and are a hydroxy group or a hydrogen atom. 1 R 2 and R 1 and R 2 and are the same or different and are a hydroxy group or a hydrogen atom. 1 R 2and R 1 and R 2 and are the same or different and are a hydroxy group or a hydrogen atom. 1 R 2 and R 1 and R 2 and are the same or different and are a hydroxy group or a hydrogen atom. 1 R 2 and R 1 and R 2 and are the same or different and are a hydroxy group or a hydrogen atom. 1 R 2 and R 1 and R 2 and are the same or different and are a hydroxy group or a hydrogen atom. 1 R 2 and R 1 and R 2 and are the same or different and are a hydroxy group or a hydrogen atom. 1 R 2 and R 1 and R 2 and are the same or different and are a hydroxy group or a hydrogen atom. 1 R 2 and R 1 and R 2 and are the same or different and are a hydroxy group or a hydrogen atom. 1 R 2 and R 1 and R 2 and are the same or different and are a hydroxy group or a hydrogen atom. 1 R 2 and R 1 and R 2and are the same or different and are a hydroxy group or a hydrogen atom. 1 R 2 and R 1 and R 2 and are the same or different and are a hydroxy group or a hydrogen atom. 1 R 2 and R 1 and R 2 and are the same or different and are a hydroxy group or a hydrogen atom. 1 R 2 and R 1 and R 2 and are the same or different and are a hydroxy group or a hydrogen atom. 1 R 2 and R 1 and R 2 and are the same or different and are a hydroxy group or a hydrogen atom. 1 R 2 and R 1 and R 2and are the same or different and are a hydroxy group or a hydrogen atom. [Aspect 244] A compound in Compound A or any of Aspects 1 to 129, wherein A is a 1,2,3-triazol-2-yl group, an oxazol-2-yl group, a thiazol-2-yl group, a 1,2,4-oxadiazol-3-yl group, a 1,2,4-thiadiazol-3-yl group, a pyridin-2-yl group, or a pyrimidin-2-yl group (the 1,2,3-triazol-2-yl group, the oxazol-2-yl group, the thiazol-2-yl group, the 1,2,4-oxadiazol-3-yl group, the 1,2,4-thiadiazol-3-yl group, the pyridin-2-yl group, and the pyrimidin-2-yl group may be substituted with a C1-C6 chain hydrocarbon group or a halogen atom). [Aspect 245] The compound A or a compound in any one of Aspects 1 to 129, wherein A is a 1,2,3-triazol-2-yl group, a 1,2,4-oxadiazol-3-yl group, a 1,2,4-thiadiazol-3-yl group, a pyridin-2-yl group, or a pyrimidin-2-yl group (the 1,2,3-triazol-2-yl group, the 1,2,4-oxadiazol-3-yl group, the 1,2,4-thiadiazol-3-yl group, the pyridin-2-yl group, and the pyrimidin-2-yl group may be substituted with a C1-C6 chain hydrocarbon group or a halogen atom). [Aspect 246] Compound A or a compound in any one of Aspects 1 to 129, wherein A is a 1,2,3-triazol-2-yl group, an oxazol-2-yl group, a thiazol-2-yl group, a 1,2,4-oxadiazol-3-yl group, a pyridin-2-yl group, or a pyrimidin-2-yl group (the 1,2,3-triazol-2-yl group, the oxazol-2-yl group, the thiazol-2-yl group, the 1,2,4-oxadiazol-3-yl group, the pyridin-2-yl group, and the pyrimidin-2-yl group may be substituted with a C1-C6 chain hydrocarbon group or a halogen atom).[Aspect 247] A compound in the present compound A or in any one of Aspects 1 to 129, wherein A is a 1,2,3-triazol-2-yl group, a 1,2,4-oxadiazol-3-yl group, a pyridin-2-yl group, or a pyrimidin-2-yl group (the 1,2,3-triazol-2-yl group, the 1,2,4-oxadiazol-3-yl group, the pyridin-2-yl group, and the pyrimidin-2-yl group may be substituted with a C1-C6 chain hydrocarbon group or a halogen atom). [Aspect 248] A compound in Aspect 244, wherein D is CR. 1 R 2 and R 1 and R 2 is a hydrogen atom. [Embodiment 249] In embodiment 244, D is CR 1 R 2 and R 1 and R 2 and are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. 1 R 2 and R 1 and R 2 and are the same or different and are a hydroxy group or a hydrogen atom. 1 R 2 and R 1 and R 2 is a hydrogen atom. 1 R 2 and R 1 and R 2 and are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. 1 R 2 and R 1 and R 2 and are the same or different and are a hydroxy group or a hydrogen atom. 1 R 2 and R 1 and R 2 is a hydrogen atom.1 R 2 and R 1 and R 2 and are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. 1 R 2 and R 1 and R 2 and are the same or different and are a hydroxy group or a hydrogen atom. 1 R 2 and R 1 and R 2 is a hydrogen atom. [Embodiment 258] In embodiment 247, D is CR 1 R 2 and R 1 and R 2 and are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. 1 R 2 and R 1 and R 2 are the same or different and are a hydroxy group or a hydrogen atom.

[0016] The following compounds are also examples of the present compound A.

[0017] [Aspect X1] In the present compound A, Z 1 Group A 2 a 5- to 7-membered aromatic heterocycle (excluding a 5-trifluoromethyl-1,2,4-oxadiazol-3-yl group) optionally substituted by one or more substituents selected from the group consisting of a C3-C8 alicyclic hydrocarbon group (the C3-C8 alicyclic hydrocarbon group is selected from the group consisting of a C3-C8 alicyclic hydrocarbon group ... 2 a 3- to 8-membered non-aromatic heterocyclic group {which may be substituted with one or more substituents selected from the group B 3 and optionally substituted with one or more substituents selected from the following} (excluding 5-trifluoromethyl-4,5-dihydro-1,2,4-oxadiazol-3-yl group), a C2-C6 chain hydrocarbon group {the C2-C6 chain hydrocarbon group is a group selected from the group C 2may be substituted with one or more substituents selected from the group consisting of OR 5 , S.R. 6 , S(O)R 7 , or S(O)R 8 and R 5 But group C 2 a methyl group, a C2-C6 chain hydrocarbon group, a (C1-C4 alkylamino)carbonyl group, a (C2-C4 dialkylamino)carbonyl group, a C3-C6 alicyclic hydrocarbon group, a 3- to 6-membered non-aromatic heterocyclic group, or a phenyl group substituted by one or more substituents selected from the group consisting of (the C2-C6 chain hydrocarbon group, the (C1-C4 alkylamino)carbonyl group, the (C2-C4 dialkylamino)carbonyl group, the C3-C6 alicyclic hydrocarbon group, the 3- to 6-membered non-aromatic heterocyclic group, and the phenyl group are optionally substituted by one or more halogen atoms), and R 6 , R 7 , and R 8 are the same or different and are a C1-C6 chain hydrocarbon group or a C3-C8 alicyclic hydrocarbon group (the C1-C6 chain hydrocarbon group and the C3-C8 alicyclic hydrocarbon group may be substituted with one or more halogen atoms). [Aspect X2] A compound of the present invention, 1 Group A 2 a 5- to 7-membered aromatic heterocycle (excluding a 5-trifluoromethyl-1,2,4-oxadiazol-3-yl group) optionally substituted by one or more substituents selected from the group consisting of a C3-C8 alicyclic hydrocarbon group (the C3-C8 alicyclic hydrocarbon group is selected from the group consisting of a C3-C8 alicyclic hydrocarbon group ... 2 a 3- to 8-membered non-aromatic heterocyclic group {which may be substituted with one or more substituents selected from the group B 3 and optionally substituted with one or more substituents selected from the following} (excluding 5-trifluoromethyl-4,5-dihydro-1,2,4-oxadiazol-3-yl group), a C2-C6 chain hydrocarbon group {the C2-C6 chain hydrocarbon group is a group selected from the group C 2 may be substituted with one or more substituents selected from the group consisting of: 5 and R 5 But group C 2A compound which is a methyl group, a C2-C6 chain hydrocarbon group, a (C1-C4 alkylamino)carbonyl group, a (C2-C4 dialkylamino)carbonyl group, a C3-C6 alicyclic hydrocarbon group, a 3- to 6-membered non-aromatic heterocyclic group, or a phenyl group, each of which is substituted by one or more substituents selected from the group consisting of (the C2-C6 chain hydrocarbon group, the (C1-C4 alkylamino)carbonyl group, the (C2-C4 dialkylamino)carbonyl group, the C3-C6 alicyclic hydrocarbon group, the 3- to 6-membered non-aromatic heterocyclic group, and the phenyl group are optionally substituted by one or more halogen atoms). [Aspect X3] A compound which is Compound A, in which D is CR 1 R 2 and R 1 and R 2 The combination of 1 is a hydrogen atom, and R 2 is a hydrogen atom; 1 is a hydrogen atom, and R 2 is a hydroxy group; or R 1 is a hydrogen atom, and R 2 and is a halogen atom. [Aspect X4] The compound A, 1 R 2 and R 1 and R 2 The combination of 1 is a hydrogen atom, and R 2 is a hydrogen atom; or R 1 is a hydrogen atom, and R 2 and is a hydroxy group. [Aspect X5] The compound of aspect X1, wherein D is CR 1 R 2 and R 1 and R 2 The combination of 1 is a hydrogen atom, and R 2 is a hydrogen atom; 1 is a hydrogen atom, and R 2 is a hydroxy group; or R 1 is a hydrogen atom, and R 2 and is a halogen atom. [Aspect X6] The compound of Aspect X1, wherein D is CR 1 R 2 and R 1and R 2 The combination of 1 is a hydrogen atom, and R 2 is a hydrogen atom; or R 1 is a hydrogen atom, and R 2 and is a hydroxy group. [Aspect X7] In aspect X2, D is CR 1 R 2 and R 1 and R 2 The combination of 1 is a hydrogen atom, and R 2 is a hydrogen atom; 1 is a hydrogen atom, and R 2 is a hydroxy group; or R 1 is a hydrogen atom, and R 2 and is a halogen atom. [Aspect X8] The compound of aspect X2, wherein D is CR 1 R 2 and R 1 and R 2 The combination of 1 is a hydrogen atom, and R 2 is a hydrogen atom; or R 1 is a hydrogen atom, and R 2 and are a hydroxy group. [Aspect X9] A compound in which X is a fluorine atom in Compound A. [Aspect X10] A compound in which X is a fluorine atom in Aspect X1. [Aspect X11] A compound in which X is a fluorine atom in Aspect X2. [Aspect X12] A compound in which X is a fluorine atom in Aspect X3. [Aspect X13] A compound in which X is a fluorine atom in Aspect X4. [Aspect X14] A compound in which X is a fluorine atom in Aspect X5. [Aspect X15] A compound in which X is a fluorine atom in Aspect X6. [Aspect X16] A compound in which X is a fluorine atom in Aspect X7. [Aspect X17] A compound in which X is a fluorine atom in Aspect X8. [Aspect X18] A compound in which X is a fluorine atom in Compound A. 2 and X 3 is a hydrogen atom. [Aspect X19] In aspect X1, X 2 and X 3 is a hydrogen atom. [Aspect X20] In aspect X2, X2 and X 3 is a hydrogen atom. [Aspect X21] In aspect X3, X 2 and X 3 is a hydrogen atom. [Aspect X22] In aspect X4, X 2 and X 3 is a hydrogen atom. [Aspect X23] In aspect X5, X 2 and X 3 is a hydrogen atom. [Aspect X24] In aspect X6, X 2 and X 3 is a hydrogen atom. [Aspect X25] In aspect X7, X 2 and X 3 is a hydrogen atom. [Aspect X26] In aspect X8, X 2 and X 3 is a hydrogen atom. [Aspect X27] In aspect X9, X 2 and X 3 is a hydrogen atom. [Aspect X28] In aspect X10, X 2 and X 3 is a hydrogen atom. [Aspect X29] In aspect X11, X 2 and X 3 is a hydrogen atom. [Aspect X30] In aspect X12, X 2 and X 3 is a hydrogen atom. [Aspect X31] In aspect X13, X 2 and X 3 is a hydrogen atom. [Aspect X32] In aspect X14, X 2 and X 3 is a hydrogen atom. [Aspect X33] In aspect X15, X 2 and X 3 is a hydrogen atom. [Aspect X34] In aspect X16, X 2 and X 3 is a hydrogen atom. [Aspect X35] In aspect X17, X 2 and X 3 is a hydrogen atom. [Aspect X36] In the compound A, X 1 is a hydrogen atom or a fluorine atom. [Aspect X37] In aspect X1, X1 is a hydrogen atom or a fluorine atom. [Aspect X38] In aspect X2, X 1 is a hydrogen atom or a fluorine atom. [Aspect X39] In aspect X3, X 1 is a hydrogen atom or a fluorine atom. [Aspect X40] In aspect X4, X 1 is a hydrogen atom or a fluorine atom. [Aspect X41] In aspect X5, X 1 is a hydrogen atom or a fluorine atom. [Aspect X42] In aspect X6, X 1 is a hydrogen atom or a fluorine atom. [Aspect X43] In aspect X7, X 1 is a hydrogen atom or a fluorine atom. [Aspect X44] In aspect X8, X 1 is a hydrogen atom or a fluorine atom. [Aspect X45] In aspect X9, X 1 is a hydrogen atom or a fluorine atom. [Aspect X46] In aspect X10, X 1 is a hydrogen atom or a fluorine atom. [Aspect X47] In aspect X11, X 1 is a hydrogen atom or a fluorine atom. [Aspect X48] In aspect X12, X 1 is a hydrogen atom or a fluorine atom. [Aspect X49] In aspect X13, X 1 is a hydrogen atom or a fluorine atom. [Aspect X50] In aspect X14, X 1 is a hydrogen atom or a fluorine atom. [Aspect X51] In aspect X15, X 1 is a hydrogen atom or a fluorine atom. [Aspect X52] In aspect X16, X 1 is a hydrogen atom or a fluorine atom. [Aspect X53] In aspect X17, X 1 is a hydrogen atom or a fluorine atom. [Aspect X54] In aspect X18, X 1 is a hydrogen atom or a fluorine atom. [Aspect X55] In aspect X19, X 1 is a hydrogen atom or a fluorine atom. [Aspect X56] In aspect X20, X 1is a hydrogen atom or a fluorine atom. [Aspect X57] In aspect X21, X 1 is a hydrogen atom or a fluorine atom. [Aspect X58] In aspect X22, X 1 is a hydrogen atom or a fluorine atom. [Aspect X59] In aspect X23, X 1 is a hydrogen atom or a fluorine atom. [Aspect X60] In aspect X24, X 1 is a hydrogen atom or a fluorine atom. [Aspect X61] In aspect X25, X 1 is a hydrogen atom or a fluorine atom. [Aspect X62] In aspect X26, X 1 is a hydrogen atom or a fluorine atom. [Aspect X63] In aspect X27, X 1 is a hydrogen atom or a fluorine atom. [Aspect X64] In aspect X28, X 1 is a hydrogen atom or a fluorine atom. [Aspect X65] In aspect X29, X 1 is a hydrogen atom or a fluorine atom. [Aspect X66] In aspect X30, X 1 is a hydrogen atom or a fluorine atom. [Aspect X67] In aspect X31, X 1 is a hydrogen atom or a fluorine atom. [Aspect X68] In aspect X32, X 1 is a hydrogen atom or a fluorine atom. [Aspect X69] In aspect X33, X 1 is a hydrogen atom or a fluorine atom. [Aspect X70] In aspect X34, X 1 is a hydrogen atom or a fluorine atom. [Aspect X71] In aspect X35, X 1 is a hydrogen atom or a fluorine atom. [Aspect X72] In the compound A, X 1 is a fluorine atom. [Aspect X73] In aspect X1, X 1 is a fluorine atom. [Aspect X74] In aspect X2, X 1 is a fluorine atom. [Aspect X75] In aspect X3, X 1 is a fluorine atom. [Aspect X76] In aspect X4, X 1is a fluorine atom. [Aspect X77] In aspect X5, X 1 is a fluorine atom. [Aspect X78] In aspect X6, X 1 is a fluorine atom. [Aspect X79] In aspect X7, X 1 is a fluorine atom. [Aspect X80] In aspect X8, X 1 is a fluorine atom. [Aspect X81] In aspect X9, X 1 is a fluorine atom. [Aspect X82] In aspect X10, X 1 is a fluorine atom. [Aspect X83] In aspect X11, X 1 is a fluorine atom. [Aspect X84] In aspect X12, X 1 is a fluorine atom. [Aspect X85] In aspect X13, X 1 is a fluorine atom. [Aspect X86] In aspect X14, X 1 is a fluorine atom. [Aspect X87] In aspect X15, X 1 is a fluorine atom. [Aspect X88] In aspect X16, X 1 is a fluorine atom. [Aspect X89] In aspect X17, X 1 is a fluorine atom. [Aspect X90] In aspect X18, X 1 is a fluorine atom. [Aspect X91] In aspect X19, X 1 is a fluorine atom. [Aspect X92] In aspect X20, X 1 is a fluorine atom. [Aspect X93] In aspect X21, X 1 is a fluorine atom. [Aspect X94] In aspect X22, X 1 is a fluorine atom. [Aspect X95] In aspect X23, X 1 is a fluorine atom. [Aspect X96] In aspect X24, X 1 is a fluorine atom. [Aspect X97] In aspect X25, X 1 is a fluorine atom. [Aspect X98] In aspect X26, X 1is a fluorine atom. [Aspect X99] In aspect X27, X 1 is a fluorine atom. [Aspect X100] In aspect X28, X 1 is a fluorine atom. [Aspect X101] In aspect X29, X 1 is a fluorine atom. [Aspect X102] In aspect X30, X 1 is a fluorine atom. [Aspect X103] In aspect X31, X 1 is a fluorine atom. [Aspect X104] In aspect X32, X 1 is a fluorine atom. [Aspect X105] In aspect X33, X 1 is a fluorine atom. [Aspect X106] In aspect X34, X 1 is a fluorine atom. [Aspect X107] In aspect X35, X 1 is a fluorine atom. [Aspect X108] In Compound A or Aspects X1 to X107, A is a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group (provided that in the pyridinyl group, the pyrazinyl group, the pyrimidinyl group, and the pyridazinyl group, at least one of the atoms constituting the pyridinyl group, the pyrazinyl group, the pyrimidinyl group, and the pyridazinyl group adjacent to the atom bonded to D is a nitrogen atom), or a group represented by formula T1, T2, T3, or T4, and L 1 is a nitrogen atom, or CR 40 and L 2 is a nitrogen atom, or CR 41 and L 3 is a nitrogen atom, or CR 42 (where L 1 , L 2 and L 3 wherein the number of nitrogen atoms is 0, 1 or 2), Q 1 is an oxygen atom or a sulfur atom, and Q 2 is an oxygen atom or a sulfur atom, and Y 1 is a nitrogen atom, or CR 46 and Y 2 is a nitrogen atom, or CR 47 and R 40 , R 41 , R42 , R 43 , R 44 , R 45 , R 46 , R 47 , and R 48 and are the same or different and are a C1-C6 chain hydrocarbon group or a hydrogen atom. [Aspect X109] In Compound A or Aspects X1 to X107, A is a pyridinyl group, a pyrimidinyl group (provided that in the pyridinyl group and the pyrimidinyl group, at least one of the atoms constituting the pyridinyl group and the pyrimidinyl group adjacent to the atom bonded to D is a nitrogen atom), or a group represented by formula T1, T2, or T3, and L 1 is a nitrogen atom, or CR 40 and L 2 is a nitrogen atom, or CR 41 and L 3 is CR 42 and Q 1 is an oxygen atom or a sulfur atom, and Q 2 is an oxygen atom or a sulfur atom, and R 40 , R 41 , R 42 , R 43 , R 44 , and R 45 are the same or different and are a C1-C6 chain hydrocarbon group or a hydrogen atom.

[0018] Examples of the compound A of the present invention include the following compounds.

[0019] [Aspect A1] In the compound A of the present invention, Z a is a 5- to 7-membered aromatic heterocycle {the 5- to 7-membered aromatic heterocycle is a group A a and optionally substituted with one or more substituents selected from the following (provided that 5-trifluoromethyl-1,2,4-oxadiazol-3-yl group and 1,2,4-triazine-3,5(2H,4H)-dione-2-yl group are excluded). [Aspect A2] Compound A of the present invention, wherein Z a is a 5- to 7-membered aromatic heterocycle {the 5- to 7-membered aromatic heterocycle is a group A 2aand optionally substituted with one or more substituents selected from the following (provided that 5-trifluoromethyl-1,2,4-oxadiazol-3-yl group and 1,2,4-triazine-3,5(2H,4H)-dione-2-yl group are excluded). 2a A group consisting of a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, a C1-C6 alkoxy group, and a halogen atom. [Aspect A3] In Compound A of the present invention, Z a is a 5- to 7-membered aromatic heterocycle {the 5- to 7-membered aromatic heterocycle is a group A 3a and optionally substituted with one or more substituents selected from the following (provided that 1,2,4-triazine-3,5(2H,4H)-dione-2-yl group is excluded). 3a A group consisting of a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group, and a halogen atom. [Aspect A4] In the compound A of the present invention, Z a is a C3-C8 alicyclic hydrocarbon group {the C3-C8 alicyclic hydrocarbon group is selected from the group B a Among the atoms constituting the C3-C8 alicyclic hydrocarbon group, X a Any atom not bonded to the benzene ring substituted with X may form a C3-C7 alicyclic hydrocarbon or a 3- to 7-membered non-aromatic heterocycle as a spiro atom, and among the atoms constituting the C3-C8 alicyclic hydrocarbon group, X a any two adjacent atoms not bonded to a benzene ring substituted with another C4-C7 alicyclic hydrocarbon, a 4- to 7-membered non-aromatic heterocycle containing the two adjacent atoms {the C4-C7 alicyclic hydrocarbon and the 4- to 7-membered non-aromatic heterocycle are included in group B a a benzene ring, or a 5- or 6-membered aromatic heterocycle {the benzene ring and the 5- or 6-membered aromatic heterocycle are each selected from the group A a and any two atoms that are not adjacent to each other among the atoms constituting the C3-C8 alicyclic hydrocarbon group (provided that both of the any two atoms are substituted with one or more substituents selected from the following) may form a ring structure. a[Aspect A5] In the compound A of the present invention, Z a Group B a [Aspect A6] In the compound A of the present invention, Z is a C3-C8 alicyclic hydrocarbon group optionally substituted with one or more substituents selected from the following. a Group B 2a Group B: Compounds which are C3-C8 alicyclic hydrocarbon groups optionally substituted with one or more substituents selected from the following: 2a : a group consisting of a C1-C6 chain hydrocarbon group, a C3-C6 alicyclic hydrocarbon group, or a cyano group. [Aspect A7] In the compound A of the present invention, Z a is a 3- to 8-membered non-aromatic heterocyclic group {the 3- to 8-membered non-aromatic heterocyclic group is a group B a Among the atoms constituting the 3- to 8-membered non-aromatic heterocyclic group, X a Any atom not bonded to the benzene ring substituted with X may form a C3-C7 alicyclic hydrocarbon or a 3- to 7-membered non-aromatic heterocyclic ring as a spiro atom, and among the atoms constituting the 3- to 8-membered non-aromatic heterocyclic group, X a any two adjacent atoms not bonded to a benzene ring substituted with another C4-C7 alicyclic hydrocarbon, a 4- to 7-membered non-aromatic heterocycle containing the two adjacent atoms {the C4-C7 alicyclic hydrocarbon and the 4- to 7-membered non-aromatic heterocycle are included in group B a a benzene ring, or a 5- or 6-membered aromatic heterocycle {the benzene ring and the 5- or 6-membered aromatic heterocycle are each selected from the group A a and any two atoms that are not adjacent to each other among the atoms constituting the 3- to 8-membered non-aromatic heterocyclic group (provided that both of the any two atoms are not X a(not bonded to a benzene ring substituted with -) may be bridged by -CH2- or -(CH2)2-) (excluding 5-trifluoromethyl-4,5-dihydro-1,2,4-oxadiazol-3-yl group and 4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl group). [Aspect A8] Compounds in which, in Compound A of the present invention, Z a is a 3- to 8-membered non-aromatic heterocyclic group {the 3- to 8-membered non-aromatic heterocyclic group is a group B 3a Among the atoms constituting the 3- to 8-membered non-aromatic heterocyclic group, X a Any atom not bonded to the benzene ring substituted with X may form a C3-C5 alicyclic hydrocarbon as a spiro atom, and among the atoms constituting the 3-8 membered non-aromatic heterocyclic group, X a Any two adjacent atoms that are not bonded to a benzene ring substituted with X may form another benzene ring containing the two adjacent atoms, and any two atoms that are not adjacent to each other among the atoms constituting the 3-8 membered non-aromatic heterocyclic group (provided that both of the two atoms are X a (not bonded to a benzene ring substituted with -) may be bridged by -CH2-) (excluding 4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl group). 3a : a group consisting of an oxo group, a thioxo group, and a C1-C6 chain hydrocarbon group. [Aspect A9] In the compound A of the present invention, Z a is a 3- to 8-membered non-aromatic heterocyclic group {the 3- to 8-membered non-aromatic heterocyclic group is a group B 3a and optionally substituted with one or more substituents selected from the following (provided that 4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl group is excluded). [Aspect A10] Compound A of the present invention, wherein Z a Group D a [Aspect A11] In the compound A of the present invention, Z is a methyl group substituted with one or more substituents selected from the following. a Group C a Compounds which are C2-C6 chain hydrocarbon groups optionally substituted with one or more substituents selected from the following: aA group consisting of a C3-C8 alicyclic hydrocarbon group, a halogen atom, and a cyano group. [Aspect A12] In the compound A of the present invention, Z a is a C2-C6 chain hydrocarbon group. [Aspect A13] Compound A of the present invention, a is OR 8a [Aspect A14] In the compound A of the present invention, Z a is OR 8a and R 8a But Group I 2a Compounds which are a C1-C2 open chain hydrocarbon group, a C3-C6 open chain hydrocarbon group, a (C2-C8 dialkylamino)carbonyl group, a C3-C6 alicyclic hydrocarbon group, a 3- to 6-membered non-aromatic heterocyclic group, or a phenyl group, each substituted by one or more substituents selected from the group consisting of (the C3-C6 open chain hydrocarbon group, the (C2-C8 dialkylamino)carbonyl group, the C3-C6 alicyclic hydrocarbon group, the 3- to 6-membered non-aromatic heterocyclic group, and the phenyl group are optionally substituted by one or more halogen atoms). 2a A group consisting of C3-C6 alicyclic hydrocarbon groups and 3- to 6-membered non-aromatic heterocyclic groups (the C3-C6 alicyclic hydrocarbon groups and the 3- to 6-membered non-aromatic heterocyclic groups may be substituted with one or more halogen atoms). [Aspect A15] In compound A of the present invention, Z a is OR 8a and R 8a But Group I 3a Compounds which are C1-C2 chain hydrocarbon groups, C3-C6 chain hydrocarbon groups, (C2-C8 dialkylamino)carbonyl groups, C3-C6 alicyclic hydrocarbon groups, 3- to 6-membered non-aromatic heterocyclic groups, or phenyl groups, each of which is substituted with one or more substituents selected from the group consisting of: 3a A group consisting of a C3-C6 alicyclic hydrocarbon group and a 3- to 6-membered non-aromatic heterocyclic group. [Aspect A16] In the compound A of the present invention, Z a But C(R 30a ) = NOR 31a [Aspect A17] In the compound A of the present invention, Z a But C(R 30a ) = NOR 31a and R 30a is a C1-C6 chain hydrocarbon group or a hydrogen atom, and R 31ais a C1-C6 chain hydrocarbon group, a C3-C8 alicyclic hydrocarbon group (the C1-C6 chain hydrocarbon group and the C3-C8 alicyclic hydrocarbon group may be substituted with one or more halogen atoms), or a hydrogen atom. [Aspect A18] Compound A of the present invention, wherein Z a is SR 9a , S(O)R 10a , S(O)R 11a , C(O)R 12a , or NR 13a R 14a [Aspect A19] In the compound A of the present invention, Z a is SR 9a , S(O)R 10a , S(O)R 11a , C(O)R 12a , or NR 13a R 14a and R 9a is a C3-C6 chain hydrocarbon group or a C3-C8 alicyclic hydrocarbon group (the C3-C6 chain hydrocarbon group and the C3-C8 alicyclic hydrocarbon group may be substituted with one or more halogen atoms), and R 10a , and R 11a are the same or different and are a C1-C6 chain hydrocarbon group or a C3-C8 alicyclic hydrocarbon group (the C1-C6 chain hydrocarbon group and the C3-C8 alicyclic hydrocarbon group may be substituted with one or more halogen atoms), and R 12a is a C3-C6 chain hydrocarbon group or a 3-8 membered non-aromatic heterocyclic group optionally substituted with one or more halogen atoms, and R 13a is a C3-C6 chain hydrocarbon group, a (C3-C6 cycloalkyl)carbonyl group, a C1-C6 alkylsulfonyl group (the C3-C6 chain hydrocarbon group, the (C3-C6 cycloalkyl)carbonyl group, and the C1-C6 alkylsulfonyl group may be substituted with one or more halogen atoms), or a hydrogen atom, and R 14ais a C1-C6 chain hydrocarbon group, a C1-C6 alkylsulfonyl group, or a (C1-C6 alkylamino)carbonyl group (the C1-C6 chain hydrocarbon group, the C1-C6 alkylsulfonyl group, and the (C1-C6 alkylamino)carbonyl group may be substituted with one or more halogen atoms). [Aspect A20] A compound in which, in Compound A of the present invention, Z a is SR 9a , S(O)R 10a , S(O)R 11a , C(O)R 12a , or NR 13a R 14a and R 9a is a C3-C6 chain hydrocarbon group or a C3-C8 alicyclic hydrocarbon group, and R 10a , and R 11a are the same or different and are a C1-C6 chain hydrocarbon group or a C3-C8 alicyclic hydrocarbon group, and R 12a is a 3- to 8-membered non-aromatic heterocyclic group, and R 13a is a C3-C6 chain hydrocarbon group, a (C3-C6 cycloalkyl)carbonyl group, or a C1-C6 alkylsulfonyl group, and R 14a is a C1-C6 chain hydrocarbon group, a C1-C6 alkylsulfonyl group, or a hydrogen atom. [Aspect A21] Compound A of the present invention, wherein Z a is a 5- to 7-membered aromatic heterocycle {the 5- to 7-membered aromatic heterocycle is a group A 2a and optionally substituted with one or more substituents selected from the following} (excluding a 5-trifluoromethyl-1,2,4-oxadiazol-3-yl group and a 1,2,4-triazine-3,5(2H,4H)-dione-2-yl group), a C3-C8 alicyclic hydrocarbon group {the C3-C8 alicyclic hydrocarbon group is a group selected from the group B a and a 3- to 8-membered non-aromatic heterocyclic group {which may be substituted with one or more substituents selected from the following}, or a 3- to 8-membered non-aromatic heterocyclic group {which may be substituted with one or more substituents selected from the following group B 3a Among the atoms constituting the 3- to 8-membered non-aromatic heterocyclic group, X aAny atom not bonded to the benzene ring substituted with X may form a C3-C7 alicyclic hydrocarbon or a 3- to 7-membered non-aromatic heterocyclic ring as a spiro atom, and among the atoms constituting the 3- to 8-membered non-aromatic heterocyclic group, X a any two adjacent atoms that are not bonded to a benzene ring substituted with X may form another C4-C7 alicyclic hydrocarbon, a 4- to 7-membered non-aromatic heterocycle, a benzene ring, or a 5- to 6-membered aromatic heterocycle containing the two adjacent atoms {the C4-C7 alicyclic hydrocarbon, the 4- to 7-membered non-aromatic heterocycle, the benzene ring, and the 5- to 6-membered aromatic heterocycle may be substituted with one or more halogen atoms}, and any two atoms that are not adjacent to each other among the atoms constituting the 3- to 8-membered non-aromatic heterocyclic group (provided that both of the two arbitrary atoms are X a (not bonded to a benzene ring substituted with -) may be bridged by -CH2-) (excluding 4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl group). [Aspect A22] In Compound A of the present invention, Z a is a 5- to 7-membered aromatic heterocycle {the 5- to 7-membered aromatic heterocycle is a group A 3a and optionally substituted with one or more substituents selected from the following} (excluding 1,2,4-triazine-3,5(2H,4H)-dione-2-yl group), a C3-C8 alicyclic hydrocarbon group {the C3-C8 alicyclic hydrocarbon group is a group selected from the group B 2a or a 3- to 8-membered non-aromatic heterocyclic group {which may be substituted with one or more substituents selected from group B 3a and optionally substituted with one or more substituents selected from the following (provided that 4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl group is excluded). [Aspect A23] Compound A of the present invention, wherein Z a is a 5- to 7-membered aromatic heterocycle {the 5- to 7-membered aromatic heterocycle is a group A 3a and optionally substituted with one or more substituents selected from the following} (excluding 1,2,4-triazine-3,5(2H,4H)-dione-2-yl group), a C3-C8 alicyclic hydrocarbon group {the C3-C8 alicyclic hydrocarbon group is a group selected from the group B 2aor a 3- to 8-membered non-aromatic heterocyclic group {which may be substituted with one or more substituents selected from group B 3a and optionally substituted with one or more substituents selected from the group consisting of (but excluding 4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl group), a C2-C6 chain hydrocarbon group, OR 8a , S.R. 9a , S(O)R 10a , S(O)R 11a , C(O)R 12a , or NR 13a R 14a and R 8a But Group I 3a a methyl group, a C2-C6 chain hydrocarbon group, a (C2-C8 dialkylamino)carbonyl group, a C3-C6 alicyclic hydrocarbon group, a 3- to 6-membered non-aromatic heterocyclic group, or a phenyl group, each of which is substituted with one or more substituents selected from the group consisting of 9a is a C3-C6 chain hydrocarbon group or a C3-C8 alicyclic hydrocarbon group, and R 10a , and R 11a are the same or different and are a C1-C6 chain hydrocarbon group or a C3-C8 alicyclic hydrocarbon group, and R 12a is a 3- to 8-membered non-aromatic heterocyclic group, and R 13a is a C3-C6 chain hydrocarbon group or a C1-C6 alkylsulfonyl group, and R 14a is a C1-C6 chain hydrocarbon group, a (C1-C6 alkylamino)carbonyl group, or a hydrogen atom. [Aspect A24] Compound A of the present invention, wherein Z a is OR 8a , S.R. 9a , S(O)R 10a , S(O)R 11a , C(O)R 12a , or NR 13a R 14a and R 8a But Group I 3a a methyl group, a C2-C6 chain hydrocarbon group, a (C2-C8 dialkylamino)carbonyl group, a C3-C6 alicyclic hydrocarbon group, a 3- to 6-membered non-aromatic heterocyclic group, or a phenyl group, each of which is substituted with one or more substituents selected from the group consisting of 9ais a C3-C6 chain hydrocarbon group or a C3-C8 alicyclic hydrocarbon group, and R 10a , and R 11a are the same or different and are a C1-C6 chain hydrocarbon group or a C3-C8 alicyclic hydrocarbon group, and R 12a is a 3- to 8-membered non-aromatic heterocyclic group, and R 13a is a C3-C6 chain hydrocarbon group or a C1-C6 alkylsulfonyl group, and R 14a is a C1-C6 chain hydrocarbon group, a (C1-C6 alkylamino)carbonyl group, or a hydrogen atom. [Aspect A25] A compound in Aspect A1, wherein X 1a is a halogen atom, and X 2a and X 3a is a hydrogen atom. [Aspect A26] A compound in aspect A2, 1a is a halogen atom, and X 2a and X 3a is a hydrogen atom. [Aspect A27] A compound in Aspect A3, 1a is a halogen atom, and X 2a and X 3a is a hydrogen atom. [Aspect A28] A compound in Aspect A4, 1a is a halogen atom, and X 2a and X 3a is a hydrogen atom. [Aspect A29] A compound in Aspect A5, 1a is a halogen atom, and X 2a and X 3a is a hydrogen atom. [Aspect A30] A compound according to Aspect A6, wherein X 1a is a halogen atom, and X 2a and X 3a is a hydrogen atom. [Aspect A31] A compound in aspect A7, 1a is a halogen atom, and X 2a and X 3a is a hydrogen atom. [Aspect A32] A compound in Aspect A8, 1a is a halogen atom, and X 2a and X 3a is a hydrogen atom. [Aspect A33] A compound according to Aspect A9, wherein X 1a is a halogen atom, and X 2a and X3a is a hydrogen atom. [Aspect A34] A compound in Aspect A10, 1a is a halogen atom, and X 2a and X 3a is a hydrogen atom. [Aspect A35] A compound in aspect A11, 1a is a halogen atom, and X 2a and X 3a is a hydrogen atom. [Aspect A36] A compound in Aspect A12, 1a is a halogen atom, and X 2a and X 3a is a hydrogen atom. [Aspect A37] In Aspect A13, X 1a is a halogen atom, and X 2a and X 3a is a hydrogen atom. [Aspect A38] In Aspect A14, X 1a is a halogen atom, and X 2a and X 3a is a hydrogen atom. [Aspect A39] In Aspect A15, X 1a is a halogen atom, and X 2a and X 3a is a hydrogen atom. [Aspect A40] In Aspect A16, X 1a is a halogen atom, and X 2a and X 3a is a hydrogen atom. [Aspect A41] A compound in Aspect A17, 1a is a halogen atom, and X 2a and X 3a is a hydrogen atom. [Aspect A42] In Aspect A18, X 1a is a halogen atom, and X 2a and X 3a is a hydrogen atom. [Aspect A43] In Aspect A19, X 1a is a halogen atom, and X 2a and X 3a is a hydrogen atom. [Aspect A44] In Aspect A20, X 1a is a halogen atom, and X 2a and X 3a is a hydrogen atom. [Aspect A45] In Aspect A21, X 1ais a halogen atom, and X 2a and X 3a is a hydrogen atom. [Aspect A46] In Aspect A22, X 1a is a halogen atom, and X 2a and X 3a is a hydrogen atom. [Aspect A47] A compound in Aspect A23, 1a is a halogen atom, and X 2a and X 3a is a hydrogen atom. [Aspect A48] In Aspect A24, X 1a is a halogen atom, and X 2a and X 3a is a hydrogen atom. [Aspect A49] A compound according to aspect A1, 1a is a halogen atom or a hydrogen atom, and X 2a and X 3a is a hydrogen atom. [Aspect A50] A compound in aspect A2, 1a is a halogen atom or a hydrogen atom, and X 2a and X 3a is a hydrogen atom. [Aspect A51] A compound in Aspect A3, 1a is a halogen atom or a hydrogen atom, and X 2a and X 3a is a hydrogen atom. [Aspect A52] A compound in Aspect A4, 1a is a halogen atom or a hydrogen atom, and X 2a and X 3a is a hydrogen atom. [Aspect A53] In Aspect A5, X 1a is a halogen atom or a hydrogen atom, and X 2a and X 3a is a hydrogen atom. [Aspect A54] In Aspect A6, X 1a is a halogen atom or a hydrogen atom, and X 2a and X 3a is a hydrogen atom. [Aspect A55] In Aspect A7, X 1a is a halogen atom or a hydrogen atom, and X 2a and X 3a is a hydrogen atom. [Aspect A56] In Aspect A8, X 1ais a halogen atom or a hydrogen atom, and X 2a and X 3a is a hydrogen atom. [Aspect A57] In Aspect A9, X 1a is a halogen atom or a hydrogen atom, and X 2a and X 3a is a hydrogen atom. [Aspect A58] In Aspect A10, X 1a is a halogen atom or a hydrogen atom, and X 2a and X 3a is a hydrogen atom. [Aspect A59] In aspect A11, the compound 1a is a halogen atom or a hydrogen atom, and X 2a and X 3a is a hydrogen atom. [Aspect A60] In Aspect A12, X 1a is a halogen atom or a hydrogen atom, and X 2a and X 3a is a hydrogen atom. [Aspect A61] A compound in Aspect A13, 1a is a halogen atom or a hydrogen atom, and X 2a and X 3a is a hydrogen atom. [Aspect A62] In Aspect A14, X 1a is a halogen atom or a hydrogen atom, and X 2a and X 3a is a hydrogen atom. [Aspect A63] In Aspect A15, X 1a is a halogen atom or a hydrogen atom, and X 2a and X 3a is a hydrogen atom. [Aspect A64] In Aspect A16, X 1a is a halogen atom or a hydrogen atom, and X 2a and X 3a is a hydrogen atom. [Aspect A65] In Aspect A17, X 1a is a halogen atom or a hydrogen atom, and X 2a and X 3a is a hydrogen atom. [Aspect A66] In Aspect A18, X 1a is a halogen atom or a hydrogen atom, and X 2a and X 3ais a hydrogen atom. [Aspect A67] In Aspect A19, X 1a is a halogen atom or a hydrogen atom, and X 2a and X 3a is a hydrogen atom. [Aspect A68] In Aspect A20, the compound 1a is a halogen atom or a hydrogen atom, and X 2a and X 3a is a hydrogen atom. [Aspect A69] In Aspect A21, the compound 1a is a halogen atom or a hydrogen atom, and X 2a and X 3a is a hydrogen atom. [Aspect A70] In Aspect A22, X 1a is a halogen atom or a hydrogen atom, and X 2a and X 3a is a hydrogen atom. [Aspect A71] A compound in Aspect A23, 1a is a halogen atom or a hydrogen atom, and X 2a and X 3a is a hydrogen atom. [Aspect A72] In Aspect A24, X 1a is a halogen atom or a hydrogen atom, and X 2a and X 3a is a hydrogen atom. [Aspect A73] A compound according to aspect A1, 1a , X 2a and X 3a is a hydrogen atom. [Aspect A74] A compound in aspect A2, 1a , X 2a and X 3a is a hydrogen atom. [Aspect A75] A compound according to Aspect A3, wherein X 1a , X 2a and X 3a is a hydrogen atom. [Aspect A76] A compound in Aspect A4, 1a , X 2a and X 3a is a hydrogen atom. [Aspect A77] In Aspect A5, X 1a , X 2a and X 3a is a hydrogen atom. [Aspect A78] A compound according to Aspect A6, wherein X 1a , X 2a and X3a is a hydrogen atom. [Aspect A79] In Aspect A7, X 1a , X 2a and X 3a is a hydrogen atom. [Aspect A80] In Aspect A8, X 1a , X 2a and X 3a is a hydrogen atom. [Aspect A81] A compound according to Aspect A9, wherein X 1a , X 2a and X 3a is a hydrogen atom. [Aspect A82] In Aspect A10, X 1a , X 2a and X 3a is a hydrogen atom. [Aspect A83] In Aspect A11, X 1a , X 2a and X 3a is a hydrogen atom. [Aspect A84] In Aspect A12, X 1a , X 2a and X 3a is a hydrogen atom. [Aspect A85] In Aspect A13, X 1a , X 2a and X 3a is a hydrogen atom. [Aspect A86] In Aspect A14, X 1a , X 2a and X 3a is a hydrogen atom. [Aspect A87] In Aspect A15, X 1a , X 2a and X 3a is a hydrogen atom. [Aspect A88] In Aspect A16, X 1a , X 2a and X 3a is a hydrogen atom. [Aspect A89] In Aspect A17, X 1a , X 2a and X 3a is a hydrogen atom. [Aspect A90] In Aspect A18, X 1a , X 2a and X 3a is a hydrogen atom. [Aspect A91] In Aspect A19, X 1a , X 2a and X 3ais a hydrogen atom. [Aspect A92] In Aspect A20, X 1a , X 2a and X 3a is a hydrogen atom. [Aspect A93] In Aspect A21, X 1a , X 2a and X 3a is a hydrogen atom. [Aspect A94] In Aspect A22, X 1a , X 2a and X 3a is a hydrogen atom. [Aspect A95] In Aspect A23, X 1a , X 2a and X 3a is a hydrogen atom. [Aspect A96] In Aspect A24, X 1a , X 2a and X 3a is a hydrogen atom. [Aspect A97] A compound according to aspect A1, 1a , X 2a and X 3a is a halogen atom. [Aspect A98] In Aspect A2, X 1a , X 2a and X 3a is a halogen atom. [Aspect A99] In Aspect A3, X 1a , X 2a and X 3a is a halogen atom. [Aspect A100] A compound according to Aspect A4, wherein X 1a , X 2a and X 3a is a halogen atom. [Aspect A101] A compound according to Aspect A5, wherein X 1a , X 2a and X 3a is a halogen atom. [Aspect A102] In Aspect A6, X 1a , X 2a and X 3a is a halogen atom. [Aspect A103] In Aspect A7, X 1a , X 2a and X 3a is a halogen atom. [Aspect A104] In Aspect A8, X 1a , X 2a and X 3ais a halogen atom. [Aspect A105] In Aspect A9, X 1a , X 2a and X 3a is a halogen atom. [Aspect A106] In Aspect A10, X 1a , X 2a and X 3a is a halogen atom. [Aspect A107] In Aspect A11, X 1a , X 2a and X 3a is a halogen atom. [Aspect A108] In Aspect A12, X 1a , X 2a and X 3a is a halogen atom. [Aspect A109] In Aspect A13, X 1a , X 2a and X 3a is a halogen atom. [Aspect A110] In Aspect A14, X 1a , X 2a and X 3a is a halogen atom. [Aspect A111] A compound according to Aspect A15, wherein X 1a , X 2a and X 3a is a halogen atom. [Aspect A112] In Aspect A16, X 1a , X 2a and X 3a is a halogen atom. [Aspect A113] In Aspect A17, X 1a , X 2a and X 3a is a halogen atom. [Aspect A114] In Aspect A18, X 1a , X 2a and X 3a is a halogen atom. [Aspect A115] In Aspect A19, X 1a , X 2a and X 3a is a halogen atom. [Aspect A116] In Aspect A20, X 1a , X 2a and X 3a is a halogen atom. [Aspect A117] In Aspect A21, X 1a , X2a and X 3a is a halogen atom. [Aspect A118] In Aspect A22, X 1a , X 2a and X 3a is a halogen atom. [Aspect A119] In Aspect A23, X 1a , X 2a and X 3a is a halogen atom. [Aspect A120] In Aspect A24, X 1a , X 2a and X 3a is a halogen atom. [Aspect A121] In the compound A of the present invention, X 1a is a halogen atom, and X 2a and X 3a is a hydrogen atom. [Aspect A122] In the compound A of the present invention, X 1a is a halogen atom or a hydrogen atom, and X 2a and X 3a is a hydrogen atom. [Aspect A123] In the compound A of the present invention, X 1a , X 2a and X 3a is a hydrogen atom. [Aspect A124] In the compound A of the present invention, X 1a , X 2a and X 3a is a halogen atom. [Aspect A125] A compound in which, in Compound A of the present invention or any of A1 to A124, A a is a group represented by the formula H1, H2, H3, or H4. [Aspect A126] A compound in which, in Compound A of the present invention or any of A1 to A124, A a is a group represented by formula H4. [Aspect A127] A compound in which, in Compound A of the present invention or any of A1 to A124, A a is a group represented by formula H4, and G 2 But, CR 2b and G 3 But, CR 3b and G 4 But, CR 4b and G 5 But, CR 5b[Aspect A128] In the compound A of the present invention or any one of A1 to A124, A a is a group represented by formula H4, and G 2 is CH and G 3 is CH and G 4 is CH and G 5 [Aspect A129] A compound in which, in Compound A of the present invention or any of A1 to A124, A a is a group represented by formula H4, and G 2 But, CR 2b and G 3 But, CR 3b and G 4 But, CR 4b and G 5 is a nitrogen atom. [Aspect A130] A compound in which, in Compound A of the present invention or any of A1 to A124, A a is a group represented by formula H4, and G 2 is CH and G 3 is CH and G 4 is CH and G 5 is a nitrogen atom. [Aspect A131] A compound in which, in Compound A of the present invention or any of A1 to A124, G 2 But, CR 2b and G 3 But, CR 3b and G 4 But, CR 4b and G 5 is a nitrogen atom or CR 5b [Aspect A132] In the compound A of the present invention or any one of A1 to A124, G 2 is CH and G 3 is CH and G 4 is CH and G 5 is a nitrogen atom or CH. [Aspect A133] A compound in which, in Compound A of the present invention or any of A1 to A124, A a is a group represented by the formula H1, H2, or H3. [Aspect A134] A compound in which, in Compound A of the present invention or any of A1 to A124, A ais a group represented by the formula H1. [Aspect A135] A compound in which, in Compound A of the present invention or any of A1 to A124, A a is a group represented by formula H1, and G 1 is a nitrogen atom, and R 1a is a C1-C6 chain hydrocarbon group or a hydrogen atom. [Aspect A136] A compound in which, in Compound A of the present invention or any of A1 to A124, A a is a group represented by formula H1, and G 1 is a nitrogen atom, and R 1a is a hydrogen atom. [Aspect A137] A compound in which, in Compound A of the present invention or any of A1 to A124, A a is a group represented by formula H1, and G 1 But, CR 1b and R 1a and R 1b and are the same or different and are a C1-C6 alkyl group or a hydrogen atom. [Aspect A138] A compound in which, in Compound A of the present invention or any of A1 to A124, A a is a group represented by formula H1, and G 1 is CH and R 1a is a hydrogen atom. [Aspect A139] A compound in which, in Compound A of the present invention or any of A1 to A124, A a is a group represented by formula H1, and G 1 is CH or a nitrogen atom, and R 1a is a hydrogen atom. [Aspect A140] A compound in which, in Compound A of the present invention or any of A1 to A124, A a is a group represented by the formula H2. [Aspect A141] A compound in which, in Compound A of the present invention or any of A1 to A124, A a is a group represented by formula H2, and R 2a , and R 3a and are the same or different and are a C1-C6 chain hydrocarbon group or a hydrogen atom. [Aspect A142] A compound in which, in Compound A of the present invention or any of A1 to A124, A a is a group represented by formula H2, and Q 1 is an oxygen atom, and R 2a , and R 3aand are the same or different and are a C1-C6 chain hydrocarbon group or a hydrogen atom. [Aspect A143] A compound in which, in Compound A of the present invention or any of A1 to A124, A a is a group represented by formula H2, and Q 1 is a sulfur atom, and R 2a , and R 3a and are the same or different and are a C1-C6 chain hydrocarbon group or a hydrogen atom. [Aspect A144] A compound in which, in Compound A of the present invention or any of A1 to A124, A a is a group represented by the formula H3. [Aspect A145] A compound in which, in Compound A of the present invention or any of A1 to A124, A a is a group represented by formula H3, and R 4a is a C1-C6 chain hydrocarbon group or a hydrogen atom. [Aspect A146] A compound in which, in Compound A of the present invention or any of A1 to A124, A a is a group represented by formula H3, and Q 2 is an oxygen atom, and R 4a is a C1-C6 chain hydrocarbon group or a hydrogen atom. [Aspect A147] A compound in which, in Compound A of the present invention or any of A1 to A124, A a is a group represented by formula H3, and Q 2 is a sulfur atom, and R 4a is a C1-C6 chain hydrocarbon group or a hydrogen atom. [Aspect A148] A compound in which, in Compound A of the present invention or any of A1 to A124, A a is a group represented by the formula H1 or H3. [Aspect A149] A compound in which, in the compound A of the present invention or any of A1 to A124, A a is a group represented by formula H1 or H3, and G 1 is CH and R 1a is a hydrogen atom, and Q 2 is an oxygen atom or a sulfur atom, and R 4a is a C1-C6 chain hydrocarbon group or a hydrogen atom. [Aspect A150] A compound in which, in Compound A of the present invention or any of A1 to A124, A ais a group represented by the formula H1, H3 or H4. [Aspect A151] A compound in which, in Compound A of the present invention or any of A1 to A124, A a is a group represented by formula H1, H3 or H4, and G 2 is CH and G 3 is CH and G 4 is CH and G 5 is a nitrogen atom or CH, and G 1 is CH and R 1a is a hydrogen atom, and R 4a is a C1-C6 chain hydrocarbon group or a hydrogen atom. [Aspect A152] A compound in which, in Compound A of the present invention or any of A1 to A124, A a is a group represented by the formula H1, H2 or H4. [Aspect A153] A compound in which, in Compound A of the present invention or any of A1 to A124, A a is a group represented by the formula H1 or H4. [Aspect A154] A compound in which, in the compound A of the present invention or any of A1 to A124, A a is a group represented by the formula H3 or H4. [Aspect A155] A compound in which, in the compound A of the present invention or any of A1 to A124, A a is a group represented by formula H3 or H4, and Q 2 is an oxygen atom, and G 2 is CH and G 3 is CH and G 4 is CH and G 5 is CH or a nitrogen atom. [Aspect A156] A compound in which, in Compound A of the present invention or any of A1 to A124, A ais a 1,2,3-triazol-2-yl group, an oxazol-2-yl group, a thiazol-2-yl group, a 1,2,4-oxadiazol-3-yl group, a 1,2,4-thiadiazol-3-yl group, a pyridin-2-yl group, or a pyrimidin-2-yl group {the 1,2,3-triazol-2-yl group, the oxazol-2-yl group, the thiazol-2-yl group, the 1,2,4-oxadiazol-3-yl group, the 1,2,4-thiadiazol-3-yl group, the pyridin-2-yl group, and the pyrimidin-2-yl group may be substituted with a C1-C6 chain hydrocarbon group or a halogen atom}. [Aspect A157] A compound in which, in Compound A of the present invention or any of A1 to A124, A a is a 1,2,3-triazol-2-yl group, a 1,2,4-oxadiazol-3-yl group, a 1,2,4-thiadiazol-3-yl group, a pyridin-2-yl group, or a pyrimidin-2-yl group {the 1,2,3-triazol-2-yl group, the 1,2,4-oxadiazol-3-yl group, the 1,2,4-thiadiazol-3-yl group, the pyridin-2-yl group, and the pyrimidin-2-yl group may be substituted with a C1-C6 chain hydrocarbon group or a halogen atom}. [Aspect A158] A compound in which, in Compound A of the present invention or any of A1 to A124, A a is a 1,2,3-triazol-2-yl group, an oxazol-2-yl group, a thiazol-2-yl group, a 1,2,4-oxadiazol-3-yl group, a pyridin-2-yl group, or a pyrimidin-2-yl group {the 1,2,3-triazol-2-yl group, the oxazol-2-yl group, the thiazol-2-yl group, the 1,2,4-oxadiazol-3-yl group, the pyridin-2-yl group, and the pyrimidin-2-yl group may be substituted with a C1-C6 chain hydrocarbon group or a halogen atom}. [Aspect A159] A compound in which, in Compound A of the present invention or any of A1 to A124, A ais a 1,2,3-triazol-2-yl group, a 1,2,4-oxadiazol-3-yl group, a pyridin-2-yl group, or a pyrimidin-2-yl group {the 1,2,3-triazol-2-yl group, the 1,2,4-oxadiazol-3-yl group, the pyridin-2-yl group, and the pyrimidin-2-yl group may be substituted with a C1-C6 chain hydrocarbon group or a halogen atom}. [Aspect A160] A compound in Aspect A125, wherein D a But, CR 5a R 6a [Aspect A161] In aspect A126, the compound a But, CR 5a R 6a [Aspect A162] In aspect A127, the compound a But, CR 5a R 6a [Aspect A163] In aspect A128, the compound is a But, CR 5a R 6a [Aspect A164] In aspect A129, the compound is a But, CR 5a R 6a [Aspect A165] In aspect A130, the compound a But, CR 5a R 6a [Aspect A166] In aspect A131, the compound a But, CR 5a R 6a [Aspect A167] In aspect A132, the compound a But, CR 5a R 6a [Aspect A168] In aspect A133, the compound is a But, CR 5a R 6a [Aspect A169] In aspect A134, the compound a But, CR 5a R 6a [Aspect A170] In aspect A135, the compound a But, CR 5a R 6a [Aspect A171] In aspect A136, the compound aBut, CR 5a R 6a [Aspect A172] In aspect A137, the compound a But, CR 5a R 6a [Aspect A173] In aspect A138, the compound a But, CR 5a R 6a [Aspect A174] In aspect A139, the compound a But, CR 5a R 6a [Aspect A175] In aspect A140, the compound a But, CR 5a R 6a [Aspect A176] In aspect A141, the compound a But, CR 5a R 6a [Aspect A177] In aspect A142, the compound a But, CR 5a R 6a [Aspect A178] In aspect A143, the compound is a But, CR 5a R 6a [Aspect A179] In aspect A144, the compound a But, CR 5a R 6a [Aspect A180] In aspect A145, the compound a But, CR 5a R 6a [Aspect A181] In aspect A146, the compound a But, CR 5a R 6a [Aspect A182] In aspect A147, the compound a But, CR 5a R 6a [Aspect A183] In aspect A148, the compound is a But, CR 5a R 6a [Aspect A184] In aspect A149, the compound a But, CR 5a R 6a [Aspect A185] In aspect A150, the compounda But, CR 5a R 6a [Aspect A186] In aspect A151, the compound is a But, CR 5a R 6a [Aspect A187] In aspect A152, the compound a But, CR 5a R 6a [Aspect A188] In aspect A153, the compound is a But, CR 5a R 6a [Aspect A189] In aspect A154, the compound a But, CR 5a R 6a [Aspect A190] In aspect A155, the compound a But, CR 5a R 6a [Aspect A191] In aspect A156, the compound is a But, CR 5a R 6a [Aspect A192] In aspect A157, the compound is a But, CR 5a R 6a [Aspect A193] In aspect A158, the compound is a But, CR 5a R 6a [Aspect A194] In aspect A159, the compound is a But, CR 5a R 6a [Aspect A195] In the compound A of the present invention, D a But, CR 5a R 6a [Aspect A196] In aspect A125, the compound a But, CR 5a R 6a and R 5a and R 6a is a hydrogen atom. [Aspect A197] In Aspect A126, a But, CR 5a R 6a and R 5a and R 6ais a hydrogen atom. [Aspect A198] In Aspect A127, a But, CR 5a R 6a and R 5a and R 6a is a hydrogen atom. [Aspect A199] In aspect A128, the compound a But, CR 5a R 6a and R 5a and R 6a is a hydrogen atom. [Aspect A200] In Aspect A129, a But, CR 5a R 6a and R 5a and R 6a is a hydrogen atom. [Aspect A201] In aspect A130, a But, CR 5a R 6a and R 5a and R 6a is a hydrogen atom. [Aspect A202] In Aspect A131, a But, CR 5a R 6a and R 5a and R 6a is a hydrogen atom. [Aspect A203] In Aspect A132, a But, CR 5a R 6a and R 5a and R 6a is a hydrogen atom. [Aspect A204] In Aspect A133, a But, CR 5a R 6a and R 5a and R 6a is a hydrogen atom. [Aspect A205] In Aspect A134, D a But, CR 5a R 6a and R 5a and R 6a is a hydrogen atom. [Aspect A206] In Aspect A135, a But, CR 5a R 6a and R 5a and R6a is a hydrogen atom. [Aspect A207] In Aspect A136, a But, CR 5a R 6a and R 5a and R 6a is a hydrogen atom. [Aspect A208] In Aspect A137, D a But, CR 5a R 6a and R 5a and R 6a is a hydrogen atom. [Aspect A209] In aspect A138, a But, CR 5a R 6a and R 5a and R 6a is a hydrogen atom. [Aspect A210] In Aspect A139, a But, CR 5a R 6a and R 5a and R 6a is a hydrogen atom. [Aspect A211] A compound in Aspect A140, a But, CR 5a R 6a and R 5a and R 6a is a hydrogen atom. [Aspect A212] In Aspect A141, a But, CR 5a R 6a and R 5a and R 6a is a hydrogen atom. [Aspect A213] In aspect A142, a But, CR 5a R 6a and R 5a and R 6a is a hydrogen atom. [Aspect A214] In Aspect A143, a But, CR 5a R 6a and R 5a and R 6a is a hydrogen atom. [Aspect A215] In aspect A144, a But, CR 5a R 6a and R 5aand R 6a is a hydrogen atom. [Aspect A216] In Aspect A145, a But, CR 5a R 6a and R 5a and R 6a is a hydrogen atom. [Aspect A217] A compound according to Aspect A146, wherein D a But, CR 5a R 6a and R 5a and R 6a is a hydrogen atom. [Aspect A218] In Aspect A147, a But, CR 5a R 6a and R 5a and R 6a is a hydrogen atom. [Aspect A219] In aspect A148, the compound a But, CR 5a R 6a and R 5a and R 6a is a hydrogen atom. [Aspect A220] In Aspect A149, D a But, CR 5a R 6a and R 5a and R 6a is a hydrogen atom. [Aspect A221] In Aspect A150, a But, CR 5a R 6a and R 5a and R 6a is a hydrogen atom. [Aspect A222] In Aspect A151, a But, CR 5a R 6a and R 5a and R 6a is a hydrogen atom. [Aspect A223] In Aspect A152, a But, CR 5a R 6a and R 5a and R 6a is a hydrogen atom. [Aspect A224] In Aspect A153, a But, CR 5a R 6a and R5a and R 6a is a hydrogen atom. [Aspect A225] In Aspect A154, D a But, CR 5a R 6a and R 5a and R 6a is a hydrogen atom. [Aspect A226] In Aspect A155, a But, CR 5a R 6a and R 5a and R 6a is a hydrogen atom. [Aspect A227] In Aspect A156, a But, CR 5a R 6a and R 5a and R 6a is a hydrogen atom. [Aspect A228] In Aspect A157, D a But, CR 5a R 6a and R 5a and R 6a is a hydrogen atom. [Aspect A229] In aspect A158, a But, CR 5a R 6a and R 5a and R 6a is a hydrogen atom. [Aspect A230] In Aspect A159, D a But, CR 5a R 6a and R 5a and R 6a is a hydrogen atom. [Aspect A231] Compound A of the present invention, a But, CR 5a R 6a and R 5a and R 6a is a hydrogen atom. [Aspect A232] In Aspect A125, a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. [Aspect A233] In Aspect A126, D a But, CR5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. [Aspect A234] In Aspect A127, D a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. [Aspect A235] In Aspect A128, D a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. [Aspect A236] In Aspect A129, D a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. [Aspect A237] In Aspect A130, D a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. [Aspect A238] In Aspect A131, a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. [Aspect A239] In Aspect A132, D a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. [Aspect A240] In Aspect A133, D a But, CR 5a R 6a and R 5aand R 6a are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. [Aspect A241] In Aspect A134, D a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. [Aspect A242] In Aspect A135, D a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. [Aspect A243] In Aspect A136, D a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. [Aspect A244] In Aspect A137, D a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. [Aspect A245] In Aspect A138, D a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. [Aspect A246] In Aspect A139, D a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. [Aspect A247] In Aspect A140, D a But, CR 5a R 6a and R 5a and R 6aare the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. [Aspect A248] In Aspect A141, D a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. [Aspect A249] In Aspect A142, D a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. [Aspect A250] In Aspect A143, D a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. [Aspect A251] In Aspect A144, D a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. [Aspect A252] In Aspect A145, D a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. [Aspect A253] In Aspect A146, D a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. [Aspect A254] In Aspect A147, D a But, CR 5a R 6a and R 5a and R 6aare the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. [Aspect A255] In Aspect A148, D a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. [Aspect A256] In Aspect A149, D a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. [Aspect A257] In Aspect A150, D a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. [Aspect A258] In Aspect A151, D a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. [Aspect A259] In Aspect A152, D a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. [Aspect A260] In Aspect A153, D a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. [Aspect A261] In Aspect A154, D a But, CR 5a R 6a and R 5a and R 6aare the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. [Aspect A262] In Aspect A155, D a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. [Aspect A263] In Aspect A156, D a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. [Aspect A264] In Aspect A157, D a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. [Aspect A265] In Aspect A158, D a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. [Aspect A266] In Aspect A159, D a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. [Aspect A267] In Compound A of the present invention, D a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. [Aspect A268] In Aspect A125, D a But, CR 5a R 6a and R 5a and R 6aare the same or different and are a hydroxy group or a hydrogen atom. [Aspect A269] In Aspect A126, D a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group or a hydrogen atom. [Aspect A270] In Aspect A127, D a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group or a hydrogen atom. [Aspect A271] In Aspect A128, D a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group or a hydrogen atom. [Aspect A272] In Aspect A129, D a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group or a hydrogen atom. [Aspect A273] In Aspect A130, D a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group or a hydrogen atom. [Aspect A274] In Aspect A131, D a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group or a hydrogen atom. [Aspect A275] In Aspect A132, D a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group or a hydrogen atom. [Aspect A276] In Aspect A133, D a But, CR 5a R6a and R 5a and R 6a are the same or different and are a hydroxy group or a hydrogen atom. [Aspect A277] In Aspect A134, D a But, CR 5a R 6a and R 5a and R 6a and are the same or different and are a hydroxy group or a hydrogen atom. [Aspect A278] In Aspect A135, D a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group or a hydrogen atom. [Aspect A279] In Aspect A136, D a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group or a hydrogen atom. [Aspect A280] In Aspect A137, D a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group or a hydrogen atom. [Aspect A281] In Aspect A138, D a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group or a hydrogen atom. [Aspect A282] In Aspect A139, D a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group or a hydrogen atom. [Aspect A283] In Aspect A140, D a But, CR 5a R 6a and R 5a and R 6aare the same or different and are a hydroxy group or a hydrogen atom. [Aspect A284] In Aspect A141, D a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group or a hydrogen atom. [Aspect A285] In Aspect A142, D a But, CR 5a R 6a and R 5a and R 6a and are the same or different and are a hydroxy group or a hydrogen atom. [Aspect A286] In Aspect A143, D a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group or a hydrogen atom. [Aspect A287] In Aspect A144, D a But, CR 5a R 6a and R 5a and R 6a and are the same or different and are a hydroxy group or a hydrogen atom. [Aspect A288] In Aspect A145, D a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group or a hydrogen atom. [Aspect A289] In Aspect A146, D a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group or a hydrogen atom. [Aspect A290] In Aspect A147, D a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group or a hydrogen atom. [Aspect A291] In Aspect A148, D a But, CR 5a R6a and R 5a and R 6a are the same or different and are a hydroxy group or a hydrogen atom. [Aspect A292] In Aspect A149, D a But, CR 5a R 6a and R 5a and R 6a and are the same or different and are a hydroxy group or a hydrogen atom. [Aspect A293] In Aspect A150, D a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group or a hydrogen atom. [Aspect A294] In Aspect A151, D a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group or a hydrogen atom. [Aspect A295] In Aspect A152, D a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group or a hydrogen atom. [Aspect A296] In Aspect A153, D a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group or a hydrogen atom. [Aspect A297] In Aspect A154, D a But, CR 5a R 6a and R 5a and R 6a and are the same or different and are a hydroxy group or a hydrogen atom. [Aspect A298] In Aspect A155, D a But, CR 5a R 6a and R 5a and R 6aare the same or different and are a hydroxy group or a hydrogen atom. [Aspect A299] In Aspect A156, D a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group or a hydrogen atom. [Aspect A300] In Aspect A157, D a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group or a hydrogen atom. [Aspect A301] In Aspect A158, D a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group or a hydrogen atom. [Aspect A302] In Aspect A159, D a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group or a hydrogen atom. [Aspect A303] In Compound A of the present invention, D a But, CR 5a R 6a and R 5a and R 6a and are the same or different and are a hydroxy group or a hydrogen atom. [Aspect A304] A compound in which, in Compound A of the present invention or any of A1 to A124, A ais a 1,2,3-triazol-2-yl group, an oxazol-2-yl group, a thiazol-2-yl group, a 1,2,4-oxadiazol-3-yl group, a 1,2,4-thiadiazol-3-yl group, a pyridin-2-yl group, or a pyrimidin-2-yl group {the 1,2,3-triazol-2-yl group, the oxazol-2-yl group, the thiazol-2-yl group, the 1,2,4-oxadiazol-3-yl group, the 1,2,4-thiadiazol-3-yl group, the pyridin-2-yl group, and the pyrimidin-2-yl group may be substituted with a C1-C6 chain hydrocarbon group}. [Aspect A305] A compound in which, in Compound A of the present invention or any of A1 to A124, A a is a 1,2,3-triazol-2-yl group, a 1,2,4-oxadiazol-3-yl group, a 1,2,4-thiadiazol-3-yl group, a pyridin-2-yl group, or a pyrimidin-2-yl group {the 1,2,3-triazol-2-yl group, the 1,2,4-oxadiazol-3-yl group, the 1,2,4-thiadiazol-3-yl group, the pyridin-2-yl group, and the pyrimidin-2-yl group may be substituted with a C1-C6 chain hydrocarbon group}. [Aspect A306] A compound in which, in Compound A of the present invention or any of A1 to A124, A a is a 1,2,3-triazol-2-yl group, an oxazol-2-yl group, a thiazol-2-yl group, a 1,2,4-oxadiazol-3-yl group, a pyridin-2-yl group, or a pyrimidin-2-yl group {the 1,2,3-triazol-2-yl group, the oxazol-2-yl group, the thiazol-2-yl group, the 1,2,4-oxadiazol-3-yl group, the pyridin-2-yl group, and the pyrimidin-2-yl group may be substituted with a C1-C6 chain hydrocarbon group}. [Aspect A307] A compound in which, in Compound A of the present invention or any of A1 to A124, A ais a 1,2,3-triazol-2-yl group, a 1,2,4-oxadiazol-3-yl group, a pyridin-2-yl group, or a pyrimidin-2-yl group {the 1,2,3-triazol-2-yl group, the 1,2,4-oxadiazol-3-yl group, the pyridin-2-yl group, and the pyrimidin-2-yl group may be substituted with a C1-C6 chain hydrocarbon group or a halogen atom}. [Aspect A308] A compound in Aspect A304, wherein D a But, CR 5a R 6a and R 5a and R 6a is a hydrogen atom. [Aspect A309] In Aspect A304, a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. [Aspect A310] In Aspect A304, D a But, CR 5a R 6a and R 5a and R 6a and are the same or different and are a hydroxy group or a hydrogen atom. a But, CR 5a R 6a and R 5a and R 6a is a hydrogen atom. [Aspect A312] In Aspect A305, a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. [Aspect A313] In Aspect A305, D a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group or a hydrogen atom. [Aspect A314] In Aspect A306, D a But, CR 5a R 6aand R 5a and R 6a is a hydrogen atom. [Aspect A315] In Aspect A306, a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. [Aspect A316] In Aspect A306, D a But, CR 5a R 6a and R 5a and R 6a and are the same or different and are a hydroxy group or a hydrogen atom. [Aspect A317] In Aspect A307, D a But, CR 5a R 6a and R 5a and R 6a is a hydrogen atom. [Aspect A318] A compound according to Aspect A307, wherein D a But, CR 5a R 6a and R 5a and R 6a are the same or different and are a hydroxy group, a halogen atom, or a hydrogen atom. [Aspect A319] In Aspect A307, D a But, CR 5a R 6a and R 5a and R 6a and are the same or different and are a hydroxy group or a hydrogen atom. [Aspect A320] In Compound A of the present invention, A a is a 1,2,3-triazol-2-yl group, a 1,2,4-oxadiazol-3-yl group, a 1,2,4-thiadiazol-3-yl group, a pyridin-2-yl group, or a pyrimidin-2-yl group (the 1,2,3-triazol-2-yl group, the 1,2,4-oxadiazol-3-yl group, the 1,2,4-thiadiazol-3-yl group, the pyridin-2-yl group, and the pyrimidin-2-yl group may be substituted with a C1-C6 chain hydrocarbon group), and D a But, CR 5a R 6a and R 5a and R6a are the same or different and are a hydroxy group or a hydrogen atom, and Z a Group A 3a a 5- or 6-membered aromatic heterocyclic group (excluding 1,2,4-triazine-3,5(2H,4H)-dione-2-yl group) optionally substituted by one or more substituents selected from the above; a C3-C6 alicyclic hydrocarbon group (the C3-C6 alicyclic hydrocarbon group may be substituted with a cyano group or a cyclopropyl group); a pyrrolidonyl group (the pyrrolidonyl group may be substituted with a C1-C4 chain hydrocarbon group); a piperidonyl group; OR 8a , S.R. 9a , S(O)R 10a , S(O)R 11a , or NR 13a R 14a and R 8a But Group I a2 a methyl group, a C3-C6 chain hydrocarbon group, a C3-C6 alicyclic hydrocarbon group, or a phenyl group, each of which is substituted with one or more substituents selected from the group consisting of 9a , R 10a , and R 11a are the same or different and are a C3-C6 chain hydrocarbon group or a C3-C6 alicyclic hydrocarbon group, and R 13a is a (C3-C6 cycloalkyl)carbonyl group or a C1-C6 alkylsulfonyl group, and R 14a is a C1-C6 chain hydrocarbon group or a hydrogen atom. a2 : The group consisting of C3-C6 alicyclic hydrocarbon groups and C5-C6 non-aromatic heterocyclic groups.

[0020] The following compounds are also examples of Compound A of the present invention.

[0021] [Aspect AX1] In the compound A of the present invention, Z a is a 5- to 7-membered aromatic heterocycle {the 5- to 7-membered aromatic heterocycle is a group A 3a and optionally substituted with one or more substituents selected from the following} (excluding 1,2,4-triazine-3,5(2H,4H)-dione-2-yl group), a C3-C8 alicyclic hydrocarbon group {the C3-C8 alicyclic hydrocarbon group is a group selected from the group B 2aor a 3- to 8-membered non-aromatic heterocyclic group {which may be substituted with one or more substituents selected from group B 3a and optionally substituted with one or more substituents selected from the group consisting of (but excluding 4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl group), a C2-C6 chain hydrocarbon group, OR 8a , S.R. 9a , S(O)R 10a , S(O)R 11a , C(O)R 12a , or NR 13a R 14a and R 8a But Group I 3a a methyl group, a C2-C6 chain hydrocarbon group, a (C2-C8 dialkylamino)carbonyl group, a C3-C6 alicyclic hydrocarbon group, a 3- to 6-membered non-aromatic heterocyclic group, or a phenyl group, each of which is substituted with one or more substituents selected from the group consisting of 9a is a C3-C6 chain hydrocarbon group or a C3-C8 alicyclic hydrocarbon group, and R 10a , and R 11a are the same or different and are a C1-C6 chain hydrocarbon group or a C3-C8 alicyclic hydrocarbon group, and R 12a is a 3- to 8-membered non-aromatic heterocyclic group, and R 13a is a C3-C6 chain hydrocarbon group or a C1-C6 alkylsulfonyl group, and R 14a is a C1-C6 chain hydrocarbon group, a (C1-C6 alkylamino)carbonyl group, or a hydrogen atom. [Aspect AX2] Compound A of the present invention, a Group A 3a a 5- or 6-membered aromatic heterocyclic group (excluding 1,2,4-triazine-3,5(2H,4H)-dione-2-yl group) optionally substituted by one or more substituents selected from the above; a C3-C6 alicyclic hydrocarbon group (the C3-C6 alicyclic hydrocarbon group may be substituted with a cyano group or a cyclopropyl group); a pyrrolidonyl group (the pyrrolidonyl group may be substituted with a C1-C4 chain hydrocarbon group); a piperidonyl group; OR 8a , S.R. 9a , S(O)R 10a , S(O)R 11a , or NR 13a R14a and R 8a But Group I a2 a methyl group, a C3-C6 chain hydrocarbon group, a C3-C6 alicyclic hydrocarbon group, or a phenyl group, each of which is substituted with one or more substituents selected from the group consisting of 9a , R 10a , and R 11a are the same or different and are a C3-C6 chain hydrocarbon group or a C3-C6 alicyclic hydrocarbon group, and R 13a is a (C3-C6 cycloalkyl)carbonyl group or a C1-C6 alkylsulfonyl group, and R 14a is a C1-C6 chain hydrocarbon group or a hydrogen atom. a is CR 5a R 6a and R 5a and R 6a The combination of 5a is a hydrogen atom, and R 6a is a hydrogen atom; 5a is a hydrogen atom, and R 6a is a hydroxy group; or R 5a is a hydrogen atom, and R 6a and are a halogen atom. [Aspect AX4] In Compound A of the present invention, D a is CR 5a R 6a and R 5a and R 6a The combination of 5a is a hydrogen atom, and R 6a is a hydrogen atom; or R 5a is a hydrogen atom, and R 6a and is a hydroxy group. [Aspect AX5] In aspect AX1, D a is CR 5a R 6a and R 5a and R 6a The combination of 5a is a hydrogen atom, and R 6a is a hydrogen atom; 5a is a hydrogen atom, and R 6a is a hydroxy group; or R 5ais a hydrogen atom, and R 6a and is a halogen atom. [Aspect AX6] In aspect AX1, D a is CR 5a R 6a and R 5a and R 6a The combination of 5a is a hydrogen atom, and R 6a is a hydrogen atom; or R 5a is a hydrogen atom, and R 6a and is a hydroxy group. [Aspect AX7] In aspect AX2, D a is CR 5a R 6a and R 5a and R 6a The combination of 5a is a hydrogen atom, and R 6a is a hydrogen atom; 5a is a hydrogen atom, and R 6a is a hydroxy group; or R 5a is a hydrogen atom, and R 6a and is a halogen atom. [Aspect AX8] In aspect AX2, D a is CR 5a R 6a and R 5a and R 6a The combination of 5a is a hydrogen atom, and R 6a is a hydrogen atom; or R 5a is a hydrogen atom, and R 6a and X is a hydroxy group. a is a fluorine atom. [Aspect AX10] In aspect AX1, X a is a fluorine atom. [Aspect AX11] In aspect AX2, X a is a fluorine atom. [Aspect AX12] In aspect AX3, X a is a fluorine atom. [Aspect AX13] In aspect AX4, X a is a fluorine atom. [Aspect AX14] In aspect AX5, X ais a fluorine atom. [Aspect AX15] In aspect AX6, X a is a fluorine atom. [Aspect AX16] In aspect AX7, X a is a fluorine atom. [Aspect AX17] In aspect AX8, X a is a fluorine atom. [Aspect AX18] In the compound A of the present invention, X 2a and X 3a is a hydrogen atom. [Aspect AX19] In aspect AX1, X 2a and X 3a is a hydrogen atom. [Aspect AX20] In aspect AX2, X 2a and X 3a is a hydrogen atom. [Aspect AX21] In aspect AX3, X 2a and X 3a is a hydrogen atom. [Aspect AX22] In aspect AX4, X 2a and X 3a is a hydrogen atom. [Aspect AX23] In aspect AX5, X 2a and X 3a is a hydrogen atom. [Aspect AX24] In aspect AX6, X 2a and X 3a is a hydrogen atom. [Aspect AX25] In aspect AX7, X 2a and X 3a is a hydrogen atom. [Aspect AX26] In aspect AX8, X 2a and X 3a is a hydrogen atom. [Aspect AX27] In aspect AX9, X 2a and X 3a is a hydrogen atom. [Aspect AX28] In aspect AX10, X 2a and X 3a is a hydrogen atom. [Aspect AX29] In aspect AX11, X 2a and X 3a is a hydrogen atom. [Aspect AX30] In aspect AX12, X 2a and X 3a is a hydrogen atom. [Aspect AX31] In aspect AX13, X 2a and X 3ais a hydrogen atom. [Aspect AX32] In aspect AX14, X 2a and X 3a is a hydrogen atom. [Aspect AX33] In aspect AX15, X 2a and X 3a is a hydrogen atom. [Aspect AX34] In aspect AX16, X 2a and X 3a is a hydrogen atom. [Aspect AX35] In aspect AX17, X 2a and X 3a is a hydrogen atom. [Aspect AX36] In the compound A of the present invention, X 1a is a hydrogen atom or a fluorine atom. [Aspect AX37] In aspect AX1, X 1a is a hydrogen atom or a fluorine atom. [Aspect AX38] In aspect AX2, X 1a is a hydrogen atom or a fluorine atom. [Aspect AX39] In aspect AX3, X 1a is a hydrogen atom or a fluorine atom. [Aspect AX40] In aspect AX4, X 1 is a hydrogen atom or a fluorine atom. [Aspect AX41] In aspect AX5, X 1a is a hydrogen atom or a fluorine atom. [Aspect AX42] In aspect AX6, X 1a is a hydrogen atom or a fluorine atom. [Aspect AX43] In aspect AX7, X 1a is a hydrogen atom or a fluorine atom. [Aspect AX44] In aspect AX8, X 1a is a hydrogen atom or a fluorine atom. [Aspect AX45] In aspect AX9, X 1a is a hydrogen atom or a fluorine atom. [Aspect AX46] In aspect AX10, X 1a is a hydrogen atom or a fluorine atom. [Aspect AX47] In aspect AX11, X 1a is a hydrogen atom or a fluorine atom. [Aspect AX48] In aspect AX12, X 1a is a hydrogen atom or a fluorine atom. [Aspect AX49] In aspect AX13, X 1ais a hydrogen atom or a fluorine atom. [Aspect AX50] In aspect AX14, X 1a is a hydrogen atom or a fluorine atom. [Aspect AX51] In aspect AX15, X 1a is a hydrogen atom or a fluorine atom. [Aspect AX52] In aspect AX16, X 1a is a hydrogen atom or a fluorine atom. [Aspect AX53] In aspect AX17, X 1a is a hydrogen atom or a fluorine atom. [Aspect AX54] In aspect AX18, X 1a is a hydrogen atom or a fluorine atom. [Aspect AX55] In aspect AX19, X 1a is a hydrogen atom or a fluorine atom. [Aspect AX56] In aspect AX20, X 1a is a hydrogen atom or a fluorine atom. [Aspect AX57] In aspect AX21, X 1a is a hydrogen atom or a fluorine atom. [Aspect AX58] In aspect AX22, X 1a is a hydrogen atom or a fluorine atom. [Aspect AX59] In aspect AX23, X 1a is a hydrogen atom or a fluorine atom. [Aspect AX60] In aspect AX24, X 1a is a hydrogen atom or a fluorine atom. [Aspect AX61] In aspect AX25, X 1a is a hydrogen atom or a fluorine atom. [Aspect AX62] In aspect AX26, X 1a is a hydrogen atom or a fluorine atom. [Aspect AX63] In aspect AX27, X 1a is a hydrogen atom or a fluorine atom. [Aspect AX64] In aspect AX28, X 1a is a hydrogen atom or a fluorine atom. [Aspect AX65] In aspect AX29, X 1a is a hydrogen atom or a fluorine atom. [Aspect AX66] In aspect AX30, X 1a is a hydrogen atom or a fluorine atom. [Aspect AX67] In aspect AX31, X 1a is a hydrogen atom or a fluorine atom. [Aspect AX68] In aspect AX32, X1a is a hydrogen atom or a fluorine atom. [Aspect AX69] In aspect AX33, X 1a is a hydrogen atom or a fluorine atom. [Aspect AX70] In aspect AX34, X 1a is a hydrogen atom or a fluorine atom. [Aspect AX71] In aspect AX35, X 1a is a hydrogen atom or a fluorine atom. [Aspect AX72] In the compound A of the present invention, X 1a is a fluorine atom. [Aspect AX73] In aspect AX1, X 1a is a fluorine atom. [Aspect AX74] In aspect AX2, X 1a is a fluorine atom. [Aspect AX75] In aspect AX3, X 1a is a fluorine atom. [Aspect AX76] In aspect AX4, X 1a is a fluorine atom. [Aspect AX77] In aspect AX5, X 1a is a fluorine atom. [Aspect AX78] In aspect AX6, X 1a is a fluorine atom. [Aspect AX79] In aspect AX7, X 1a is a fluorine atom. [Aspect AX80] In aspect AX8, X 1a is a fluorine atom. [Aspect AX81] In aspect AX9, X 1a is a fluorine atom. [Aspect AX82] In aspect AX10, X 1a is a fluorine atom. [Aspect AX83] In aspect AX11, X 1a is a fluorine atom. [Aspect AX84] In aspect AX12, X 1a is a fluorine atom. [Aspect AX85] In aspect AX13, X 1a is a fluorine atom. [Aspect AX86] In aspect AX14, X 1a is a fluorine atom. [Aspect AX87] In aspect AX15, X 1a is a fluorine atom. [Aspect AX88] In aspect AX16, X 1a is a fluorine atom. [Aspect AX89] In aspect AX17, X1a is a fluorine atom. [Aspect AX90] In aspect AX18, X 1a is a fluorine atom. [Aspect AX91] In aspect AX19, X 1a is a fluorine atom. [Aspect AX92] In aspect AX20, X 1a is a fluorine atom. [Aspect AX93] In aspect AX21, X 1a is a fluorine atom. [Aspect AX94] In aspect AX22, X 1a is a fluorine atom. [Aspect AX95] In aspect AX23, X 1a is a fluorine atom. [Aspect AX96] In aspect AX24, X 1a is a fluorine atom. [Aspect AX97] In aspect AX25, X 1a is a fluorine atom. [Aspect AX98] In aspect AX26, X 1a is a fluorine atom. [Aspect AX99] In aspect AX27, X 1a is a fluorine atom. [Aspect AX100] In aspect AX28, X 1a is a fluorine atom. [Aspect AX101] In aspect AX29, X 1a is a fluorine atom. [Aspect AX102] In aspect AX30, X 1a is a fluorine atom. [Aspect AX103] In aspect AX31, X 1a is a fluorine atom. [Aspect AX104] In aspect AX32, X 1a is a fluorine atom. [Aspect AX105] In aspect AX33, X 1a is a fluorine atom. [Aspect AX106] In aspect AX34, X 1a is a fluorine atom. [Aspect AX107] In aspect AX35, X 1a is a fluorine atom. [Aspect AX108] In the compound A of the present invention or any of aspects AX1 to AX107, A a is a group represented by the formula H1, H3 or H4. [Aspect AX109] Compounds of the present invention in which A is a group represented by the formula H1, H3 or H4.a is a group represented by formula H1, H3 or H4, and G 2 is CH and G 3 is CH and G 4 is CH and G 5 is a nitrogen atom or CH, and G 1 is CH and R 1a is a hydrogen atom, and R 4a is a C1-C6 chain hydrocarbon group or a hydrogen atom. [Aspect AX110] A compound in which, in Compound A of the present invention or any of Aspects AX1 to AX107, A a is a group represented by the formula H1 or H4. [Aspect AX111] A compound in which, in Compound A of the present invention or any of Aspects AX1 to AX107, A a is a 1,2,3-triazol-2-yl group, an oxazol-2-yl group, a thiazol-2-yl group, a 1,2,4-oxadiazol-3-yl group, a 1,2,4-thiadiazol-3-yl group, a pyridin-2-yl group, or a pyrimidin-2-yl group {the 1,2,3-triazol-2-yl group, the oxazol-2-yl group, the thiazol-2-yl group, the 1,2,4-oxadiazol-3-yl group, the 1,2,4-thiadiazol-3-yl group, the pyridin-2-yl group, and the pyrimidin-2-yl group may be substituted with a C1-C6 chain hydrocarbon group or a halogen atom}. [Aspect AX112] A compound according to Compound A of the present invention or any of Aspects AX1 to AX107, wherein A a is a 1,2,3-triazol-2-yl group, a 1,2,4-oxadiazol-3-yl group, a 1,2,4-thiadiazol-3-yl group, a pyridin-2-yl group, or a pyrimidin-2-yl group {the 1,2,3-triazol-2-yl group, the 1,2,4-oxadiazol-3-yl group, the 1,2,4-thiadiazol-3-yl group, the pyridin-2-yl group, and the pyrimidin-2-yl group may be substituted with a C1-C6 chain hydrocarbon group or a halogen atom}. [Aspect AX113] A compound according to Compound A of the present invention or any of Aspects AX1 to AX107, wherein A ais a 1,2,3-triazol-2-yl group, an oxazol-2-yl group, a thiazol-2-yl group, a 1,2,4-oxadiazol-3-yl group, a pyridin-2-yl group, or a pyrimidin-2-yl group {the 1,2,3-triazol-2-yl group, the oxazol-2-yl group, the thiazol-2-yl group, the 1,2,4-oxadiazol-3-yl group, the pyridin-2-yl group, and the pyrimidin-2-yl group may be substituted with a C1-C6 chain hydrocarbon group or a halogen atom}. [Aspect AX114] A compound according to Compound A of the present invention or any of Aspects AX1 to AX107, wherein A a is a 1,2,3-triazol-2-yl group, a 1,2,4-oxadiazol-3-yl group, a pyridin-2-yl group, or a pyrimidin-2-yl group {the 1,2,3-triazol-2-yl group, the 1,2,4-oxadiazol-3-yl group, the pyridin-2-yl group, and the pyrimidin-2-yl group may be substituted with a C1-C6 chain hydrocarbon group or a halogen atom}. [Aspect AX115] A compound according to Compound A of the present invention or any of Aspects AX1 to AX107, wherein A a is a 1,2,3-triazol-2-yl group, a 1,2,4-oxadiazol-3-yl group, a 1,2,4-thiadiazol-3-yl group, a pyridin-2-yl group, or a pyrimidin-2-yl group {the 1,2,3-triazol-2-yl group, the 1,2,4-oxadiazol-3-yl group, the 1,2,4-thiadiazol-3-yl group, the pyridin-2-yl group, and the pyrimidin-2-yl group may be substituted with a C1-C6 chain hydrocarbon group}.

[0022] Next, the method for producing the present compound (including the compound of the present invention) will be described.

[0023] Production Method A The compound represented by formula (IA) (hereinafter referred to as compound (IA)) can be produced by reacting a compound represented by formula (B1) (hereinafter referred to as compound (B1)) with a compound represented by formula (M1) (hereinafter referred to as compound (M1)) in the presence of a palladium catalyst. [In the formula, X 51represents a chlorine atom, a bromine atom, an iodine atom, or a triflyloxy group; Met 51 represents B(OH)2, 4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl group, tributylstannyl group, ZnBr, MgBr, or MgCl; A 1is a methyl group substituted with one or more substituents selected from Group D, a C2-C6 chain hydrocarbon group optionally substituted with one or more substituents selected from Group C, a 5- to 7-membered aromatic heterocycle optionally substituted with one or more substituents selected from Group A {any two adjacent atoms not bonded to the benzene ring substituted with X among the atoms constituting the 5- to 7-membered aromatic heterocyclic group are replaced by another C4-C7 alicyclic hydrocarbon containing the two adjacent atoms, a 4- to 7-membered non-aromatic heterocycle {the C4-C7 alicyclic hydrocarbon and the 4- to 7-membered non-aromatic heterocycle are and a C3-C8 alicyclic hydrocarbon group or a 3- to 8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group may be substituted with one or more substituents selected from Group B}, a benzene ring or a 5- to 6-membered aromatic heterocyclic ring {the benzene ring and the 5- to 6-membered aromatic heterocyclic ring may be substituted with one or more substituents selected from Group A}}, a C3-C8 alicyclic hydrocarbon group or a 3- to 8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group may be substituted with one or more substituents selected from Group B, and the atoms constituting the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group Any atom not bonded to the benzene ring substituted with X among the atoms constituting the C3-C8 alicyclic hydrocarbon group and the 3-8 membered non-aromatic heterocyclic group may form a C3-C7 alicyclic hydrocarbon or a 3-7 membered non-aromatic heterocycle as a spiro atom, and any two adjacent atoms not bonded to the benzene ring substituted with X among the atoms constituting the C3-C8 alicyclic hydrocarbon group and the 3-8 membered non-aromatic heterocyclic group may form another C4-C7 alicyclic hydrocarbon, 4-7 membered non-aromatic heterocycle containing the two adjacent atoms {the C4-C7 alicyclic hydrocarbon and the 4-7 membered non-aromatic heterocycle may be one or more substituted groups selected from Group B group}, a benzene ring, or a 5- or 6-membered aromatic heterocycle {the benzene ring and the 5- or 6-membered aromatic heterocycle may be substituted with one or more substituents selected from Group A}, and any two atoms that are not adjacent to each other among the atoms constituting the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group (provided that neither of the two atoms is bonded to the benzene ring substituted with X) may be bridged by —CH— or —(CH)—} (provided that A 1 In Met 51or the atom bonded to the benzene ring in compound (IA) is a carbon atom), and other symbols have the same meanings as above.] The reaction is usually carried out in a solvent. Examples of the solvent used in the reaction include hydrocarbons such as hexane, toluene, and xylene (hereinafter referred to as hydrocarbons); ethers such as methyl tert-butyl ether (hereinafter referred to as MTBE), tetrahydrofuran (hereinafter referred to as THF), and 1,2-dimethoxyethane (hereinafter referred to as DME) (hereinafter referred to as ethers); halogenated hydrocarbons such as dichloromethane, chloroform, and chlorobenzene (hereinafter referred to as halogenated hydrocarbons); amides such as dimethylformamide (hereinafter referred to as DMF) and N-methylpyrrolidone (hereinafter referred to as NMP) (hereinafter referred to as amides); esters such as methyl acetate and ethyl acetate (hereinafter referred to as esters); nitriles such as acetonitrile and propionitrile (hereinafter referred to as nitriles); dimethyl sulfoxide (hereinafter referred to as DMSO); water; and mixtures of two or more thereof. Examples of palladium catalysts used in the reaction include palladium(II) acetate and [1,1'-bis(diphenylphosphino)ferrocene]palladium(II) dichloride. A base may be added to the reaction, if necessary. Examples of bases used in the reaction, if necessary, include organic bases such as triethylamine and pyridine (hereinafter referred to as organic bases); alkali metal carbonates such as sodium carbonate and potassium carbonate (hereinafter referred to as alkali metal carbonates); alkali metal bicarbonates such as sodium bicarbonate and potassium bicarbonate (hereinafter referred to as alkali metal bicarbonates); sodium fluoride; and tripotassium phosphate. In the reaction, compound (M1) is typically used in a ratio of 0.5 to 2 moles, a palladium catalyst is typically used in a ratio of 0.01 to 0.3 moles, and a base is typically used in a ratio of 1 to 10 moles, relative to 1 mole of compound (B1). The reaction temperature is typically in the range of 0 to 150°C. The reaction time is typically in the range of 0.1 to 120 hours. After completion of the reaction, compound (IA) can be isolated by post-treatment such as adding water to the reaction mixture, extracting with an organic solvent, and drying and concentrating the obtained organic layer. Compound (M1) is known or can be produced according to a known method.

[0024] Production Method B Compound (IA) can also be produced by reacting a compound represented by formula (B2) (hereinafter referred to as compound (B2)) with a compound represented by formula (M2) (hereinafter referred to as compound (M2)) in the presence of a palladium catalyst. [wherein the symbols have the same meanings as above (provided that A 1 In this case, X 51 Or, the atom bonded to the benzene ring shown in compound (IA) is a carbon atom.) The reaction can be carried out in accordance with Production Method A, using compound (M2) instead of compound (B1) and compound (B2) instead of compound (M1). Compound (M2) is known or can be produced in accordance with a known method.

[0025] Production Method C The compound represented by formula (IB) (hereinafter referred to as compound (IB)) can be produced by reacting compound (B1) with a compound represented by formula (M3) (hereinafter referred to as compound (M3)) in the presence of a copper catalyst and a base. [In the ceremony, Z 51 is OR 5 , S.R. 6 , or NR 11 R 12The other symbols have the same meanings as above.] The reaction is usually carried out in a solvent. Examples of solvents used in the reaction include hydrocarbons, ethers, halogenated hydrocarbons, amides, esters, nitriles, DMSO, water, and mixtures of two or more thereof. Examples of copper catalysts used in the reaction include copper(I) iodide and copper(I) bromide. A ligand may be added to the reaction as needed. Examples of ligands used in the reaction as needed include diamines (hereinafter referred to as diamines) such as N,N'-dimethylethylenediamine and trans-N,N'-dimethylcyclohexane-1,2-diamine; and amino acid derivatives such as N-methylglycine. When a ligand is used in the reaction, the ligand is usually used in a ratio of 0.01 to 4.0 moles per mole of compound (B1). Examples of bases used in the reaction include organic bases, alkali metal carbonates, alkali metal hydrogencarbonates, and tripotassium phosphate. Relative to 1 mole of compound (B1), compound (M3) is typically used in a ratio of 0.5 to 2 moles, copper catalyst typically in a ratio of 0.01 to 0.5 moles, and base typically in a ratio of 1 to 10 moles. The reaction temperature is typically in the range of 0 to 150°C. The reaction time is typically in the range of 0.1 to 120 hours. After completion of the reaction, compound (IB) can be isolated by adding water to the reaction mixture, extracting with an organic solvent, and performing post-treatment such as drying and concentrating the resulting organic layer. Compound (M3) is known or can be produced according to a known method.

[0026] Production Method C-1 The compound represented by formula (IC) (hereinafter referred to as compound (IC)) can be produced by reacting compound (B3) with a compound represented by formula (M3-1) (hereinafter referred to as compound (M3-1)) in the presence of a copper catalyst and a base. [In the formula, ring A 10a 5-7-membered aromatic nitrogen-containing heterocycle optionally substituted with one or more substituents selected from Group A {among the atoms constituting the 5-7-membered aromatic nitrogen-containing heterocycle, any two adjacent atoms not bonded to the benzene ring substituted with X may form another C4-C7 alicyclic hydrocarbon containing the two adjacent atoms, a 4-7-membered non-aromatic heterocycle {the C4-C7 alicyclic hydrocarbon and the 4-7-membered non-aromatic heterocycle may be substituted with one or more substituents selected from Group B}, a benzene ring, or a 5-6-membered aromatic heterocycle {the benzene ring and the 5-6-membered aromatic heterocycle may be substituted with one or more substituents selected from Group A}}, a 3-8-membered non-aromatic nitrogen-containing heterocycle {the 3-8-membered non-aromatic nitrogen-containing heterocycle may be substituted with one or more substituents selected from Group B, and among the atoms constituting the 3-8-membered non-aromatic nitrogen-containing heterocycle, any atom not bonded to the benzene ring substituted with X may be substituted as a spiro atom with a C3-C7 alicyclic hydrocarbon, a 4-7-membered non-aromatic heterocycle {the C4-C7 alicyclic hydrocarbon and the 4-7-membered non-aromatic heterocycle may be substituted with one or more substituents selected from Group B}, a benzene ring, or a 5-6-membered aromatic heterocycle {the benzene ring and the 5-6-membered aromatic heterocycle may be substituted with one or more substituents selected from Group A}} any two adjacent atoms not bonded to the benzene ring substituted with X among the atoms constituting the 3-8 membered non-aromatic nitrogen-containing heterocycle may form another C4-C7 alicyclic hydrocarbon, 4-7 membered non-aromatic heterocycle (the C4-C7 alicyclic hydrocarbon and the 4-7 membered non-aromatic heterocycle may be substituted with one or more substituents selected from Group B), a benzene ring, or a 5-6 membered aromatic heterocycle (the benzene ring and the 5-6 membered aromatic heterocycle may be substituted with one or more substituents selected from Group A), and any two atoms not adjacent to each other among the atoms constituting the 3-8 membered non-aromatic nitrogen-containing heterocycle (with the proviso that neither of the two atoms is bonded to the benzene ring substituted with X) may be bridged by -CH- or -(CH)-; other symbols have the same meanings as above. The reaction can be carried out using compound (M3-1) instead of compound (M3) according to Production Method C. Compound (M3-1) is known or can be produced according to a known method.

[0027] Production Method D A compound represented by formula (ID) (hereinafter referred to as compound (ID)) can be produced by reacting a compound represented by formula (B3) (hereinafter referred to as compound (B3)) with a compound represented by formula (M4) (hereinafter referred to as compound (M4)) in the presence of a base. [In the formula, X 91 is an oxygen atom, NH, or NR 92 represents R 91 and R 92 are the same or different and represent a C1-C7 chain hydrocarbon group optionally substituted with one or more substituents selected from Group C, or a hydrogen atom; other symbols have the same meanings as above.] The reaction is usually carried out in a solvent. Examples of solvents used in the reaction include hydrocarbons, ethers, halogenated hydrocarbons, amides, esters, nitriles, DMSO, and mixtures of two or more thereof. Examples of bases used in the reaction include organic bases, alkali metal carbonates, alkali metal bicarbonates, and tripotassium phosphate. In the reaction, compound (M4) is usually used in a ratio of 0.5 to 10 moles and a base is usually used in a ratio of 1 to 10 moles per mole of compound (B3). The reaction temperature is usually in the range of 0 to 80°C. The reaction time is usually in the range of 0.1 to 120 hours. After completion of the reaction, compound (ID) can be isolated by adding water to the reaction mixture, extracting with an organic solvent, and performing post-treatment such as drying and concentrating the obtained organic layer. Compound (M4) is known or can be produced according to a known method.

[0028] Production Method E The compound represented by formula (IE) (hereinafter referred to as compound (IE)) can be produced by reacting compound (B3) with a compound represented by formula (M5) (hereinafter referred to as compound (M5)). [In the formula, X 92 represents a chlorine atom or a bromine atom, R 93represents a C1-C6 chain hydrocarbon group optionally substituted with one or more substituents selected from Group C, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group may be substituted with one or more substituents selected from Group B}, a phenyl group, a 5- to 6-membered aromatic heterocyclic group {the phenyl group and the 5- to 6-membered aromatic heterocyclic group may be substituted with one or more substituents selected from Group A} (provided that R 93 (wherein the atom bonded to Mg or the carbonyl group in compound (I-E) is a carbon atom), and other symbols have the same meanings as above.) The reaction is usually carried out in a solvent. Examples of solvents used in the reaction include hydrocarbons, ethers, and mixtures of two or more thereof. In the reaction, compound (M5) is usually used in a ratio of 0.5 to 5 moles per mole of compound (B3). The reaction temperature is usually in the range of −78°C to 150°C. The reaction time is usually in the range of 0.1 to 120 hours. After completion of the reaction, compound (I-E) can be isolated by adding water to the reaction mixture, extracting with an organic solvent, and performing post-treatment such as drying and concentrating the obtained organic layer. Compound (M5) is known or can be produced by a method similar to that known.

[0029] Production Method E-1 The compound represented by formula (IF) (hereinafter referred to as compound (IF)) can be produced by reacting compound (B3) with a compound represented by formula (M6) (hereinafter referred to as compound (M6)) in the presence of a base. [In the formula, ring A 12represents a 3-8-membered non-aromatic nitrogen-containing heterocyclic group optionally substituted with one or more substituents selected from Group B, or a 5-6-membered aromatic nitrogen-containing heterocyclic group optionally substituted with one or more substituents selected from Group A, and the other symbols have the same meanings as above.] The reaction is usually carried out in a solvent. Examples of solvents used in the reaction include hydrocarbons, ethers, halogenated hydrocarbons, amides, esters, nitriles, DMSO, and mixtures of two or more thereof. Examples of bases used in the reaction include organic bases, alkali metal carbonates, alkali metal hydrogencarbonates, and tripotassium phosphate. In the reaction, compound (M6) is usually used in a ratio of 0.5 to 10 moles, and a base is usually used in a ratio of 1 to 10 moles, relative to 1 mole of compound (B3). The reaction temperature is usually in the range of 0 to 80°C. The reaction time is usually in the range of 0.1 to 120 hours. After completion of the reaction, compound (IF) can be isolated by post-treatment such as adding water to the reaction mixture, extracting with an organic solvent, and drying and concentrating the obtained organic layer. Compound (M6) is known or can be produced according to a known method.

[0030] Production Method F A compound represented by formula (IG) (hereinafter referred to as compound (IG)) can be produced by reacting a compound represented by formula (B4) (hereinafter referred to as compound (B4)) with a compound represented by formula (M7) (hereinafter referred to as compound (M7)) or a salt of M7. [In the formula, the symbols have the same meanings as above.] Examples of salts of compound (M7) include hydrochloride and sulfate. The reaction is usually carried out in a solvent. Examples of solvents used in the reaction include alcohols such as methanol and ethanol (hereinafter referred to as alcohols); hydrocarbons; ethers; halogenated hydrocarbons; amides; esters; nitriles; and mixtures of two or more of these. A base may be added to the reaction, if necessary. Examples of bases used in the reaction, if necessary, include organic bases, alkali metal carbonates, alkali metal bicarbonates, sodium hydride, and tripotassium phosphate. When a base is used in the reaction, the base is usually used in a ratio of 1 to 10 moles per mole of compound (B4). In the reaction, compound (M7) or a salt of compound (M7) is usually used in a ratio of 1 to 10 moles per mole of compound (B4). The reaction temperature is usually in the range of 0 to 150°C. The reaction time is usually in the range of 0.1 to 120 hours. After completion of the reaction, compound (IG) can be isolated by post-treatment such as adding water to the reaction mixture, extracting with an organic solvent, and drying and concentrating the obtained organic layer. Compound (M7) and a salt of compound (M7) are known or can be produced according to known methods.

[0031] Production Method G The compound represented by formula (I-H) (hereinafter referred to as compound (I-H)) and the compound represented by formula (II) (hereinafter referred to as compound (II)) can be produced by reacting a compound represented by formula (B5) (hereinafter referred to as compound (B5)) with an oxidizing agent. [In the formula, R 51 is R 7 or R 8and the other symbols have the same meanings as above.] First, a method for producing compound (I-H) from compound (B5) will be described. The reaction is usually carried out in a solvent. Examples of solvents used in the reaction include halogenated hydrocarbons, nitriles, alcohols, acetic acid, water, and mixtures of two or more of these. Examples of oxidizing agents used in the reaction include sodium periodate, m-chloroperbenzoic acid (hereinafter referred to as mCPBA), and hydrogen peroxide. When hydrogen peroxide is used as the oxidizing agent, an acid, a base, or a catalyst may be added as needed. Examples of acids used in the reaction as needed include trifluoroacetic acid. When an acid is used in the reaction, the acid is usually used in a ratio of 0.01 to 1 mol per mol of compound (B5). Examples of bases used in the reaction as needed include sodium carbonate. When a base is used in the reaction, the base is usually used in a ratio of 0.01 to 1 mol per mol of compound (B5). Examples of catalysts used in the reaction as needed include sodium tungstate. When a catalyst is used in the reaction, the catalyst is typically used in a ratio of 0.01 to 0.5 moles per mole of compound (B5). The oxidizing agent is typically used in a ratio of 1 to 1.2 moles per mole of compound (B5). The reaction temperature is typically in the range of -20 to 80°C. The reaction time is typically in the range of 0.1 to 12 hours. After completion of the reaction, water is added to the reaction mixture, followed by extraction with an organic solvent. The resulting organic layer is washed, as necessary, with an aqueous solution of a reducing agent (e.g., sodium sulfite, sodium thiosulfate) and an aqueous solution of a base (e.g., sodium bicarbonate). The organic layer is dried and concentrated to obtain compound (I-H).

[0032] Next, a method for producing compound (II) from compound (I-H) will be described. The reaction is typically carried out in a solvent. Examples of solvents used in the reaction include halogenated hydrocarbons, nitriles, alcohols, acetic acid, water, and mixtures of two or more of these. Examples of oxidizing agents used in the reaction include mCPBA and hydrogen peroxide. When hydrogen peroxide is used as the oxidizing agent, a base or catalyst may be added as needed. Examples of bases used in the reaction as needed include sodium carbonate. When a base is used in the reaction, the base is typically used in a ratio of 0.01 to 1 mole per mole of compound (IG). Examples of catalysts used in the reaction as needed include sodium tungstate. When a catalyst is used in the reaction, the catalyst is typically used in a ratio of 0.01 to 0.5 moles per mole of compound (I-H). The oxidizing agent is typically used in a ratio of 1 to 2 moles per mole of compound (I-H). The reaction temperature is typically within the range of −20 to 120°C. The reaction time is usually in the range of 0.1 to 12 hours. After completion of the reaction, water is added to the reaction mixture, which is then extracted with an organic solvent. The resulting organic layer is washed, as necessary, with an aqueous solution of a reducing agent (e.g., sodium sulfite, sodium thiosulfate) and an aqueous solution of a base (e.g., sodium bicarbonate). Compound (II) can be obtained by drying and concentrating the organic layer.

[0033] Compound (II) can also be produced in a one-step reaction (one-pot) by reacting compound (B5) with an oxidizing agent. The reaction can be carried out in a similar manner to the method for producing compound (II) from compound (I-H), using the oxidizing agent in a proportion of usually 2 to 5 moles per mole of compound (B5). Compound (B5) can be produced in a similar manner to Production Method C.

[0034] Production Method H The compound represented by formula (I-J) (hereinafter referred to as compound (I-J)) can be produced by reacting compound (B1) with a compound represented by formula (M8) (hereinafter referred to as compound (M8)) to produce an organolithium reactant, and reacting the resulting organolithium reactant with a compound represented by formula (M9) (hereinafter referred to as compound (M9)). [In the formula, X 57 represents a butyl group, a sec-butyl group, or a tert-butyl group; X 58 is an oxygen atom, NH, or NR 54 represents R 53 and R 54 are the same or different and represent a C1-C6 chain hydrocarbon group or a hydrogen atom, and other symbols have the same meanings as above.] First, a method for producing an organolithium reactant from compound (B1) will be described. The reaction is usually carried out in a solvent. Examples of solvents used in the reaction include hydrocarbons, ethers, and mixtures of two or more of these. In the reaction, compound (M8) is usually used in a ratio of 0.5 to 2 moles per mole of compound (B1). The reaction temperature is usually in the range of -78°C to 150°C. The reaction time is usually in the range of 0.1 to 120 hours.

[0035] Next, a method for producing compound (I-J) from the organolithium reactant will be described. The reaction is typically carried out in a solvent. Examples of solvents used in the reaction include hydrocarbons, ethers, and mixtures of two or more of these. Compound (M9) is typically used in a ratio of 0.5 to 2 moles per mole of the organolithium reactant. The reaction temperature is typically between -78°C and 150°C. The reaction time is typically between 0.1 and 120 hours. After completion of the reaction, compound (I-J) can be isolated by adding water to the reaction mixture, extracting with an organic solvent, and performing post-treatment such as drying and concentrating the resulting organic layer. Compound (B1) and compound (M9) are known compounds or can be produced by known methods. Compound (M8) is a commercially available compound or can be produced by known methods.

[0036] Production Method I The compound represented by formula (I-K) (hereinafter referred to as compound (I-K)) can be produced by reacting compound (B1) with a compound represented by formula (M10) (hereinafter referred to as compound (M10)) in the presence of a copper catalyst and a base. [In the formula, X 56 represents a sodium atom or a potassium atom, and other symbols have the same meanings as above.] The reaction can be carried out in accordance with Production Method C, except that compound (M10) is used in place of compound (M3). Compound (M10) is a commercially available compound, or can be produced in accordance with known methods.

[0037] Intermediate Production Method A The compound represented by formula (C2) (hereinafter referred to as compound (C2)) can be produced by reacting a compound represented by formula (M11) (hereinafter referred to as compound (M11)) with a compound represented by formula (M8) (hereinafter referred to as compound (M8)) to produce an organolithium reactant, which is then reacted with a compound represented by formula (C1) (hereinafter referred to as compound (C1)). [In the formula, X 52 represents a bromine atom or an iodine atom, and other symbols have the same meanings as above (provided that in A, R 1 a carbon atom substituted with, or X 52 and the atom bonded to is a carbon atom).] The reaction can be carried out in accordance with Production Method H, using Compound (M11) instead of Compound (B1) and Compound (C1) instead of Compound (M9). Compound (M11) and Compound (C1) are commercially available compounds, or can be produced in accordance with known methods.

[0038] Intermediate Production Method B Compound (C2) can also be produced by reacting compound (M11) with a compound represented by formula (M12) (hereinafter referred to as compound (M12)) to produce a Grignard reagent, and then reacting the Grignard reagent with compound (C1). [In the formula, X 54 represents a chlorine atom or a bromine atom, and other symbols have the same meanings as above (provided that in A, R 1a carbon atom substituted with, or X 52 and the atom bonded to is a carbon atom).] The reaction can be carried out in accordance with Production Method H, using compound (M11) instead of compound (B1), compound (M12) instead of compound (M8), and compound (C1) instead of compound (M9). Compound (M12) is a commercially available compound, or can be produced in accordance with a known method.

[0039] Intermediate Production Method C The compound represented by formula (C3) (hereinafter referred to as compound (C3)) can be produced by reacting compound (B1) with bis(pinacolato)diboron in the presence of a base and a palladium catalyst. [wherein the symbols have the same meanings as defined above.] The reaction can be carried out according to Production Method A, except that bis(pinacolato)diboron is used in place of Compound (M1).

[0040] Intermediate Production Method D The compound represented by formula (C5) (hereinafter referred to as compound (C5)) can be produced by thiocarbonylating a compound represented by formula (C4) (hereinafter referred to as compound (C4)). [wherein the symbols have the same meanings as defined above.] The thiocarbonylation reaction can be carried out according to the method described in Tetrahedron, 1985, 41, 5061-5087, etc.

[0041] Intermediate Production Method E The compound represented by formula (C6) (hereinafter referred to as compound (C6)) can be produced by reacting compound (C4) with a compound represented by formula (M13) (hereinafter referred to as compound (M13)) or a salt of compound (M13). [In the formula, the symbols have the same meanings as above.] Examples of salts of compound (M13) include hydrochloride and sulfate. The reaction is usually carried out in a solvent. Examples of solvents used in the reaction include hydrocarbons, ethers, halogenated hydrocarbons, amides, esters, nitriles, alcohols, and mixtures of two or more thereof. A base may be added to the reaction, if necessary. Examples of bases used in the reaction, if necessary, include organic bases, alkali metal carbonates, alkali metal bicarbonates, sodium hydride, and tripotassium phosphate. When a base is used in the reaction, the base is usually used in a ratio of 1 to 10 moles per mole of compound (C4). In the reaction, compound (M13) or a salt of compound (M13) is usually used in a ratio of 1 to 10 moles per mole of compound (C4). The reaction temperature is usually in the range of 0 to 150°C. The reaction time is usually in the range of 0.1 to 120 hours. After completion of the reaction, compound (C6) can be isolated by post-treatment such as adding water to the reaction mixture, extracting with an organic solvent, and drying and concentrating the obtained organic layer. Compound (M13) or a salt of compound (M13) is known or can be produced according to a known method.

[0042] Intermediate Production Method F The compound represented by formula (C7) (hereinafter referred to as compound (C7)) can be produced by reacting compound (M11) with a compound represented by formula (M14) (hereinafter referred to as compound (M14)). [wherein the symbols have the same meanings as above (provided that in A, R 1 a carbon atom substituted with, or X 52 and the atom bonded to is a carbon atom).] The reaction can be carried out in accordance with Production Method A, using compound (M11) instead of compound (B1) and compound (M14) instead of compound (M1). The reaction can also be carried out in accordance with the method described in Angewandte Chemie International Edition, 2020, 59, 22460-22464, etc. Compound (M14) is known or can be produced in accordance with a known method.

[0043] Intermediate Production Method G The compound represented by formula (C8) (hereinafter referred to as compound (C8)) can be produced by dehydroxylating compound (C2). [In the formula, the symbols have the same meanings as above.] Examples of dehydroxylation methods include catalytic hydrogen reduction and reaction with phosphorus tribromide. First, a method for producing compound (C8) by catalytic hydrogen reduction will be described. The catalytic hydrogen reduction can be carried out by reacting compound (C2) with hydrogen in the presence of a solvent and a catalyst. Examples of solvents used in the reaction include alcohols, esters, acetic acid, and mixtures of two or more thereof. Examples of catalysts used in the reaction include palladium on carbon. The hydrogen pressure in the reaction is usually 1 to 5 atmospheres. The catalyst is usually used in a ratio of 0.01 to 1 mole per mole of compound (C2). The reaction temperature is usually in the range of 10 to 50°C. The reaction time is usually in the range of 0.1 to 120 hours.

[0044] Next, a method for producing compound (C8) by reaction with phosphorus tribromide will be described. The reaction is typically carried out in a solvent. Examples of solvents used in the reaction include hydrocarbons, ethers, and mixtures of two or more of these. Phosphorus tribromide is typically used in a ratio of 1 to 10 moles per mole of compound (C2). The reaction temperature typically ranges from 0°C to 150°C. The reaction time typically ranges from 0.1 to 120 hours. After completion of the reaction, water is added to the reaction mixture, and the organic layer is washed with an alkaline aqueous solution (e.g., saturated aqueous sodium bicarbonate solution) as needed. Compound (C8) can be isolated by post-treatment such as drying and concentration of the resulting organic layer.

[0045] Intermediate Production Method H Compound (C2) can be produced by reacting a compound represented by formula (M15) (hereinafter referred to as compound (M15)) with compound (M8) to produce an organolithium reactant, and reacting the resulting organolithium reactant with a compound represented by formula (M16) (hereinafter referred to as compound (M16)). [In the formula, the symbols have the same meanings as defined above.] The reaction can be carried out in accordance with Production Method H, using compound (M15) instead of compound (B1) and compound (M16) instead of compound (M9). Compounds (M15) and (M16) are commercially available compounds, or can be produced in accordance with known methods.

[0046] Intermediate Production Method I Compound (C2) can also be produced by reacting compound (M15) with a compound represented by formula (M12) (hereinafter referred to as compound (M12)) to produce a Grignard reagent, and then reacting the Grignard reagent with compound (M16). [In the formula, the symbols have the same meanings as defined above.] The reaction can be carried out in accordance with Production Method H, except that compound (M15) is used in place of compound (B1), compound (M12) is used in place of compound (M8), and compound (M16) is used in place of compound (M9).

[0047] Intermediate Production Method J Compound (C4) can be produced by oxidizing compound (C2). [In the formula, the symbols have the same meanings as defined above.] The oxidation reaction can be carried out according to the method described in Natural Product Reports, 2011, 28, 1722-1754, etc.

[0048] Intermediate Production Method K The compound represented by formula (C9) (hereinafter referred to as compound (C9)) can be produced by reacting compound (C2) with a compound represented by formula (M17) (hereinafter referred to as compound (M17)) in the presence of a base. [In the formula, X 55represents a chlorine atom, a bromine atom, an iodine atom, a mesyloxy group, or a triflyloxy group, and other symbols have the same meanings as above.] The reaction is usually carried out in a solvent. Examples of solvents used in the reaction include nitriles, ethers, hydrocarbons, amides, DMSO, and mixtures of two or more of these. Examples of bases used in the reaction include alkali metal hydrides such as sodium hydride (hereinafter referred to as alkali metal hydrides), alkali metal carbonates, organic bases, and tripotassium phosphate. X 55is a bromine atom, an iodine atom, or a triflyloxy group, the reaction may be carried out by adding a metal catalyst and a ligand as needed. Examples of the metal catalyst used in the reaction as needed include palladium catalysts such as palladium(II) acetate and [1,1'-bis(diphenylphosphino)ferrocene]palladium(II) dichloride; nickel catalysts such as bis(cyclooctadiene)nickel(0) and nickel(II) chloride; and copper catalysts such as copper(I) iodide and copper(I) chloride. When a metal catalyst is used in the reaction, the metal catalyst is usually used in a ratio of 0.01 to 1 mole per mole of compound (C2). Examples of ligands used in the reaction, if necessary, include triphenylphosphine, xantphos, 2,2'-bis(diphenylphosphino)-1,1'-binaphthyl, 1,1'-bis(diphenylphosphino)ferrocene, 2-dicyclohexylphosphino-2',4',6'-triisopropylbiphenyl, 2-dicyclohexylphosphino-2',6'-dimethoxybiphenyl, 1,2-bis(diphenylphosphino)ethane, 2,2'-bipyridine, 2-aminoethanol, 8-hydroxyquinoline, and 1,10-phenanthroline. When a ligand is used in the reaction, the ligand is typically used in a ratio of 0.01 to 1 mole per mole of compound (C2). In the reaction, compound (M17) is typically used in a ratio of 1 to 10 moles, and a base is typically used in a ratio of 1 to 10 moles per mole of compound (C2). The reaction temperature is usually in the range of -20°C to 200°C. The reaction time is usually in the range of 0.1 to 72 hours. After completion of the reaction, water is added to the reaction mixture, and the mixture is extracted with an organic solvent. The obtained organic layer is then dried and concentrated, and other post-treatment procedures are carried out to obtain compound (C9). Compound (M17) is known or can be produced according to known methods.

[0049] Intermediate Production Method L The compound represented by formula (C11) (hereinafter referred to as compound (C11)) can be produced by reacting a compound represented by formula (M18) (hereinafter referred to as compound (M18)) with a compound represented by formula (C10) (hereinafter referred to as compound (C10)) in the presence of a base. [In the formula, D 51 , and X53 The combination of 51 is CR 1 R 2 and X 53 is a chlorine atom, a bromine atom, an iodine atom, a mesyloxy group, or a triflyloxy group; or 51 is C=O or C=S, and X 53 represents a combination in which ring A is a chlorine atom; 11 represents a 5- to 6-membered non-aromatic nitrogen-containing heterocyclic group or a 5- to 6-membered aromatic nitrogen-containing heterocyclic group {the 5- to 6-membered non-aromatic nitrogen-containing heterocyclic group and the 5- to 6-membered aromatic nitrogen-containing heterocyclic group may be substituted with one or more substituents selected from Group J}, and the other symbols have the same meanings as above.] The reaction is usually carried out in a solvent. Examples of solvents used in the reaction include alcohols, nitriles, ethers, hydrocarbons, amides, DMSO, water, and mixtures of two or more thereof. Examples of bases used in the reaction include alkali metal hydrides, alkali metal carbonates, organic bases, and tripotassium phosphate. In the reaction, compound (M18) is usually used in a ratio of 1 to 10 moles, and a base is usually used in a ratio of 1 to 10 moles, relative to 1 mole of compound (C10). The reaction temperature is usually in the range of -20°C to 200°C. The reaction time is usually in the range of 0.1 to 72 hours. After the reaction is complete, water is added to the reaction mixture, followed by extraction with an organic solvent, and the resulting organic layer is dried, concentrated, and other post-treatments to obtain compound (C11). Compound (C10) and compound (M18) are known or can be produced according to known methods.

[0050] The compound of the present invention can be mixed or used in combination with one or more components selected from the group consisting of Group (a), Group (b), Group (c), and Group (d) below (hereinafter referred to as the present component). The term "mixed or used in combination" means that the compound of the present invention and the present component are used simultaneously, separately, or with a time interval. When the compound of the present invention and the present component are used simultaneously, the compound of the present invention and the present component may be contained in separate preparations or in a single preparation. One aspect of the present invention is a composition (hereinafter referred to as Composition A) containing one or more components selected from the group consisting of Group (a), Group (b), Group (c), and Group (d) (i.e., the present component) and the compound of the present invention.

[0051] Group (a) includes acetylcholinesterase inhibitors (e.g., carbamate insecticides, organophosphate insecticides), GABAergic chloride channel blockers (e.g., phenylpyrazole insecticides), sodium channel modulators (e.g., pyrethroid insecticides), nicotinic acetylcholine receptor competitive modulators (e.g., neonicotinoid insecticides), nicotinic acetylcholine receptor allosteric modulators, glutamate-gated chloride channel allosteric modulators (e.g., macrolide insecticides), juvenile hormone mimics, multisite inhibitors, chordotonal organ TRPV channel modulators, mite growth inhibitors, microbial insect midgut membrane disruptors, mitochondrial ATP synthase inhibitors, oxidative phosphorylation uncouplers, nicotinic acetylcholine receptor channel blockers (e.g., nereistoxin insecticides), chitin biosynthesis inhibitors, molting inhibitors, ecdysone receptor agonists, octopamine receptor agonists, mitochondrial electron transport chain complex I, II, The group consisting of inhibitors of classes III and IV, voltage-dependent sodium channel blockers, acetyl-CoA carboxylase inhibitors, ryanodine receptor modulators (e.g., diamide insecticides), chordotonal organ modulators, microbial insecticides, and other insecticidal, acaricidal, and nematicidal active ingredients, which are described in the IRAC mechanism-based classification.

[0052] Group (b) consists of nucleic acid synthesis inhibitors (e.g., phenylamide fungicides, acylamino acid fungicides), cell division and cytoskeleton inhibitors (e.g., MBC fungicides), respiratory inhibitors (e.g., QoI fungicides, QiI fungicides), amino acid synthesis and protein synthesis inhibitors (e.g., anilinopyrimidine fungicides), signal transduction inhibitors, lipid synthesis and membrane synthesis inhibitors, sterol biosynthesis inhibitors (e.g., DMI fungicides such as triazoles), cell wall biosynthesis inhibitors, melanin synthesis inhibitors, plant defense inducers, multisite contact-active fungicides, microbial fungicides, and other fungicidal active ingredients. These are listed in the FRAC classification based on the mechanism of action.

[0053] Group (c) is a group of plant growth regulators (including mycorrhizal fungi and rhizobia).

[0054] Group (d) is a group of repellent ingredients.

[0055] Examples of combinations of the present component and the compound of the present invention are described below. For example, alanycarb + SX refers to a combination of alanycarb and SX. The abbreviation SX refers to any one of the present compounds selected from the compound group SX1 to SX216. The present components described below are all known components and can be obtained from commercially available preparations or produced by known methods. When the present component is a microorganism, it can also be obtained from a bacterial depository. The number in parentheses indicates the CAS RN (registered trademark).

[0056] Combinations of the present ingredient of the above group (a) with the compound of the present invention: abamectin + SX, acephate + SX, acequinocyl + SX, acetamiprid + SX, acetoprole + SX, acrinathrin + SX, acinonapyr + SX, afidopyropen + SX, afoxolaner + SX, alanycarb + SX, aldicarb + SX, allethrin + SX, alpha-cypermethrin + SX, alpha-endosulfan + SX, aluminum phosphide + SX, Amitraz + SX, azadirachtin + SX, azamethiphos + SX, azinphos-ethyl + SX, azinphos-methyl + SX, azocyclotin + SX, Celastrus angulatus bark + SX, bendiocarb + SX, benfluthrin + SX, benfuracarb + SX, bensultap + SX, bentiofluormin + SX, benzoximate + SX, benzpyrimoxan + SX, beta-cyfluthrin + SX SX, beta-cypermethrin + SX, bifenazate + SX, bifenthrin + SX,Bioallethrin + SX, bioresmethrin + SX, bistrifluron + SX, bisulfufen + SX, borax + SX, boric acid + SX, broflanilide + SX, bromopropylate + SX, buprofezin + SX, butocarboxim + SX, butoxycarboxim + SX, cadusafos + SX, calcium phosphide + SX, carbaryl + SX, carbofuran + SX, carbosulfan + SX, Cartap hydrochloride + SX, cartap + SX, chinomethionate + SX, chlorantraniliprole + SX, chlordane + SX, chlorethoxyfos + SX, chlorfenapyr + SX, chlorfenvinphos + SX, chlorfluazuron + SX, chlormephos + SX, chloropicrin + SX, chlorpyrifos + SX, chlorpyrifos-methyl + SX, chromafenozide + SX, clofentezine + SX, clothianidin + SX, concanamycin A + SX, coumaphos + SX, cryolite + SX,Cyanophos + SX, cyantraniliprole + SX, cybenzoxasulfyl + SX, cyclaniliprole + SX, cyclobutrifluram + SX, cycloprothrin + SX, cycloxaprid + SX, cyenopyrafen + SX, cyetpyrafen + SX, cyflumetofen + SX, cyfluthrin + SX, cyhalodiamide + SX, cyhalothrin + SX, cyhexatin + SX, cypermethrin + SX, Cyphenothrin + SX, cyproflanilide + SX, cyromazine + SX, dazomet + SX, deltamethrin + SX, demeton-S-methyl + SX, diafenthiuron + SX, diazinon + SX, dichlorvos + SX, dichloromezotiaz + SX, dicofol + SX, dicrotophos + SX, diflovidazin + SX, diflubenzuron + SX, dimefluthrin + SX, Dimethoate + SX, dimethylvinphos + SX, dimpropyridaz + SX, dinotefuran + SX, disodium octaborate + SX,Disulfoton + SX, DNOC (2-methyl-4,6-dinitrophenol) + SX, doramectin + SX, dried leaves of Dryopteris filix (mas) + SX, emamectin benzoate + SX, empenthrin + SX, endosulfan + SX, EPN (O-ethyl O-(4-nitrophenyl) phenylphosphonothioate) + SX, epsilon-metofluthrin + SX, epsilon-momfluorothrin + SX, esfenvalerate + SX, ethiofencarb + SX, ethion + SX, Ethiprole + SX, ethoprophos + SX, etofenprox + SX, etoxazole + SX, Artemisia absinthium extract + SX, Azadirachta indica extract + SX, Cassia nigricans extract + SX, Clitoria ternatea extract + SX, Symphytum officinale extract + SX, Chenopodium ambrosioides extract + SX, Tansy extract + SX, Urtica dioica extract + SX, Mistletoe extract (extract of Viscum album) + SX,Famphur + SX, fenamiphos + SX, fenazaquin + SX, fenbutatin oxide + SX, fenitrothion + SX, fenmezoditiaz + SX, fenobucarb + SX, fenoxycarb + SX, fenpropathrin + SX, fenpyroximate + SX, fenthion + SX, fenvalerate + SX, fipronil + SX, flometoquin + SX, flonicamid + SX, Fluacrypyrim + SX, Fluazaindolizine + SX, Fluazuron + SX, Flubendiamide + SX, Fluchlordiniliprole + SX, Flucycloxuron + SX, Flucythrinate + SX, Fluensulfone + SX, Flufenoprox + SX, Flufenoxuron + SX, Flufiprole + SX, Flumethrin + SX, Flumetnicam + SX, Flupentiofenox + SX Flupyradifurone + SX, flupyrimin + SX, flupyroxystrobin + SX, fluralaner + SX, fluvalinate + SX,Fluxametamide + SX, formetanate + SX, fosthiazate + SX, furamethrin + SX, furathiocarb + SX, gamma-cyhalothrin + SX, GS-omega / kappa HXTX-Hv1a peptide + SX, halfenprox + SX, halofenozide + SX, heptafluthrin + SX, heptenophos + SX, hexaflumuron + SX, hexythiazox + SX, Potassium salt of hop beta acid + SX, hydramethylnon + SX, hydroprene + SX, imicyafos + SX, imidacloprid + SX, imidaclothiz + SX, imiprothrin + SX, indazapyroxamet + SX, indoxacarb + SX, isocycloseram + SX, isofenphos + SX, isoflualanam + SX, isoprocarb + SX, isopropyl-O-(methoxyaminothiophosphoryl) salicylate salicylate + SX, isoxathion + SX, ivermectin + SX, kadethrin + SX, kappa-tefluthrin + SX,Kappa-bifenthrin + SX, kinoprene + SX, lambda-cyhalothrin + SX, ledprona + SX, lenoremycin + SX, lepimectin + SX, lime sulfur + SX, lotilaner + SX, lufenuron + SX, machine oil + SX, malathion + SX, mecarbam + SX, meperfluthrin + SX, metaflumizone + SX, metam + SX, methamidophos + SX, Methidathion + SX, methiocarb + SX, methomyl + SX, methoprene + SX, methoxychlor + SX, methoxyfenozide + SX, methyl bromide + SX, metofluthrin + SX, metolcarb + SX, metoxadiazone + SX, mevinphos + SX, milbemectin + SX, milbemycin oxime + SX, mivorilaner + SX, modoflaner + SX, momfluorothrin + SX Monocrotophos + SX, moxidectin + SX, naled + SX, nicofluprole + SX, nicotine + SX,Nicotine sulfate + SX, nitenpyram + SX, novaluron + SX, noviflumuron + SX, Chenopodium anthelminticum seed oil + SX, omethoate + SX, oxamyl + SX, oxazosulfyl + SX, oxydemeton-methyl + SX, parathion + SX, parathion-methyl + SX, permethrin + SX, phenothrin + SX, phenthoate + SX, phorate + SX, phosalone + SX, phosmet + SX, phosphamidon + SX, phosphine + SX, phoxim + SX, pioxaniliprole + SX, piperflanilide + SX, pirimicarb + SX, pirimiphos-methyl + SX, prallethrin + SX, profenofos + SX, profluthrin + SX, propargite + SX, propetamphos + SX, propoxur + SX, propylene glycol alginate + SX, prothiofos + SX, Piflubumide + SX, pymetrozine + SX, pyraclofos + SX,Pyrethrins + SX, pyridaben + SX, pyridalyl + SX, pyridaphenthion + SX, pyrifluquinazone + SX, pyrimidifen + SX, pyriminostrobin + SX, pyriprole + SX, pyriproxyfen + SX, quinalphos + SX, resmethrin + SX, rotenone + SX, ryanodine + SX, sarolaner + SX, selamectin + SX, sigma-cypermethrin + SX SX, silafluofen + SX, sodium borate + SX, sodium metaborate + SX, spidoxamat + SX, spinetoram + SX, spinosad + SX, spirobudifen + SX, spirodiclofen + SX, spiromesifen + SX, spiropidione + SX, spirotetramat + SX, sulfiflumin + SX, sulfluramid + SX, sulfotep + SX, sulfoxaflor + SX, sulfoxamyl + SX, sulfur + SX, sulfuryl fluoride + SX, tartar emetic + SX, tau-fluvalinate + SX,Tebufenozide + SX, tebufenpyrad + SX, tebupirimfos + SX, teflubenzuron + SX, tefluthrin + SX, temephos + SX, terbufos + SX, terpene constituents of the extract of Chenopodium ambrosioides near ambrosioides + SX, tetrachlorantraniliprole + SX, tetrachlorvinphos + SX, tetradifon + SX, tetramethrin + SX, tetramethylfluthrin + SX, Tetraniliprole + SX, theta-cypermethrin + SX, thiacloprid + SX, thiamethoxam + SX, thiocyclam + SX, thiodicarb + SX, thiofanox + SX, thiometon + SX, thiosultap disodium + SX, thiosultap monosodium + SX, thiapyrachlor + SX, tigolaner + SX, thioantraniliprole + SX, tioxazafen + SX, Tolfenpyrad + SX, tralomethrin + SX, transfluthrin + SX,Triazamate + SX, triazophos + SX, trichlorfon + SX, trifluenfuronate + SX, triflumezopyrim + SX, triflumuron + SX, trimethacarb + SX, trioxyflanilide + SX, tyclopyrazoflor + SX, umifoxolaner + SX, vadescana + SX, vamidothion + SX, Quassia amara wood extract + SX, 3,5-dimethylphenyl N-methylcarbamate (XMC) + SX, Xylylcarb + SX, zeta-cypermethrin + SX, zinc phosphide + SX, 4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]-2-methyl-N-(1-oxothietan-3-yl)benzamide (1241050-20-3) + SX, 3-methoxy-N-(5-{5-(trifluoromethyl)-5-[3-(trifluoromethyl)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}indan-1-yl)propanamide (1118626-57-5) + SX, N-{4-chloro-3-[(1-cyanocyclopropyl)carbamoyl]phenyl}-1-methyl-4-(methanesulfonyl)-3-(1,1,2,2,2-pentafluoroethyl)-1H-pyrazole-3-carboxamide (1400768-21-9) + SX,N-[3-chloro-1-(pyridin-3-yl)-1H-pyrazol-4-yl]-2-(methanesulfonyl)propanamide (2396747-83-2) + SX, N-[4-chloro-2-(pyridin-3-yl)-1,3-thiazol-5-yl]-N-ethyl-3-(methanesulfonyl)propanamide + SX, 1,4-dimethyl-2-[2-(pyridin-3-yl)-2H-indazol-5-yl]-1,2,4-triazolidine-3,5-dione (2171099-09-3) + SX, 2-isopropyl-5-[(3,4,4-trifluoro-3-buten-1-yl)sulfonyl]-1,3,4-thiadiazole (2058052-95-0) + SX, N-({2-fluoro-4-[(2S,3S)-2-hydroxy-3-(3,4,5-trichlorophenyl)-3-(trifluoromethyl)pyrrolidin-1-yl]phenyl}methyl)cyclopropanecarboxamide + SX, 7-fluoro-N-[1-(methylsulfanyl)-2-methylpropan-2-yl]-2-(pyridin-3-yl)-2H-indazole-4-carboxamide + SX, 7-fluoro-N-[1-(methanesulfinyl)-2-methylpropan-2-yl]-2-(pyridin-3-yl)-2H-indazole-4-carboxamide + SX, 7-fluoro-N-[1-(methanesulfonyl)-2-methylpropan-2-yl]-2-(pyridin-3-yl)-2H-indazole-4-carboxamide + SX, N-[1-(difluoromethyl)cyclopropyl]-2-(pyridin-3-yl)-2H-indazole-4-carboxamide + SX, 2,9-dihydro-9-(methoxymethyl)-2-(pyridin-3-yl)-10H-pyrazolo[3,4-f]pyrido[2,3-b][1,4]oxazepin-10-one (2607927-97-7) + SX, (S)-2-chloro-N-(3-ethylpentan-2-yl)furan-3-carboxamide + SX, Cry1Ab protein from Bacillus thuringiensis (Bacillus thuringiensis Cry1Ab protein) + SX, Cry1Ac protein from Bacillus thuringiensis (Bacillus thuringiensis Cry1Ac protein) + SX, Cry1Fa protein from Bacillus thuringiensis (Bacillus thuringiensis Cry1Fa protein) + SX, Cry1A.105 protein from Bacillus thuringiensis (Bacillus thuringiensis Cry1A.105 protein) + SX, Cry2Ab protein from Bacillus thuringiensis (Bacillus thuringiensis Cry2Ab protein) protein) + SX, Bacillus thuringiensis-derived Vip3A protein (Bacillus thuringiensis Vip3A protein) + SX, Bacillus thuringiensis-derived mCry3A protein (Bacillus thuringiensis mCry3A protein) + SX, Bacillus thuringiensis-derived Cry3Ab protein (Bacillus thuringiensis Cry3Ab protein) + SX, Bacillus thuringiensis-derived Cry3Bb protein (Bacillus thuringiensis Cry3Bb protein) + SX, Bacillus thuringiensis-derived Cry34Ab1 / Cry35Ab1 protein (Bacillus thuringiensis Cry34Ab1 / Cry35Ab1 protein) + SX,Adoxophyes orana granulovirus BV-0001 (GV strain BV-0001) + SX, Anticarsia gemmatalis multiple nucleocapsid nucleopolyhedrovirus (MNPV) + SX, Autographa californica MNPV + SX, Cydia pomonella granulosis virus V15 (GV strain V15) + SX, Cydia pomonella granulosis virus V22 (GV strain V22) + SX, Cryptophlebia leucotreta granulosis virus (GV) + SX, Dendrolimus punctatus cypovirus + SX, Helicoverpa armigera nucleopolyhedrovirus BV-0003 + SX, Helicoverpa zea nucleopolyhedrovirus (NPV) + SX, Lymantria dispar nucleopolyhedrovirus (NPV) + SX, Mamestra brassicae nucleopolyhedrovirus (NPV) + SX, Mamestra configurata nucleopolyhedrovirus (NPV) + SX, Neodiprion abietis nucleopolyhedrovirus (NPV) + SX, Neodiprion lecontei NPV + SX, Neodiprion sertifer NPV + SX, Nosema locustae + SX,Orgyia pseudotsugata nucleopolyhedrovirus (NPV) + SX, Pieris rapae granulosis virus (GV) + SX, Plodia interpunctella granulosis virus (GV) + SX, Spodoptera exigua nucleopolyhedrovirus (MNPV) + SX, Spodoptera littoralis nucleopolyhedrovirus (MNPV) + SX, Spodoptera litura nucleopolyhedrovirus (NPV) + SX, Arthrobotrys dactyloides + SX, Bacillus firmus strain GB-126 + SX, Bacillus firmus strain I-1582 + SX, Bacillus firmus strain NCIM2637 + SX SX, Bacillus megaterium + SX, Bacillus sp. strain AQ175 + SX, Bacillus sp. strain AQ177 + SX, Bacillus sp. strain AQ178 + SX, Bacillus sphaericus strain 2362 serotype H5a5b + SX, Bacillus sphaericus strain ABTS1743 + SX, Bacillus thuringiensis strain AQ52 + SX, Bacillus thuringiensis strain BD#32 + SX, Bacillus thuringiensis strain CR-371 + SX, Bacillus thuringiensis subsp. Aizawai strain ABTS-1857 + SX, Bacillus thuringiensis subsp. Aizawai strain AM65-52 + SX, Bacillus thuringiensis subsp. Aizawai strain GC-91 + SX,Bacillus thuringiensis subsp. Aizawai strain NB200 + SX, Bacillus thuringiensis subsp. Aizawai Serotype strain H-7 + SX, Bacillus thuringiensis subsp. Kurstaki strain ABTS351 + SX, Bacillus thuringiensis subsp. Kurstaki strain BMP123 + SX, Bacillus thuringiensis subsp. Kurstaki strain CCT1306 + SX, Bacillus thuringiensis subsp. Kurstaki strain EG2348 + SX, Bacillus thuringiensis subsp. Kurstaki strain EG7841 + SX, Bacillus thuringiensis subsp. Kurstaki strain EVB113-19 + SX, Bacillus thuringiensis subsp. Kurstaki strain F810 + SX, Bacillus thuringiensis subsp. Kurstaki strain HD-1 + SX, Bacillus thuringiensis subsp. Kurstaki strain PB54 + SX, Bacillus thuringiensis subsp. Kurstaki strain SA-11 + SX, Bacillus thuringiensis subsp. Kurstaki strain SA-12 + SX, Bacillus thuringiensis subsp. Tenebriosis strain NB176 + SX, Bacillus thuringiensis subsp. Thuringiensis strain MPPL002 + SX, Bacillus thuringiensis subsp. morrisoni + SX, Bacillus thuringiensis var. colmeri + SX,Bacillus thuringiensis var. darmstadiensis strain 24-91 + SX, Bacillus thuringiensis var. dendrolimus + SX, Bacillus thuringiensis var. galleriae + SX, Bacillus thuringiensis var. israelensis strain BMP144 + SX, Bacillus thuringiensis var. israelensis serotype strain H-14 + SX, Bacillus thuringiensis var. japonensis strain buibui + SX, Bacillus thuringiensis var. san diego strain M-7 + SX, Bacillus thuringiensis var. 7216 + SX, Bacillus thuringiensis var. aegypti + SX, Bacillus thuringiensis var. T36 + SX, Beauveria bassiana strain ANT-03 + SX, Beauveria bassiana strain ATCC74040 + SX, Beauveria bassiana strain GHA + SX, Beauveria brongniartii + SX, Burkholderia rinogensis strain A396 + SX, Chromobacterium subtsugae strain PRAA4-1T + SX, Dactyllela ellipsospora + SX, Dactylaria thaumasia + SX, Hirsutella minnesotensis + SX, Hirsutella rhossiliensis + SX, Hirsutella thompsonii + SX, Lagenidium giganteum + SX, Lecanicillium lecanii strain KV01 + SX,Lecanicillium lecanii conidia of strain DAOM198499 + SX, Lecanicillium lecanii conidia of strain DAOM216596 + SX, Lecanicillium muscarium strain Ve6 + SX, Metarhizium anisopliae strain F52 + SX, Metarhizium anisopliae var. acridum + SX, Metarhizium anisopliae var. anisopliae BIPESCO 5 / F52 + SX, Metarhizium flavoviride + SX, Monacrosporium phymatopagum + SX, Paecilomyces fumosoroseus Apopka strain 97 + SX, Paecilomyces lilacinus strain 251 + SX, Paecilomyces tenuipes strain T1 + SX, Paenibacillus popilliae + SX, Pasteuria nishizawae strain Pn1 + SX, Pasteuria penetrans + SX, Pasteuria usgae + SX, Pasteuria thornei + SX, Serratia entomophila + SX, Verticillium chlamydosporium + SX, Verticillium lecani strain NCIM1312 + SX, Wolbachia pipientis + SX。,

[0057] Combinations of the present ingredient of the above group (b) with the compound of the present invention: acibenzolar-S-methyl + SX, aldimorph + SX, ametoctradin + SX, aminopyrifen + SX, amisulbrom + SX, anilazine + SX, azaconazole + SX, azoxystrobin + SX, basic copper sulfate + SX, benalaxyl + SX, benalaxyl-M + SX, benodanil + SX, benomyl + SX, benthiavalicarb + SX, Benthiavalicarb-isopropyl + SX, benzovindiflupyr + SX, bifemetstrobin + SX, binapacryl + SX, biphenyl + SX, bitertanol + SX, bixafen + SX, blasticidin S + SX, Bordeaux mixture + SX, boscalid + SX, bromothalonil + SX, bromuconazole + SX, bupirimate + SX, captafol + SX, captan + SX, Carbendazim + SX, carboxin + SX, carpropamid + SX, chinomethionate + SX, chitin + SX, chloroinconazide + SX,Chloroneb + ​​SX, chlorothalonil + SX, chlozolinate + SX, colletochlorin B + SX, copper(II) acetate + SX, copper(II) hydroxide + SX, copper oxychloride + SX, copper(II) sulfate + SX, coumoxystrobin + SX, cyazofamid + SX, cyflufenamid + SX, cymoxanil + SX, cyproconazole + SX, cyprodinil + SX, Dichlobentiazox + SX, dichlofluanid + SX, diclocymet + SX, diclomezine + SX, dicloran + SX, diethofencarb + SX, difenoconazole + SX, diflumetorim + SX, dimethachlone + SX, dimethirimol + SX, dimethomorph + SX, dimoxystrobin + SX, diniconazole + SX, diniconazole-M + SX, dinocap + SX, Dipotassium hydrogenphosphite + SX, dipymetitrone + SX, dithianon + SX,Dodecylbenzenesulphonic acid bisethylenediamine copper(II) salt + SX, dodemorph + SX, dodine + SX, edifenphos + SX, enoxastrobin + SX, epoxiconazole + SX, etaconazole + SX, ethaboxam + SX, ethirimol + SX, etridiazole + SX, garlic extract (Allium sativum) + SX, extract of the cotyledons of lupine plantlets (BLAD) + SX, horsetail extract (Equisetum arvense) + SX SX, tea tree extract (Melaleuca alternifolia) + SX, giant knotweed extract (Reynoutria sachalinensis) + SX, nasturtium extract (Tropaeolus majus) + SX, famoxadone + SX, fenamidone + SX, fenaminstrobin + SX, fenarimol + SX, fenbuconazole + SX, feneptamidoquin + SX, fenfuram + SX, fenhexamid + SX, fenopyramide + SX, fenoxanil + SX Fenpiclonil + SX, fenpicoxamid + SX,Fenpropidin + SX, fenpropimorph + SX, fenpyrazamine + SX, triphenyltin acetate + SX, triphenyltin chloride + SX, fentin hydroxide + SX, ferbam + SX, ferimzone + SX, florylpicoxamid + SX, fluazinam + SX, flubeneteram + SX, fludioxonil + SX, flufenoxadiazam + SX, flufenoxystrobin + SX, fluindapyr + SX, flumetylsulforim + SX, flumorph + SX, fluopicolide + SX, fluopyram + SX, fluopimomide + SX, fluoroimide + SX, fluoxapiprolin + SX, fluoxastrobin + SX, fluoxytioconazole + SX, fluquinconazole + SX, fluquinometoate + SX, flusilazole + SX, flusulfamide + SX, flutianil + SX, flutolanil + SX, Flutriafol + SX, fluxapyroxad + SX, folpet + SX, fosetyl + SX,Fosetyl aluminum + SX, fuberidazole + SX, furalaxyl + SX, furametpyr + SX, galquin + SX, guazatine + SX, hexaconazole + SX, hymexazole + SX, imazalil + SX, imibenconazole + SX, iminoctadine + SX, iminoctadine triacetate + SX, inpyrfluxam + SX, iodocarb + SX, ipconazole + SX Ipfentrifluconazole + SX, ipflufenoquin + SX, iprobenfos + SX, iprodione + SX, iprovalicarb + SX, isofetamide + SX, isofleucine + SX, isoflucipram + SX, isoprothiolane + SX, isopyrazam + SX, isotianil + SX, kasugamycin + SX, kresoxim-methyl + SX, laminarin + SX, oak leaves and bark of quercus + SX, mancozeb + SX, Mandestrobin + SX, mandipropamid + SX, maneb + ​​SX, mefentrifluconazole + SX, mepanipyrim + SX,Mepronil + SX, meptyldinocap + SX, metalaxyl + SX, metalaxyl-M + SX, metarylpicoxamid + SX, metconazole + SX, methasulfocarb + SX, metiram + SX, metominostrobin + SX, metrafenone + SX, metyltetraprole + SX, myclobutanil + SX, naftifine + SX, nuarimol + SX, octhilinone + SX Ofurace + SX, orysastrobin + SX, oxadixyl + SX, oxathiapiprolin + SX, oxine-copper + SX, oxolinic acid + SX, oxpoconazole + SX, oxpoconazole fumarate + SX, oxycarboxin + SX, oxytetracycline + SX, pefurazoate + SX, penconazole + SX, pencycuron + SX, penflufen + SX, penthiopyrad + SX, phenamacril + SX, Phosphorous acid + SX, phthalide + SX, picarbutrazox + SX, picoxystrobin + SX,Piperalin + SX, polyoxins + SX, potassium hydrogencarbonate + SX, potassium dihydrogenphosphite + SX, probenazole + SX, prochloraz + SX, procymidone + SX, propamidine + SX, propamocarb + SX, propiconazole + SX, propineb + ​​SX, proquinazid + SX, prothiocarb + SX, prothioconazole + SX, pydiflumetofen + SX, pyraclostrobin + SX, Pyrametostrobin + SX, pyraoxystrobin + SX, pyrapropoyne + SX, pyraziflumid + SX, pyrazophos + SX, pyribencarb + SX, pyributicarb + SX, pyridaclomethyl + SX, pyrifenox + SX, pyrimethanil + SX, pyrimorph + SX, pyriophenone + SX, pyrisoxazole + SX, pyroquilon + SX, Quillaja extract + SX, Quinconazole + SX, quinofumelin + SX, quinoxyfen + SX, quintozene + SX,Quinoa saponins (Chenopodiaceae) + SX, seboctylamine + SX, sedaxane + SX, silthiofam + SX, simeconazole + SX, sodium hydrogencarbonate + SX, spiroxamine + SX, streptomycin + SX, sulfur + SX, tebuconazole + SX, tebufloquin + SX, teclofthalam + SX, tecnazene + SX, terbinafine + SX, tetraconazole + SX Thiabendazole + SX, thifluzamide + SX, thiophanate + SX, thiophanate-methyl + SX, thiram + SX, thymol + SX, tiadinil + SX, tolclofos-methyl + SX, tolfenpyrad + SX, tolprocarb + SX, tolylfluanid + SX, triadimefon + SX, triadimenol + SX, triazoxide + SX, triclopyricarb + SX, tricyclazole + SX, Tridemorph + SX, trifloxystrobin + SX, triflumizole + SX, triforine + SX,トリチコナゾール(triticonazole) + SX, バリダマイシン(validamycin) + SX, バリフェナレート(valifenalate) + SX, ビンクロゾリン(vinclozolin) + SX, マスタードパウダー(yellow mustard powder) + SX, zinc thiazole + SX, ジネブ(zineb) + SX, ジラム(ziram) + SX, ゾキサミド(zoxamide) + SX, N'-[4-({3-[(4-chlorophenyl)methyl]-1,2,4-thiadiazol-5-yl}oxy)-2,5-dimethylphenyl]-N-ethyl-N-methylmethanimidamide (1202781-91-6) + SX, N'-{4-[(4,5-d ichlorothiazol-2-yl)oxy]-2,5-dimethylphenyl}-N-ethyl-N-methylmethanimidamide (929908-57-6) + SX, N'-(2,5-dimethyl-4-phenoxyphenyl)-N-ethyl-N-methylmethanimidamide (1052688-31-9) + SX, N'-[5-chloro-4-(2-fluorophenoxy)-2-methylphenyl]-N-ethyl-N-methylmethanimidamide (2055589-28-9) + SX, N'-[2-chloro-4-(2-fluorophenoxy)-5-methylphenyl]-N-ethyl-N-methylmethanimidamide (2055756-21-1) + SX, N'-(2-chloro-4-phenoxy-5-methylphenyl)-N-ethyl-N-methylmethanimidamide (2062599-39-5) + SX, N'-[4-(1-hydroxy-1-phenyl-2,2,2-trifluoroethyl)-2-methyl-5-methoxyphenyl]-N-isopropyl-N-methylmethanimidamide (2101814-55-3) + SX,N'-[5-bromo-6-(1-methyl-2-propoxyethoxy)-2-methylpyridin-3-yl]-N-ethyl-N-methylmethanimidamide (1817828-69-5) + SX, [4-(difluoromethoxy)phenyl]methyl 4-[(N-ethyl-N-methylamino)methylidene]amino-2,5-dimethylbenzoate + SX, 4-(2-bromo-4-fluorophenyl)-N-(2-chloro-6-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine (1362477-26-6) + SX, 2-[6-(3-fluoro-4-methoxyphenyl)-5-methylpyridin-2-yl]quinazoline (1257056-97-5) + SX, ethyl (2Z)-3-amino-2-cyano-3-phenylacrylate (39491-78-6) + SX, N-[(2-chlorothiazol-5-yl)methyl]-N-ethyl-6-methoxy-3-nitropyridin-2-amine (1446247-98-8) + SX, 5-(4-chlorobenzyl)-2-(chloromethyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentan-1-ol (1394057-11-4) + SX, (1R, 2S, 5S)-5-(4-chlorobenzyl)-2-(chloromethyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentan-1-ol (1801930-06-2) + SX, (1S, 2R, 5R)-5-(4-chlorobenzyl)-2-(chloromethyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentan-1-ol (1801930-07-3) + SX, 2-(chloromethyl)-5-(4-fluorobenzyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentan-1-ol (1394057-13-6) + SX, (1R, 2S, 5S)-2-(chloromethyl)-5-(4-fluorobenzyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentan-1-ol (1801930-08-4) + SX, (1S, 2R, 5R)-2-(chloromethyl)-5-(4-fluorobenzyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentan-1-ol (1801930-09-5) + SX, methyl 3-[(4-chlorophenyl)methyl]-2-hydroxy-1-methyl-2-(1H-1,2,4-triazol-1-ylmethyl)cyclopentan-1-carboxylate (1791398-02-1) + SX, 1-(2,4-difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)-1-[1-(4-bromo-2,6-difluorophenoxy)cyclopropyl]ethanol (2019215-86-0) + SX, 1-(2,4-difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)-1-[1-(4-chloro-2,6-difluorophenoxy)cyclopropyl]ethanol (2019215-84-8) + SX, 1-[2-(1-chlorocyclopropyl)-3-(2-fluorophenyl)-2-hydroxypropyl]-1H-imidazole-5-carbonitrile (2018316-13-5) + SX, 1-[2-(1-chlorocyclopropyl)-3-(2,3-difluorophenyl)-2-hydroxypropyl]-1H-imidazole-5-carbonitrile (2018317-25-2) + SX, 2-[6-(4-bromophenoxy)-2-(trifluoromethyl)pyridin-3-yl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol (2082661-43-4) + SX, 2-[6-(4-chlorophenoxy)-2-(trifluoromethyl)pyridin-3-yl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol (2082660-27-1) + SX, methyl ({2-methyl-5-[1-(4-methoxy-2-methylphenyl)-1H-pyrazol-3-yl]phenyl}methyl)carbamate (1605879-98-8) + SX, 2-(difluoromethyl)-N-[1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]pyridine-3-carboxamide (1616239-21-4) + SX, 2-(difluoromethyl)-N-[3-ethyl-1,1-dimethyl-2,3-dihydro-1H-inden-4-yl]pyridine-3-carboxamide (1847460-02-9) + SX, 2-(difluoromethyl)-N-[3-propyl-1,1-dimethyl-2,3-dihydro-1H-inden-4-yl]pyridine-3-carboxamide (1847460-05-2) + SX, (2E,3Z)-5-{[1-(4-chlorophenyl)-1H-pyrazol-3-yl]oxy}-2-(methoxyimino)-N,3-dimethylpent-3-enamide (1445331-27-0) + SX, (2E,3Z)-5-{[1-(2,4-dichlorophenyl)-1H-pyrazol-3-yl]oxy}-2-(methoxyimino)-N,3-dimethylpent-3-enamide (1445331-54-3) + SX, 5-chloro-4-({2-[6-(4-chlorophenoxy)pyridin-3-yl]ethyl}amino)-6-methylpyrimidine (1605340-92-8) + SX, 4,4-dimethyl-2-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)isoxazolidin-3-one (2098918-25-1) + SX, 5,5-dimethyl-2-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)isoxazolidin-3-one (2098918-26-2) + SX, N-ethyl-2-methyl-N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)propanamide + SX, N,2-dimethoxy-N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)propanamide + SX, N-methoxy-N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)cyclopropanecarboxamide + SX, N-methoxy-N'-methyl-N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)urea + SX, N'-ethyl-N-methoxy-N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)urea + SX, N,N'-dimethoxy-N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)urea + SX, N-acetyl-2-(ethanesulfonyl)-N-[2-(methoxycarbonyl)-4-(trifluoromethoxy)phenyl]-4-(trifluoromethyl)benzamide (2043675-28-9) + SX, 3-(4-bromo-7-fluoroindol-1-yl)butan-2-yl N-[(3-hydroxy-4-methoxypyridin-2-yl)carbonyl]-L-alaninate + SX,3-(7-bromoindol-1-yl)butan-2-yl N-[(3-hydroxy-4-methoxypyridin-2-yl)carbonyl]-L-alaninate + SX, 3-(7-bromo-4-fluoroindol-1-yl)butan-2-yl N-[(3-hydroxy-4-methoxypyridin-2-yl)carbonyl]-L-alaninate + SX, 3-(3,5-dichloropyridin-2-yl)butan-2-yl N-[(3-hydroxy-4-methoxypyridin-2-yl)carbonyl]-L-alaninate + SX, 3-(3,5-dichloropyridin-2-yl)butan-2-yl N-{[3-(acetoxymethoxy)-4-methoxypyridin-2-yl]carbonyl}-L-alaninate + SX, (1S)-1-[1-(naphthalen-1-yl)cyclopropyl]ethyl N-[(3-hydroxy-4-methoxypyridin-2-yl)carbonyl]-L-alaninate + SX, (1S)-1-[1-(naphthalen-1-yl)cyclopropyl]ethyl N-[(3-acetoxy-4-methoxypyridin-2-yl)carbonyl]-L-alaninate + SX, (1S)-1-[1-(naphthalen-1-yl)cyclopropyl]ethyl N-{[3-(acetoxymethoxy)-4-methoxypyridin-2-yl]carbonyl}-L-alaninate + SX, N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)cyclopropanecarboxamide + SX, N-allyl-N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)acetamide + SX, N-allyl-N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)propanamide + SX, N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)propanamide + SX, 3,3,3-trifluoro-N-({2-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)propanamide + SX, 3,3,3-trifluoro-N-({3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)propanamide + SX, 3,3,3-trifluoro-N-({2,3-difluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)propanamide + SX, N-({2,3-difluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)butanamide + SX, N-methoxy-N-methyl-N'-({ 4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)urea + SX, N,N-diethyl-N'-({ 4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)urea + SX, N-methyl-N'-({ 4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)urea + SX, 1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)pyrrolidin-2-one + SX, 1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)piperidin-2-one + SX,4-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)morpholin-3-one + SX, 2-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)isoxazolidin-3-one + SX, 3,3-dimethyl-1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)piperidin-2-one + SX, 2-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)-1,2-oxazinan-3-one + SX, 1-({3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)azepan-2-one + SX, 4,4-dimethyl-1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)pyrrolidin-2-one + SX, 5-methyl-1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)pyrrolidin-2-one + SX, ethyl 1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)-1H-pyrazole-4-carboxylate + SX, N-methyl-1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)-1H-pyrazole-4-carboxamide + SX, N-propyl-1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)-1H-pyrazole-4-carboxamide + SX, N-methoxy-1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)-1H-pyrazole-4-carboxamide + SX, N-methoxy-N-methyl-1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)-1H-pyrazole-4-carboxamide + SX, N,N-dimethyl-1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)-1H-1,2,4-triazol-3-amine + SX, N-methyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide + SX, methyl 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propanoate + SX, ethyl 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propanoate + SX, methyl 2-[2-(trifluoromethyl)-4-(4-chlorophenoxy)phenyl]-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propanoate + SX, 1-(2,3-dimethylpyridin-5-yl)-4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinoline + SX, 1-[2-(difluoromethyl)-3-methylpyridin-5-yl]-4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinoline + SX, 2,2-difluoro-N-[6-({[1-(1-methyl-1H-tetrazol-5-yl)benzimidazol-2-yl]oxy}methyl)pyridin-2-yl]-2-phenoxyacetamide + SX,1-[2-(1-chlorocyclopropyl)-3-(3-chloro-2-fluorophenyl)-2-hydroxypropyl]-1H-imidazole-5-carbonitrile + SX, ethyl 1-[(4-{[2-(trifluoromethyl)-1,3-dioxolan-2-yl]methoxy}phenyl)methyl]-1H-pyrazole-4-carboxylate + SX, ethyl 1-[(4-{[(1Z)-2-ethoxy-3,3,3-trifluoro-1-propen-1-yl]oxy}phenyl)methyl]-1H-pyrazole-4-carboxylate + SX, 6-chloro-3-(3-cyclopropyl-2-fluorophenoxy)-N-[2-(2,4-dimethylphenyl)-2,2-difluoroethyl]-5-methylpyridazine-4-carboxamide + SX, 6-chloro-3-(3-cyclopropyl-2-fluorophenoxy)-N-[2-(3,4-dimethylphenyl)-2,2-difluoroethyl]-5-methylpyridazine-4-carboxamide + SX, 6-chloro-N-[2-(2-chloro-4-methylphenyl)-2,2-difluoroethyl]-3-(3-cyclopropyl-2-fluorophenoxy)-5-methylpyridazine-4-carboxamide + SX, 2-[cyano(2,6-difluoropyridin-4-yl)amino]-N-(2,2-dimethylcyclobutyl)-5-methylthiazole-4-carboxamide + SX, 2-[cyano(2,6-difluoropyridin-4-yl)amino]-N-(spiro[3.4]octan-1-yl)-5-methylthiazole-4-carboxamide + SX, 2-[cyano(2,6-difluoropyridin-4-yl)amino]-N-hexyl-5-methylthiazole-4-carboxamide + SX, 2-[acetyl(2,6-difluoropyridin-4-yl)amino]-N-(2,2-dimethylcyclobutyl)-5-methylthiazole-4-carboxamide + SX, 2-[(2-methoxyacetyl)(2,6-difluoropyridin-4-yl)amino]-N-(2,2-dimethylcyclobutyl)-5-methylthiazole-4-carboxamide + SX, 2-[(2-methylpropanoyl)(2,6-difluoropyridin-4-yl)amino]-N-(2,2-dimethylcyclobutyl)-5-methylthiazole-4-carboxamide + SX, 2-[(2,6-difluoropyridin-4-yl)amino]-N-(2,2-dimethylcyclobutyl)-5-methylthiazole-4-carboxamide + SX, 2-{[(oxetan-3-yl)carbonyl](2,6-difluoropyridin-4-yl)amino}-N-(2,2-dimethylcyclobutyl)-5-methylthiazole-4-carboxamide + SX, 2-{[(oxolan-3-yl)carbonyl](2,6-difluoropyridin-4-yl)amino}-N-(2,2-dimethylcyclobutyl)-5-methylthiazole-4-carboxamide + SX, 2-{[(oxan-4-yl)carbonyl](2,6-difluoropyridin-4-yl)amino}-N-(2,2-dimethylcyclobutyl)-5-met hylthiazole-4-carboxamide + SX, 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-N-[1-(2-fluorophenyl)ethyl]pyrimidin-2-amine + SX,5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-N-[1-(2,6-difluorophenyl)ethyl]pyrimidin-2-amine + SX, 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-N-[1-(3,5-difluorophenyl)ethyl]pyrimidin-2-amine + SX, 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-N-[1-(6-chloropyridin-3-yl)ethyl]pyrimidin-2-amine + SX, 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-N-[1-(2-fluorophenyl)cyclopropyl]pyrimidin-2-amine + SX, 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-N-[1-(2,6-difluorophenyl)cyclopropyl]pyrimidin-2-amine + SX, 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-N-[1-(2-fluoro-3-methoxyphenyl)cyclopropyl]pyrimidin-2-amine + SX, 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-2-{[1-(2,6-difluorophenyl)cyclopropyl]oxy}pyrimidine + SX, 3-[3-(3-cyclopropyl-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5-[(2,4-dimethylphenyl)methyl]-5,6-dihydro-4H-1,2,4-oxadiazine + SX, (5S)-3-[3-(3-cyclopropyl-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5-[(2,4-dimethylphenyl)methyl]-5,6-dihydro-4H-1,2,4-oxadiazine + SX,3-[3-(3-chloro-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5-[(4-bromo-2-methylphenyl)methyl]-5,6-dihydro-4H-1,2,4-oxadiazine + SX, 3-[3-(3-chloro-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5-[(2-chloro-4-methylphenyl)methyl]-5,6-dihydro-4H-1,2,4-oxadiazine + SX, (5S)-3-[3-(3-chloro-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5-[(2-chloro-4-methylphenyl)methyl]-5,6-dihydro-4H-1,2,4-oxadiazine + SX, (5R)-3-[3-(3-chloro-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5-[(2-chloro-4-methylphenyl)methyl]-5,6-dihydro-4H-1,2,4-oxadiazine + SX, N-((2S)-1-{3-[2-(5-fluoro-2-methoxyphenyl)-2-hydroxyethyl]-5-[(E)-1-(isopropoxyimino)ethyl]-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl}-3-methylbutan-2-yl)-2-methylpropanamide + SX, N-((2S)-1-{3-[2-(5-fluoro-2-methoxyphenyl)-2-hydroxyethyl]-5-[(E)-1-(isopropoxyimino)ethyl]-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl}-3-methylbutan-2-yl)-2,2-dimethylpropanamide + SX, N-((2S)-1-{3-[2-(5-fluoro-2-methoxyphenyl)-2-hydroxyethyl]-5-[(E)-1-(isopropoxyimino)ethyl]-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl}propan-2-yl)-2-methylpropanamide + SX, N-((2S)-1-{3-[2-(2-methoxyphenyl)-2-hydroxyethyl]-5-[(E)-1-(isopropoxyimino)ethyl]-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl}propan-2-yl)-2-methylpropanamide + SX, N-((2S)-1-{3-[2-(5-fluoro-2-methoxyphenyl)-2-(2-cyanoethoxy)ethyl]-5-[1-(isopropoxyimino)ethyl]-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl}propan-2-yl)-2-methylpropanamide + SX, methyl ({5-[1-(2,6-difluoro-4-isopropylphenyl)-1H-pyrazol-3-yl]-2-methylphenyl}methyl)carbamate + SX, methyl ({5-[1-(2,6-difluoro-4-cyclopropylphenyl)-1H-pyrazol-3-yl]-2-methylphenyl}methyl)carbamate + SX, methyl ({5-[1-(2,6-difluoro-4-methoxyphenyl)-1H-pyrazol-3-yl]-2-methylphenyl}methyl)carbamate + SX, methyl (Z)-2-(5-cyclopentyl-2-methylphenoxy)-3-methoxyprop-2-enoate + SX, methyl (Z)-2-(5-cyclohexyl-2-methylphenoxy)-3-methoxyprop-2-enoate + SX, methyl (Z)-2-[(3-isopropyl-1H-pyrazol-1-yl)-2-methylphenoxy]-3-methoxyprop-2-enoate + SX, 1-(4,5-dimethyl-1H-benzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinoline + SX, 1-(4,5-dimethyl-1H-benzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-3,4-dihydroisoquinoline + SX, 1-(pyrazolo[1,5-a]pyridin-3-yl)-4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinoline + SX, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-6-fluoro-3,3-dimethylisoquinolin-4(3H)-one + SX, N-[2-(pyridin-2-yl)-2-(1-methylpyrazol-4-yl)propyl]-5-(2,4-difluorophenyl)isoxazole-3-carboxamide + SX, N-[2-(6-chloropyridin-2-yl)-2-(1-methylpyrazol-4-yl)propyl]-5-(2,4-difluorophenyl)isoxazole-3-carboxamide + SX, N-[2-(6-cyanopyridin-2-yl)-2-(1-methylpyrazol-4-yl)propyl]-5-(2,4-difluorophenyl)isoxazole-3-carboxamide + SX, N-[(2S)-2-(6-chloro-4-methoxypyridin-2-yl)-2-(1-methylpyrazol-4-yl)propyl]-5-(2,4-difluorophenyl)isoxazole-3-carboxamide + SX, N-[(2R)-2-(6-chloro-4-methoxypyridin-2-yl)-2-(1-methylpyrazol-4-yl)propyl]-5-(2,4-difluorophenyl)isoxazole-3-carboxamide + SX, N-(2-{6-[(1E)-(methoxyimino)ethyl]pyridin-2-yl}-2-(1-methylpyrazol-4-yl)propyl)-5-(2,4-difluorophenyl)isoxazole-3-carboxamide + SX, N-[2-(5-methylpyridin-2-yl)-2-(1-methylpyrazol-4-yl)propyl]-5-(2,4-difluorophenyl)isoxazole-3-carboxamide + SX, N-[2-(6-chloropyridin-2-yl)-2-(1-methylpyrazol-4-yl)propyl]-5-(2,4-dichlorophenyl)isoxazole-3-carboxamide + SX, methyl 6-(2-{[5-(2,4-difluorophenyl)isoxazole-3-carbonyl]amino}-1-methyl-1-(1-methylpyrazol-4-yl)ethyl)pyridine-3-carboxylate + SX, N-[2-(6-chloropyridin-2-yl)-2-(1-methylpyrazol-4-yl)propyl]-5-(3,5-difluoropyridin-2-yl)isoxazole-3-carboxamide + SX, N-[2-(6-chloropyridin-2-yl)-2-(1-methylpyrazol-4-yl)propyl]-3-(2,4-difluorophenyl)-1,2,4-oxadiazole-5-carboxamide + SX, N-[2-(6-chloropyridin-2-yl)-2-(1-methylpyrazol-4-yl)propyl]-5-(2,4-difluorophenyl)-1,3,4-thiadiazole-2-carboxamide + SX, N-[2-(5-chloropyridin-2-yl)-2-(1-methylpyrazol-4-yl)propyl]-5-(2,4-difluorophenyl)-1,3,4-thiadiazole-2-carboxamide + SX, N-[2-(6-chloropyridin-2-yl)-2-(1-methylpyrazol-4-yl)propyl]-5-(3,5-difluoropyridin-2-yl)-1,3,4-thiadiazole-2-carboxamide + SX, N-[2-(6-cyanopyridin-2-yl)-2-(1-methylpyrazol-4-yl)propyl]-5-(3,5-difluoropyridin-2-yl)-1,3,4-thiadiazole-2-carboxamide + SX, N-[2-(6-chloropyridin-2-yl)-2-(1-methylpyrazol-4-yl)propyl]-5-(2,6-difluoropyridin-3-yl)-1,3,4-thiadiazole-2-carboxamide + SX, Agrobacterium radiobactor strain K1026 + SX, Agrobacterium radiobactor strain K84 + SX, Bacillus amyloliquefaciens strain PTA-4838 (Aveo™ EZ Nematicide) + SX, Bacillus amyloliquefaciens strain AT332 + SX, Bacillus amyloliquefaciens strain B3 + SX, Bacillus amyloliquefaciens strain D747 + SX, Bacillus amyloliquefaciens strain DB101 + SX, Bacillus amyloliquefaciens strain DB102 + SX, Bacillus amyloliquefaciens strain GB03 + SX, Bacillus amyloliquefaciens strain FZB24 + SX, Bacillus amyloliquefaciens strain FZB42 + SX, Bacillus amyloliquefaciens strain IN937a + SX, Bacillus amyloliquefaciens strain MBI600 + SX, Bacillus amyloliquefaciens strain QST713 + SX,Bacillus amyloliquefaciens isolate strain B246 + SX, Bacillus amyloliquefaciens strain F727 + SX, Bacillus amyloliquefaciens subsp. plantarum strain D747 + SX, Bacillus licheniformis strain HB-2 + SX, Bacillus licheniformis strain SB3086 + SX, Bacillus pumilus strain AQ717 + SX, Bacillus pumilus strain BUF-33 + SX, Bacillus pumilus strain GB34 + SX, Bacillus pumilus strain QST2808 + SX, Bacillus simplex strain CGF2856 + SX, Bacillus subtilis strain AQ153 + SX, Bacillus subtilis strain AQ743 + SX, Bacillus subtilis strain BU1814 + SX, Bacillus subtilis strain D747 + SX, Bacillus subtilis strain DB101 + SX, Bacillus subtilis strain FZB24 + SX, Bacillus subtilis strain GB03 + SX, Bacillus subtilis strain HAI0404 + SX, Bacillus subtilis strain IAB / BS03 + SX, Bacillus subtilis strain MBI600 + SX, Bacillus subtilis strain QST30002 / AQ30002 + SX, Bacillus subtilis strain QST30004 / AQ30004 + SX, Bacillus subtilis strain QST713 + SX, Bacillus subtilis strain QST714 + SX,Bacillus subtilis var. Amyloliquefaciens strain FZB24 + SX, Bacillus subtilis strain Y1336 + SX, Burkholderia cepacia + SX, Burkholderia cepacia type Wisconsin strain J82 + SX, Burkholderia cepacia type Wisconsin strain M54 + SX, Candida oleophila strain O + SX, Candida saitoana + SX, Chaetomium cupreum + SX, Clonostachys rosea + SX, Coniothyrium minitans strain CGMCC8325 + SX, Coniothyrium minitans strain CON / M / 91-8 + SX, cryptococcus albidus + SX, Erwinia carotovora subsp. carotovora strain CGE234M403 + SX, Fusarium oxysporum strain Fo47 + SX, Gliocladium catenulatum strain J1446 + SX, Paenibacillus polymyxa strain AC-1 + SX, Paenibacillus polymyxa strain BS-0105 + SX, Pantoea agglomerans strain E325 + SX, Phlebiopsis gigantea strain VRA1992 + SX, Pseudomonas aureofaciens strain TX-1 + SX, Pseudomonas chlororaphis strain 63-28 + SX, Pseudomonas chlororaphis strain AFS009 + SX, Pseudomonas chlororaphis strain MA342 + SX, Pseudomonas fluorescens strain 1629RS + SX,Pseudomonas fluorescens strain A506 + SX, Pseudomonas fluorescens strain CL145A + SX, Pseudomonas fluorescens strain G7090 + SX, Pseudomonas sp. strain CAB-02 + SX, Pseudomonas syringae strain 742RS + SX, Pseudomonas syringae strain MA-4 + SX, Pseudozyma flocculosa strain PF-A22UL + SX, Pseudomonas rhodesiae strain HAI-0804 + SX, Pythium oligandrum strain DV74 + SX, Pythium oligandrum strain M1 + SX, Streptomyces griseoviridis strain K61 + SX, Streptomyces lydicus strain WYCD108US + SX, Streptomyces lydicus strain WYEC108 + SX, Talaromyces flavus strain SAY-Y-94-01 + SX, Talaromyces flavus strain V117b + SX, Trichoderma asperellum strain ICC012 + SX, Trichoderma asperellum SKT-1 + SX, Trichoderma asperellum strain T25 + SX, Trichoderma asperellum strain T34 + SX, Trichoderma asperellum strain TV1 + SX, Trichoderma atroviride strain CNCM 1-1237 + SX, Trichoderma atroviride strain LC52 + SX, Trichoderma atroviride strain IMI 206040 + SX, Trichoderma atroviride strain SC1 + SX,Trichoderma atroviride strain SKT-1 + SX, Trichoderma atroviride strain T11 + SX, Trichoderma gamsii strain ICC080 + SX, Trichoderma harzianum strain 21 + SX, Trichoderma harzianum strain DB104 + SX, Trichoderma harzianum strain DSM 14944 + SX, Trichoderma harzianum strain ESALQ-1303 + SX, Trichoderma harzianum strain ESALQ-1306 + SX, Trichoderma harzianum strain IIHR-Th-2 + SX, Trichoderma harzianum strain ITEM908 + SX, Trichoderma harzianum strain kd + SX, Trichoderma harzianum strain MO1 + SX, Trichoderma harzianum strain SF + SX, Trichoderma harzianum strain T22 + SX, Trichoderma harzianum strain T39 + SX, Trichoderma harzianum strain T78 + SX, Trichoderma harzianum strain TH35 + SX, Trichoderma polysporum strain IMI206039 + SX, trichoderma stromaticum + SX, Trichoderma virens strain G-41 + SX, Trichoderma virens strain GL-21 + SX, Trichoderma viride + SX, Variovorax paradoxus strain CGF4526 + SX, Harpin protein + SX。,

[0058] Combinations of the present ingredient in group (c) above with the compound of the present invention: 1-methylcyclopropene + SX, 1,3-diphenylurea + SX, 2,3,5-triiodobenzoic acid + SX, (1H-indol-3-yl)acetic acid (IAA) + SX, 4-(1H-indol-3-yl)butyric acid (IBA) + SX, 2-(4-chloro-2-methylphenoxy)acetic acid (MCPA) + SX, 4-(4-chloro-2-methylphenoxy)butyric acid (MCPB) + SX, 4-chlorophenoxyacetic acid (4-CPA) + SX, 5-aminolevulinic acid hydrochloride + SX, 6-benzylaminopurine + SX, abscisic acid + SX, AVG (aminoethoxyvinylglycine) + SX, anisiflupurin + SX, ancymidol + SX, butralin + SX, calcium carbonate + SX, calcium chloride + SX, calcium formate + SX, calcium peroxide + SX, calcium polysulfide + SX, calcium sulfate + SX, chlormequat chloride + SX, chlorpropham + SX, choline chloride + SX, cloprop + SX, cyanamide + SX, Cyclanilide + SX,Daminozide + SX, decan-1-ol + SX, dichlorprop + SX, dikegulac + SX, dimethipin + SX, diquat + SX, ethephon + SX, ethychlozate + SX, flumetralin + SX, flurprimidol + SX, forchlorfenuron + SX, formononetin + SX, gibberellin A + SX, gibberellin A3 + SX, inabenfide + SX, Kinetin + SX, lipochitooligosaccharide SP104 + SX, maleic hydrazide + SX, mefluidide + SX, mepiquat chloride + SX, oxidized glutathione + SX, paclobutrazol + SX, pendimethalin + SX, prohexadione calcium + SX, prohydrojasmon + SX, pyraflufen-ethyl + SX, sintophen + SX, sodium 1-naphthaleneacetate + SX, sodium cyanate + SX, Thidiazuron + SX, triapenthenol + SX, tribufos + SX, trinexapac-ethyl + SX,Uniconazole-P + SX, 2-(naphthalen-1-yl)acetamide + SX, [4-oxo-4-(2-phenylethyl)amino]butyric acid + SX, Methyl 5-(trifluoromethyl)benzo[b]thiophene-2-carboxylate + SX, 3-[(6-chloro-4-phenylquinazolin-2-yl)amino]propan-1-ol + SX, Claroideoglomus etunicatum + SX, Claroideoglomus claroideum + SX, Funneliformis mosseae + SX, Gigaspora margarita + SX, Gigaspora rosea + SX, Glomus aggregatum + SX, Glomus deserticola + SX, Glomus monosporum + SX, Paraglomus brasillianum + SX, Rhizophagus clarus + SX, Rhizophagus intraradices RTI-801 + SX, Rhizophagus irregularis DAOM 197198 + SX, Azorhizobium caulinodans + SX, Azospirillum amazonense + SX, Azospirillum brasilense XOH + SX, Azospirillum brasilense Ab-V5 + SX, Azospirillum brasilense Ab-V6 + SX, Azospirillum caulinodans + SX, Azospirillum halopraeferens + SX, Azospirillum irakense + SX, Azospirillum lipoferum + SX, Bradyrhizobium elkanii SEMIA 587 + SX, Bradyrhizobium elkanii SEMIA 5019 + SX, Bradyrhizobium japonicum TA-11 + SX,Bradyrhizobium japonicum USDA 110 + SX, Bradyrhizobium liaoningense + SX, Bradyrhizobium lupini + SX, Delftia acidovorans RAY209 + SX, Mesorhizobium ciceri + SX, Mesorhizobium huakii + SX, Mesorhizobium loti + SX, Rhizobium etli + SX, Rhizobium galegae + SX, Rhizobium leguminosarum bv. Phaseoli + SX, Rhizobium leguminosarum bv. Trifolii + SX, Rhizobium leguminosarum bv. Viciae + SX, Rhizobium trifolii + SX, Rhizobium tropici + SX, Sinorhizobium fredii + SX, Sinorhizobium meliloti + SX, Zucchini Yellow Mosaik Virus weak strain + SX. ,

[0059] Combinations of the present component of the above group (d) with the compound of the present invention: anthraquinone + SX, deet + SX, icaridin + SX.

[0060] The ratio of the compound of the present invention to the present component is not particularly limited, and examples thereof include a weight ratio (compound of the present invention:present component) of 1000:1 to 1:1000, 500:1 to 1:500, 100:1 to 1:100, 50:1, 20:1, 10:1, 9:1, 8:1, 7:1, 6:1, 5:1, 4:1, 3:1, 2:1, 1:1, 1:2, 1:3, 1:4, 1:5, 1:6, 1:7, 1:8, 1:9, 1:10, 1:20, 1:50, and the like.

[0061] The present compound, the compound of the present invention, or Composition A can control plant diseases caused by plant pathogenic microorganisms such as fungi, oomycetes, Phytomyxea, and bacteria. Examples of fungi include Ascomycota, Basidiomycota, Blastocladiomycota, Chytridiomycota, Mucoromycota, and Olpidiomycota. Specific examples include the following: The scientific name of the plant pathogenic microorganism that causes each disease is shown in parentheses.

[0062] Rice diseases: Blast (Pyricularia oryzae), Brown spot (Cochliobolus miyabeanus), Sheath blight (Rhizoctonia solani), Bakanae disease (Gibberella fujikuroi), Yellowing and wilting disease (Sclerophthora macrospora), False blast and panicle blight (Epicoccum nigrum), Seedling blight (Trichoderma viride, Rhizopus oryzae), Suspected sheath blight (Red sclerotium pathogen (Waitea circinata), Brown sclerotium pathogen (Ceratobasidium setariae), Brown sheath blight pathogen (Thanatephorus cucumeris)), False smut (Ustilaginoidea virens), Black kernel smut (Tilletia horrida, Tilletia barclayana);Wheat diseases: Powdery mildew (Blumeria graminis), head blight (Fusarium graminearum, Fusarium avenaceum, Fusarium culmorum, Microdochium nivale), yellow rust (Puccinia striiformis), black rust (Puccinia graminis), red rust (Puccinia recondita), pink snow blight (Microdochium nivale, Microdochium majus), small snow blight (Typhula incarnata, Typhula ishikariensis), large snow blight (Sclerotinia borealis), brown snow blight (Pythium spp.), naked smut (Ustilago tritici), grass smut (Tilletia caries, Tilletia controversa), eyespot (Pseudocercosporella herpotrichoides), leaf blight (Septoria tritici), rotten blight (Stagonospora nodorum), yellow spot (Pyrenophora tritici-repentis), seedling damping off caused by Rhizoctonia fungi (Rhizoctonia solani), damping off (Gaeumannomyces graminis), rice blast (Pyricularia graminis-tritici);Barley diseases: powdery mildew (Blumeria graminis), head blight (Fusarium graminearum, Fusarium avenaceum, Fusarium culmorum, Microdochium nivale), yellow rust (Puccinia striiformis), black rust (Puccinia graminis), small rust (Puccinia hordei), ear bunt (Ustilago nuda), scald (Rhynchosporium secalis), net blotch (Pyrenophora teres), leaf spot (Cochliobolus sativus), leaf spot (Pyrenophora graminea), leaf spot (Ramularia collo-cygni), seedling damping-off (Rhizoctonia solani); corn diseases: rust (Puccinia sorghi), southern rust (Puccinia polysora), sooty blight (Setosphaeria turcica), tropical rust (Physopella zeae), southern leaf blight (Cochliobolus heterostrophus), anthracnose (Colletotrichum graminicola), gray leaf spot (Cercospora zeae-maydis), brown spot (Kabatiella zeae), Phaeosphaeria leaf spot (Phaeosphaeria maydis), Diplodia disease (Stenocarpella maydis, Stenocarpella macrospora), stalk rot (Fusarium graminearum, Fusarium verticilioides, Colletotrichum graminicola), smut (Ustilago maydis), Physoderma maydis, tar spot (Phyllachora maydis);Cotton diseases: anthracnose (Colletotrichum gossypii), white mold (Ramularia areola), black spot (Alternaria macrospora, Alternaria gossypii), black root rot (Thielaviopsis basicola); coffee diseases: rust (Hemileia vastatrix), leaf spot (Cercospora coffeicola); rapeseed diseases: sclerotinia sclerotiorum, black spot (Alternaria brassicae), root rot (Phoma lingam), light leaf spot (Pyrenopeziza brassicae); sugarcane diseases: rust (Puccinia melanocephela, Puccinia kuehnii), smut (Ustilago scitaminea); sunflower diseases: rust (Puccinia helianthi), downy mildew (Plasmopara Citrus diseases: black spot (Diaporthe citri), scab (Elsinoe fawcetti), green mold (Penicillium digitatum), blue mold (Penicillium italicum), late blight (Phytophthora parasitica, Phytophthora citrophthora), aspergillus niger, white mold (Geotrichum candidum var. citri-aurantii), sooty spot (Cladosporium cladosporioides);Apple diseases: Monilinia mali, canker (Valsa ceratosperma), powdery mildew (Podosphaera leucotricha), leaf spot (Alternaria alternata apple pathotype), black spot (Venturia inaequalis), anthracnose (Glomerella cingulata, Colletotrichum acutatum), brown spot (Diplocarpon mali), ring spot (Botryosphaeria berengeriana), late blight (Phytophtora cactorum), red spot (Gymnosporangium juniperi-virginianae, Gymnosporangium yamadae); Pear diseases: black spot (Venturia nashicola, Venturia pirina), black spot (Alternaria alternata Japanese pear pathotype), red spot (Gymnosporangium haraeanum); Peach diseases: brown rot (Monilinia fructicola), black scab (Cladosporium carpophilum), phomopsis rot (Phomopsis sp.), leaf crinkle (Taphrina deformans), powdery mildew (Podosphaera leucotricha); grape diseases: black rot (Elsinoe ampelina), late rot (Glomerella cingulata, Colletotrichum acutatum), powdery mildew (Uncinula necator), rust (Neophysopella sp.), black rot (Guignardia bidwellii), downy mildew (Plasmopara viticola), brown spot (Pseudocercospora vitis), white rot (Coniella castaneicola); persimmon diseases: anthracnose (Gloeosporium kaki, Colletotrichum acutatum), leaf drop (Cercospora kaki, Mycosphaerella nawae), powdery mildew (Phyllactinia kakicola);Fig diseases: Rust (Phakopsora nishidana); Cucurbit diseases: Anthracnose (Colletotrichum lagenarium), Powdery mildew (Sphaerotheca fuliginea), Blight (Didymella bryoniae), Brown spot (Corynespora cassiicola), Blight (Fusarium oxysporum), Downy mildew (Pseudoperonospora cubensis), Late blight (Phytophthora capsici), Damping-off (Pythium sp.), Root rot (Phomopsis sp.); Tomato diseases: Ring spot (Alternaria solani), Leaf mold (Cladosporium fulvum), Leaf mold (Pseudocercospora fuligena), Late blight (Phytophthora infestans), Powdery mildew (Leveillula taurica); Diseases of eggplant: brown spot (Phomopsis vexans), powdery mildew (Erysiphe cichoracearum), black blight (Corynespora melongenae), sooty mold (Mycovellosiella nattrassii), brown spot (Thanatephorus cucumeris); diseases of cruciferous vegetables: black spot (Alternaria japonica), white spot (Cercosporella brassicae), clubroot (Plasmodiophora brassicae), downy mildew (Peronospora parasitica), white rust (Albugo candida), sooty mold (Alternaria brassicicola); diseases of leeks: rust (Puccinia allii), black spot (Alternaria porri), black rot (Sclerotium cepivorum), small sclerotial rot (Botrytis squamosa), leaf blight (Stemphylium vesicarium, Stempphylium botryosum), white silk disease (Sclerotium rolfsii), white spot leaf blight (Botrytis squamosa);Soybean diseases: Purple spot (Cercospora kikuchii), black rot (Elsinoe glycines), black spot (Diaporthe phaseolorum var. sojae), rust (Phakopsora pachyrhizi), brown ring spot (Corynespora cassiicola), anthracnose (Colletotrichum glycines, Colletotrichum truncatum), leaf rot (Rhizoctonia solani), brown spot (Septoria glycines), leaf spot (Cercospora sojina), sclerotinia sclerotiorum, powdery mildew (Microsphaera diffusa), stem rot (Phytophthora sojae), downy mildew (Peronospora manshurica), sudden death (Fusarium virguliforme), black root rot (Calonectria ilicicola), Diaporthe / Phomopsis Diseases of soybeans include: complex (Diaporthe longicolla, Diaporthe phaseolorum, Phomopsis longicolla), pod anomalies of soybeans caused by various pathogenic fungi; diseases of common beans: Sclerotinia sclerotiorum, rust (Uromyces appendiculatus), angular spot (Phaeoisariopsis griseola), anthracnose (Colletotrichum lindemuthianum), root rot (Fusarium solani); diseases of peanuts: black spot (Cercospora personata), brown spot (Cercospora arachidicola), southern blight (Sclerotium rolfsii), black root rot (Calonectria ilicicola); diseases of peas: powdery mildew (Erysiphe pisi), root rot (Fusarium solani);Potato diseases: summer blight (Alternaria solani), late blight (Phytophthora infestans), scarlet rot (Phytophthora erythroseptica), powdery scab (Spongospora subterranea f. sp. subterranea), verticillium wilt (Verticillium albo-atrum, Verticillium dahliae, Verticillium nigrescens), dry rot (Fusarium solani), canker (Synchytrium endobioticum); strawberry diseases: powdery mildew (Sphaerotheca humuli), anthracnose (Glomerella cingulata, Colletotrichum acutatum); tea diseases: net blight (Exobasidium reticulatum), white spot (Elsinoe leucospila), ring spot (Pestalotiopsis Diseases of tobacco: red spot (Alternaria longipes), anthracnose (Colletotrichum tabacum), downy mildew (Peronospora tabacina), late blight (Phytophthora nicotianae); Diseases of sugar beet: brown spot (Cercospora beticola), leaf rot (Thanatephorus cucumeris), root rot (Thanatephorus cucumeris), black r...

Claims

1. Formula (I) [wherein A represents a 5- to 6-membered non-aromatic nitrogen-containing heterocyclic group or a 5- to 6-membered aromatic nitrogen-containing heterocyclic group (provided that in the 5- to 6-membered non-aromatic nitrogen-containing heterocyclic group and the 5- to 6-membered aromatic nitrogen-containing heterocyclic group, at least one of the atoms adjacent to the atom bonding to D and constituting the 5- to 6-membered non-aromatic nitrogen-containing heterocyclic group and the 5- to 6-membered aromatic nitrogen-containing heterocyclic group is a nitrogen atom) {the 5- to 6-membered non-aromatic nitrogen-containing heterocyclic group and the 5- to 6-membered aromatic nitrogen-containing heterocyclic group may be substituted with one or more substituents selected from group J}, D represents CR 1 R 2 , C=O, C=S, or C=N-OR 10 X represents a halogen atom; 1 , X 2 , and X 3 are the same or different and represent a halogen atom or a hydrogen atom; Z 1 represents a methyl group substituted with one or more substituents selected from Group D, a C2-C6 chain hydrocarbon group {the C2-C6 chain hydrocarbon group may be substituted with one or more substituents selected from Group C}, a 5- to 7-membered aromatic heterocyclic group {the 5- to 7-membered aromatic heterocyclic group may be substituted with one or more substituents selected from Group A, and any two adjacent atoms not bonded to the benzene ring substituted with X among the atoms constituting the 5- to 7-membered aromatic heterocyclic group are replaced by another C4-C7 alicyclic hydrocarbon containing the two adjacent atoms, a 4- to 7-membered non-aromatic heterocyclic ring {the C4-C7 alicyclic hydrocarbon and the 4- to 7-membered non-aromatic heterocycle may be substituted with one or more substituents selected from Group B}, a benzene ring or a 5- to 6-membered aromatic heterocycle {the benzene ring and the 5- to 6-membered aromatic heterocycle may be substituted with one or more substituents selected from Group A} (excluding a 5-trifluoromethyl-1,2,4-oxadiazol-3-yl group), a C3-C8 alicyclic hydrocarbon group {the C3-C8 alicyclic hydrocarbon group may be substituted with one or more substituents selected from Group B, and among the atoms constituting the C3-C8 alicyclic hydrocarbon group, X may be Any atom not bonded to the substituted benzene ring may form a C3-C7 alicyclic hydrocarbon or a 3- to 7-membered non-aromatic heterocycle as a spiro atom, and any two adjacent atoms not bonded to the benzene ring substituted with X among the atoms constituting the C3-C8 alicyclic hydrocarbon group may form another C4-C7 alicyclic hydrocarbon containing the two adjacent atoms, a 4- to 7-membered non-aromatic heterocycle (the C4-C7 alicyclic hydrocarbon and the 4- to 7-membered non-aromatic heterocycle may be substituted with one or more substituents selected from Group B), a benzene ring, or a 5- to 6-membered aromatic heterocycle (the benzene ring and the 5- or 6-membered aromatic heterocycle may be substituted with one or more substituents selected from Group A}, and among the atoms constituting the C3-C8 alicyclic hydrocarbon group, any two atoms that are not adjacent to each other (provided that neither of the any two atoms is bonded to the benzene ring substituted with X) may be bridged by —CH2— or —(CH2)2—}, a 3- to 8-membered non-aromatic heterocyclic group {the 3- to 8-membered non-aromatic heterocyclic group may be substituted with one or more substituents selected from Group B, and among the atoms constituting the 3- to 8-membered non-aromatic heterocyclic group,Any atom not bonded to the benzene ring substituted with X may form a C3-C7 alicyclic hydrocarbon or a 3- to 7-membered non-aromatic heterocycle as a spiro atom, and any two adjacent atoms not bonded to the benzene ring substituted with X among the atoms constituting the 3- to 8-membered non-aromatic heterocyclic group may be another C4-C7 alicyclic hydrocarbon containing the two adjacent atoms, a 4- to 7-membered non-aromatic heterocycle {the C4-C7 alicyclic hydrocarbon and the 4- to 7-membered non-aromatic heterocycle may be substituted with one or more substituents selected from group B}, a benzene ring, or a 5- to 6-membered aromatic heterocycle. a 3- to 8-membered non-aromatic heterocyclic group (the benzene ring and the 5- or 6-membered aromatic heterocyclic ring may be substituted with one or more substituents selected from Group A), and any two atoms that are not adjacent to each other among the atoms constituting the 3- to 8-membered non-aromatic heterocyclic group (provided that neither of the two atoms is bonded to the benzene ring substituted with X) may be bridged by —CH— or —(CH)—) (excluding a 5-trifluoromethyl-4,5-dihydro-1,2,4-oxadiazol-3-yl group), a cyano group, OR, 5 , S.R. 6 , S(O)R 7 , S(O)R 8 , C(O)R 9 , N.R. 11 R 12 , or C(R 35 ) = NOR 36 represents R 1 and R 2 are the same or different and each represent a C1-C4 chain hydrocarbon group optionally substituted with one or more substituents selected from Group E, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group (the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group may be substituted with one or more substituents selected from Group B), a phenyl group, a 5- to 6-membered aromatic heterocyclic group (the phenyl group and the 5- to 6-membered aromatic heterocyclic group may be substituted with one or more substituents selected from Group G), OR 13 , S.R. 14 , S(O)R 15 , S(O)R 16 , N.R. 17 R 18 , C(O)R 19 , C(R 20 ) = NOR 21 , a cyano group, a nitro group, a halogen atom, or a hydrogen atom, or R 1 and R 2 may form, together with the carbon atom to which they are attached, a C3-C8 alicyclic hydrocarbon or a 3- to 8-membered non-aromatic heterocycle (the C3-C8 alicyclic hydrocarbon and the 3- to 8-membered non-aromatic heterocycle may be substituted with one or more substituents selected from Group B); R 5 is a methyl group, a C2-C6 chain hydrocarbon group, a C1-C6 alkylsulfonyl group, a (C1-C6 alkyl)carbonyl group, a (C1-C6 alkoxy)carbonyl group, a (C1-C6 alkylamino)carbonyl group, or a (C2-C8 dialkylamino)carbonyl group substituted by one or more substituents selected from Group C {the C2-C6 chain hydrocarbon group, the C1-C6 alkylsulfonyl group, the (C1-C6 alkyl)carbonyl group, the (C1-C6 alkoxy)carbonyl group, the (C1-C6 alkylamino)carbonyl group, a (C2-C8 dialkylamino)carbonyl group, and the (C2-C8 dialkylamino)carbonyl group may be substituted with one or more substituents selected from Group C}, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group may be substituted with one or more substituents selected from Group B}, a phenyl group, or a 5- to 6-membered aromatic heterocyclic group {the phenyl group and the 5- to 6-membered aromatic heterocyclic group may be substituted with one or more substituents selected from Group A}, R 6 means a C1-C6 chain hydrocarbon group, a (C1-C6 alkyl)carbonyl group, a (C1-C6 alkoxy)carbonyl group, a (C1-C6 alkylamino)carbonyl group, a (C2-C8 dialkylamino)carbonyl group {the C1-C6 chain hydrocarbon group, the (C1-C6 alkyl)carbonyl group, the (C1-C6 alkoxy)carbonyl group, the (C1-C6 alkylamino)carbonyl group, and the (C2-C8 dialkylamino)carbonyl group a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group may be substituted with one or more substituents selected from Group C}, a phenyl group, or a 5- to 6-membered aromatic heterocyclic group {the phenyl group and the 5- to 6-membered aromatic heterocyclic group may be substituted with one or more substituents selected from Group A}, R 7 and R 8 are the same or different and represent a C1-C6 chain hydrocarbon group, a C1-C6 alkylamino group, a C2-C8 dialkylamino group (the C1-C6 chain hydrocarbon group, the C1-C6 alkylamino group, and the C2-C8 dialkylamino group are optionally substituted with one or more substituents selected from Group C), a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group (the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group are optionally substituted with one or more substituents selected from Group B), a phenyl group, or a 5- to 6-membered aromatic heterocyclic group (the phenyl group and the 5- to 6-membered aromatic heterocyclic group are optionally substituted with one or more substituents selected from Group A), R 9 means a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group, a C1-C6 alkylamino group, a C2-C8 dialkylamino group, a (C1-C6 alkyl)(C3-C6 cycloalkyl)amino group, a C3-C6 cycloalkylamino group {the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, the C1-C6 alkylamino group, the C2-C8 dialkylamino group, the (C1-C6 alkyl)(C3-C6 cycloalkyl)amino group, and the C3-C6 cycloalkylamino group. R represents a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group may be substituted with one or more substituents selected from Group C}, a phenyl group, a 5- to 6-membered aromatic heterocyclic group {the phenyl group and the 5- to 6-membered aromatic heterocyclic group may be substituted with one or more substituents selected from Group A}, an amino group, or a hydrogen atom; 10 and R 36 are the same or different and represent a C1-C6 chain hydrocarbon group optionally substituted with one or more substituents selected from Group C, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group (the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group may be substituted with one or more substituents selected from Group B), or a hydrogen atom; R 11 means a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group, a C1-C6 alkylsulfonyl group, a (C1-C6 alkyl)carbonyl group, a (C1-C6 alkoxy)carbonyl group, a (C1-C6 alkylamino)carbonyl group, a (C2-C8 dialkylamino)carbonyl group {the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, the C1-C6 alkylsulfonyl group, the (C1-C6 alkyl)carbonyl group, the (C1-C6 alkoxy)carbonyl group, the (C1-C6 alkylamino)carbonyl group, a (C2-C8 dialkylamino)carbonyl group, and the (C2-C8 dialkylamino)carbonyl group may be substituted with one or more substituents selected from Group C}, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group may be substituted with one or more substituents selected from Group B}, a phenyl group, a 5- to 6-membered aromatic heterocyclic group {the phenyl group and the 5- to 6-membered aromatic heterocyclic group may be substituted with one or more substituents selected from Group A}, or a hydrogen atom; 12 means a C1-C6 chain hydrocarbon group, a C1-C6 alkylsulfonyl group, a (C1-C6 alkyl)carbonyl group, a (C3-C6 cycloalkyl)carbonyl group, a (C1-C6 alkoxy)carbonyl group, a (C1-C6 alkylamino)carbonyl group, a (C2-C8 dialkylamino)carbonyl group {the C1-C6 chain hydrocarbon group, the C1-C6 alkylsulfonyl group, the (C1-C6 alkyl)carbonyl group, the (C3-C6 cycloalkyl)carbonyl group, the (C1-C6 alkoxy)carbonyl group, the (C1-C a (C2-C8 dialkylamino)carbonyl group, and the (C2-C8 dialkylamino)carbonyl group may be substituted with one or more substituents selected from Group C}, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group may be substituted with one or more substituents selected from Group B}, a phenyl group, or a 5- to 6-membered aromatic heterocyclic group {the phenyl group and the 5- to 6-membered aromatic heterocyclic group may be substituted with one or more substituents selected from Group A}, R 13 and R 14 are the same or different and represent a C1-C6 chain hydrocarbon group optionally substituted with one or more substituents selected from Group E, a C1-C6 alkylsulfonyl group, a (C1-C6 alkyl)carbonyl group, a (C1-C6 alkoxy)carbonyl group, a (C1-C6 alkylamino)carbonyl group, a (C2-C8 dialkylamino)carbonyl group {the C1-C6 alkylsulfonyl group, the (C1-C6 alkyl)carbonyl group, the (C1-C6 alkoxy)carbonyl group, the (C1-C6 alkylamino)carbonyl group, and the (C2-C8 dialkylamino)carbonyl group are optionally substituted with one or more halogen atoms}, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group are optionally substituted with one or more substituents selected from Group B}, or a hydrogen atom; R 15 and R 16 are the same or different and represent a C1-C6 chain hydrocarbon group optionally substituted with one or more substituents selected from Group E, a C1-C6 alkoxy group, a C1-C6 alkylamino group, a C2-C8 dialkylamino group (the C1-C6 alkoxy group, the C1-C6 alkylamino group, and the C2-C8 dialkylamino group are optionally substituted with one or more halogen atoms), a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group (the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group are optionally substituted with one or more substituents selected from Group B), a phenyl group, a 5- to 6-membered aromatic heterocyclic group (the phenyl group and the 5- to 6-membered aromatic heterocyclic group are optionally substituted with one or more substituents selected from Group G), or an amino group, R 17 and R 23 are the same or different and each represents a C1-C6 chain hydrocarbon group optionally substituted by one or more substituents selected from Group E, a C1-C6 alkoxy group, a C1-C6 alkylsulfonyl group, a (C1-C6 alkyl)carbonyl group, a (C1-C6 alkoxy)carbonyl group, a (C1-C6 alkylamino)carbonyl group, a (C2-C8 dialkylamino)carbonyl group {the C1-C6 alkoxy group, the C1-C6 alkylsulfonyl group, the (C1-C6 alkyl)carbonyl group, the (C1-C6 alkoxy)carbonyl group, the (C1- a (C6 alkylamino)carbonyl group, and the (C2-C8 dialkylamino)carbonyl group may be substituted with one or more halogen atoms}, a C3-C8 alicyclic hydrocarbon group, a 3-8 membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3-8 membered non-aromatic heterocyclic group may be substituted with one or more substituents selected from Group B}, a phenyl group, a 5-6 membered aromatic heterocyclic group {the phenyl group and the 5-6 membered aromatic heterocyclic group may be substituted with one or more substituents selected from Group G}, or a hydrogen atom; 18 and R 24 are the same or different and are each a C1-C6 chain hydrocarbon group optionally substituted by one or more substituents selected from Group E, a C1-C6 alkylsulfonyl group, a (C1-C6 alkyl)carbonyl group, a (C1-C6 alkoxy)carbonyl group, a (C1-C6 alkylamino)carbonyl group, a (C2-C8 dialkylamino)carbonyl group {the C1-C6 alkylsulfonyl group, the (C1-C6 alkyl)carbonyl group, the (C1-C6 alkoxy)carbonyl group, the (C1-C6 alkylamino)carbonyl group, a (C2-C8 dialkylamino)carbonyl group, and the (C2-C8 dialkylamino)carbonyl group may be substituted with one or more halogen atoms}, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group may be substituted with one or more substituents selected from Group B}, a phenyl group, a 5- to 6-membered aromatic heterocyclic group {the phenyl group and the 5- to 6-membered aromatic heterocyclic group may be substituted with one or more substituents selected from Group G}, or a hydrogen atom; 19 represents a C1-C6 chain hydrocarbon group optionally substituted with one or more substituents selected from Group E, a C1-C6 alkoxy group, a C1-C6 alkylamino group, a C2-C8 dialkylamino group {the C1-C6 alkoxy group, the C1-C6 alkylamino group, and the C2-C8 dialkylamino group are optionally substituted with one or more halogen atoms}, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group are optionally substituted with one or more substituents selected from Group B}, a phenyl group, a 5- to 6-membered aromatic heterocyclic group {the phenyl group and the 5- to 6-membered aromatic heterocyclic group are optionally substituted with one or more substituents selected from Group G}, a hydroxy group, an amino group, or a hydrogen atom; R 20 , R 26 , and R 35 are the same or different and represent a C1-C6 chain hydrocarbon group optionally substituted with one or more substituents selected from group C, or a hydrogen atom; R 21 and R 27 are the same or different and represent a C1-C6 chain hydrocarbon group optionally substituted with one or more substituents selected from Group E, a C3-C8 alicyclic hydrocarbon group, a 3-8 membered non-aromatic heterocyclic group (the C3-C8 alicyclic hydrocarbon group and the 3-8 membered non-aromatic heterocyclic group may be substituted with one or more substituents selected from Group B), a phenyl group, a 5-6 membered aromatic heterocyclic group (the phenyl group and the 5-6 membered aromatic heterocyclic group may be substituted with one or more substituents selected from Group G), or a hydrogen atom, R 22 is a C1-C6 chain hydrocarbon group optionally substituted by one or more substituents selected from Group E, a C1-C6 alkylsulfonyl group, a (C1-C6 alkyl)carbonyl group, a (C1-C6 alkoxy)carbonyl group, a (C1-C6 alkylamino)carbonyl group, a (C2-C8 dialkylamino)carbonyl group {the C1-C6 alkylsulfonyl group, the (C1-C6 alkyl)carbonyl group, the (C1-C6 alkoxy)carbonyl group, the (C1-C6 alkylamino)carbonyl group, a (C2-C8 dialkylamino)carbonyl group, and the (C2-C8 dialkylamino)carbonyl group may be substituted with one or more halogen atoms}, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group may be substituted with one or more substituents selected from Group B}, a phenyl group, or a 5- to 6-membered aromatic heterocyclic group {the phenyl group and the 5- to 6-membered aromatic heterocyclic group may be substituted with one or more substituents selected from Group G}, R 25 represents a C1-C6 chain hydrocarbon group which may be substituted with one or more substituents selected from Group E, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group may be substituted with one or more substituents selected from Group B}, an amino group, a hydroxy group, or a hydrogen atom. Group A: a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group, a C1-C6 alkylamino group, a C2-C8 dialkylamino group, a (C1-C6 alkyl)carbonyl group, a (C1-C6 alkoxy)carbonyl group, a (C1-C6 alkylamino)carbonyl group, a (C2-C8 dialkylamino)carbonyl group, a (C1-C6 alkyl)carbonylamino group, a (C1-C6 alkoxy)carbonylamino group {the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, the C1-C6 alkylamino group, the C2-C8 dialkylamino group, the (C1-C6 alkyl)carbonyl group, the ( the (C1-C6 alkoxy)carbonyl group, the (C1-C6 alkylamino)carbonyl group, the (C2-C8 dialkylamino)carbonyl group, the (C1-C6 alkyl)carbonylamino group, and the (C1-C6 alkoxy)carbonylamino group are optionally substituted with one or more halogen atoms}, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group are optionally substituted with one or more substituents selected from group F}, a halogen atom, a cyano group, a nitro group, a hydroxy group, and a sulfanyl group.Group B: oxo group, thioxo group, C1-C6 chain hydrocarbon group, C1-C6 alkoxy group, C1-C6 alkylamino group, C2-C8 dialkylamino group, (C1-C6 alkyl)carbonyl group, (C1-C6 alkoxy)carbonyl group, (C1-C6 alkylamino)carbonyl group, (C2-C8 dialkylamino)carbonyl group, (C1-C6 alkyl)carbonylamino group, (C1-C6 alkoxy)carbonylamino group {the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, the C1-C6 alkylamino group, the C2-C8 dialkylamino group, the (C1-C6 alkyl)carbonyl the (C1-C6 alkoxy)carbonyl group, the (C1-C6 alkylamino)carbonyl group, the (C2-C8 dialkylamino)carbonyl group, the (C1-C6 alkyl)carbonylamino group, and the (C1-C6 alkoxy)carbonylamino group are optionally substituted with one or more halogen atoms}, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group are optionally substituted with one or more substituents selected from group F}, a halogen atom, a cyano group, a nitro group, a hydroxy group, and a sulfanyl group. Group C: the group consisting of a C1-C6 alkoxy group, a C1-C6 alkylamino group, a C2-C8 dialkylamino group, a C1-C6 alkylsulfanyl group, a C1-C6 alkylsulfinyl group, a C1-C6 alkylsulfonyl group {the C1-C6 alkoxy group, the C1-C6 alkylamino group, the C2-C8 dialkylamino group, the C1-C6 alkylsulfanyl group, the C1-C6 alkylsulfinyl group and the C1-C6 alkylsulfonyl group are optionally substituted with one or more halogen atoms}, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group are optionally substituted with one or more substituents selected from Group F}, a halogen atom, a cyano group, a nitro group, a hydroxy group, and a sulfanyl group.Group D: a C1-C6 alkoxy group, a C1-C6 alkylamino group, a C2-C8 dialkylamino group, a C1-C6 alkylsulfanyl group, a C1-C6 alkylsulfinyl group, a C1-C6 alkylsulfonyl group, a (C1-C6 alkyl)carbonyl group, a (C1-C6 alkoxy)carbonyl group, a (C1-C6 alkylamino)carbonyl group, a (C2-C8 dialkylamino)carbonyl group, a (C1-C6 alkyl)carbonylamino group, a (C1-C6 alkoxy)carbonylamino group {the C1-C6 alkoxy group, the C1-C6 alkylamino group, the C2-C8 dialkylamino group, the C1-C6 alkylsulfanyl group, the C1-C6 alkylsulfinyl group, the C1-C6 alkylsulfonyl group, the (C the (C1-C6 alkyl)carbonyl group, the (C1-C6 alkoxy)carbonyl group, the (C1-C6 alkylamino)carbonyl group, the (C2-C8 dialkylamino)carbonyl group, the (C1-C6 alkyl)carbonylamino group and the (C1-C6 alkoxy)carbonylamino group are optionally substituted with one or more halogen atoms}, a C3-C8 alicyclic hydrocarbon group, a 3-8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3-8-membered non-aromatic heterocyclic group are optionally substituted with one or more substituents selected from group F}, a phenyl group, a 5- or 6-membered aromatic heterocycle {the phenyl group and the 5- or 6-membered aromatic heterocycle are optionally substituted with one or more substituents selected from group A}, and a cyano group.Group E: a C1-C6 alkoxy group, a C1-C6 alkylamino group, a C2-C8 dialkylamino group, a C1-C6 alkylsulfanyl group, a C1-C6 alkylsulfinyl group, a C1-C6 alkylsulfonyl group {the C1-C6 alkoxy group, the C1-C6 alkylamino group, the C2-C8 dialkylamino group, the C1-C6 alkylsulfanyl group, the C1-C6 alkylsulfinyl group, and the C1-C6 alkylsulfonyl group are substituted with one or more halogen atoms; the group consisting of a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group may be substituted with one or more substituents selected from group F}, a phenyl group, a 5- to 6-membered aromatic heterocyclic group {the phenyl group and the 5- to 6-membered aromatic heterocyclic group may be substituted with one or more substituents selected from group G}, a halogen atom, a cyano group, a nitro group, a hydroxy group, and a sulfanyl group. Group F: a group consisting of an oxo group, a thioxo group, a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group, a C1-C6 alkylsulfanyl group, a C1-C6 alkylsulfinyl group, a C1-C6 alkylsulfonyl group (the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, the C1-C6 alkylsulfanyl group, the C1-C6 alkylsulfinyl group, and the C1-C6 alkylsulfonyl group are optionally substituted with one or more halogen atoms), a hydroxy group, a sulfanyl group, a halogen atom, and a cyano group.Group G: C1-C6 chain hydrocarbon group, C1-C6 alkoxy group, C1-C6 alkylsulfanyl group, C1-C6 alkylsulfinyl group, C1-C6 alkylsulfonyl group, C1-C6 alkylamino group, C2-C8 dialkylamino group, (C1-C6 alkyl)carbonyl group, (C1-C6 alkoxy)carbonyl group, (C1-C6 alkylamino)carbonyl group, (C2-C8 dialkylamino)carbonyl group, (C1-C6 alkyl)carbonylamino group, (C1-C6 alkoxy)carbonylamino group {the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, the C1-C6 alkylsulfanyl group, the C1-C6 alkylsulfinyl group, the C1-C6 alkylsulfonyl group, the C1 the group consisting of a -C6 alkylamino group, the C2-C8 dialkylamino group, the (C1-C6 alkyl)carbonyl group, the (C1-C6 alkoxy)carbonyl group, the (C1-C6 alkylamino)carbonyl group, the (C2-C8 dialkylamino)carbonyl group, the (C1-C6 alkyl)carbonylamino group and the (C1-C6 alkoxy)carbonylamino group are optionally substituted with one or more halogen atoms}, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group are optionally substituted with one or more substituents selected from group F}, an amino group, a nitro group, a cyano group, a hydroxy group, a sulfanyl group, and a halogen atom. Group H: a group consisting of a C1-C6 alkylsulfanyl group, a C1-C6 alkylsulfinyl group, a C1-C6 alkylsulfonyl group, a C1-C6 alkylamino group, a C2-C8 dialkylamino group (the C1-C6 alkylsulfanyl group, the C1-C6 alkylsulfinyl group, the C1-C6 alkylsulfonyl group, the C1-C6 alkylamino group and the C2-C8 dialkylamino group are optionally substituted with one or more halogen atoms), a C3-C8 alicyclic hydrocarbon group, a 3-8-membered non-aromatic heterocyclic group (the C3-C8 alicyclic hydrocarbon group and the 3-8-membered non-aromatic heterocyclic group are optionally substituted with one or more substituents selected from Group F), a phenyl group, a 5-6-membered aromatic heterocyclic group (the phenyl group and the 5-6-membered aromatic heterocyclic group are optionally substituted with one or more substituents selected from Group G}, a hydroxy group, and a halogen atom.Group J: a methyl group optionally substituted with one or more substituents selected from Group H, a C2-C6 chain hydrocarbon group {the C2-C6 chain hydrocarbon group may be substituted with one or more substituents selected from Group E}, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group may be substituted with one or more substituents selected from Group B}, OR. 22 , N.R. 23 R 24 , C(O)R 25 , C(R 26 ) = NOR 27 , the group consisting of an amino group, a cyano group, a nitro group, and a halogen atom.], or an N-oxide or a salt thereof to a plant or soil in which the plant is grown.

2. Formula (II) [In the formula, A a is a compound of formula H1, H2, H3, or H4 [Wherein, # is D a represents a bonding site with 1 is a nitrogen atom or CR 1b represents 2 is a nitrogen atom or CR 2b represents 3 is a nitrogen atom or CR 3b represents 4 is a nitrogen atom or CR 4b represents 5 is a nitrogen atom or CR 5b (where G 2 , G 3 , G 4 , and G 5 The number of nitrogen atoms is 0 or 1. 1 and Q 2 are the same or different and represent an oxygen atom or a sulfur atom; R 1a , R 2a , R 3a , R 1b , R 2b , R 4b , and R 5b are the same or different, and are in the group H1 a a methyl group which may be substituted by one or more substituents selected from the group consisting of a C2-C6 chain hydrocarbon group (the C2-C6 chain hydrocarbon group is selected from the group consisting of a a a C3-C8 alicyclic hydrocarbon group {which may be substituted with one or more substituents selected from the group F a may be substituted with one or more substituents selected from the group consisting of OR 24a , N.R. 25a R 26a , C(O)R 27a , C(R 28a ) = NOR 29a , an amino group, a cyano group, a nitro group, a hydrogen atom, or a halogen atom; R 4a and R 3b are the same or different, and are in the group H2 a a methyl group which may be substituted by one or more substituents selected from the group consisting of a C2-C6 chain hydrocarbon group (the C2-C6 chain hydrocarbon group is selected from the group consisting of a a a C3-C8 alicyclic hydrocarbon group {which may be substituted with one or more substituents selected from the group F a may be substituted with one or more substituents selected from the group consisting of OR 32a , N.R. 33a R 34a , C(O)R 35a , C(R 36a ) = NOR 37a , an amino group, a cyano group, a nitro group, a hydrogen atom, or a halogen atom; D a is CR 5a R 6a , C=O, C=S, or C=N-OR 7a represents X a represents a halogen atom; X 1a , X 2a , and X 3a are the same or different and represent a hydrogen atom or a halogen atom; Z a is group D a a C2 chain hydrocarbon group (the C2 chain hydrocarbon group is selected from the group C2 a a C3-C6 chain hydrocarbon group {which may be substituted with one or more substituents selected from the group C1 a a 5- to 7-membered aromatic heterocyclic group {which may be substituted with one or more substituents selected from the following}, a 5- to 7-membered aromatic heterocyclic group {which may be substituted with one or more substituents selected from the following group A a and optionally substituted with one or more substituents selected from the following} (excluding a 5-trifluoromethyl-1,2,4-oxadiazol-3-yl group and a 1,2,4-triazine-3,5(2H,4H)-dione-2-yl group), a C3-C8 alicyclic hydrocarbon group {the C3-C8 alicyclic hydrocarbon group is a group selected from the group B a Among the atoms constituting the C3-C8 alicyclic hydrocarbon group, X a Any atom not bonded to the benzene ring substituted with X may form a C3-C7 alicyclic hydrocarbon or a 3- to 7-membered non-aromatic heterocycle as a spiro atom, and among the atoms constituting the C3-C8 alicyclic hydrocarbon group, X a any two adjacent atoms not bonded to a benzene ring substituted with another C4-C7 alicyclic hydrocarbon, a 4- to 7-membered non-aromatic heterocycle containing the two adjacent atoms {the C4-C7 alicyclic hydrocarbon and the 4- to 7-membered non-aromatic heterocycle are included in group B a a benzene ring, or a 5- or 6-membered aromatic heterocycle {the benzene ring and the 5- or 6-membered aromatic heterocycle are each selected from the group A a and any two atoms that are not adjacent to each other among the atoms constituting the C3-C8 alicyclic hydrocarbon group (provided that both of the any two atoms are substituted with one or more substituents selected from the following) may form a ring structure. a a 3- to 8-membered non-aromatic heterocyclic group {which is not bonded to a benzene ring substituted with -CH2- or -(CH2)2-, and which may be bridged by -CH2- or -(CH2)2-}, a 3- to 8-membered non-aromatic heterocyclic group {which is a 3- to 8-membered non-aromatic heterocyclic group selected from the group B a Among the atoms constituting the 3- to 8-membered non-aromatic heterocyclic group, X a Any atom not bonded to the benzene ring substituted with X may form a C3-C7 alicyclic hydrocarbon or a 3- to 7-membered non-aromatic heterocyclic ring as a spiro atom, and among the atoms constituting the 3- to 8-membered non-aromatic heterocyclic group, X a any two adjacent atoms not bonded to a benzene ring substituted with another C4-C7 alicyclic hydrocarbon, a 4- to 7-membered non-aromatic heterocycle containing the two adjacent atoms {the C4-C7 alicyclic hydrocarbon and the 4- to 7-membered non-aromatic heterocycle are included in group B a a benzene ring, or a 5- or 6-membered aromatic heterocycle {the benzene ring and the 5- or 6-membered aromatic heterocycle are each selected from the group A a and any two atoms that are not adjacent to each other among the atoms constituting the 3- to 8-membered non-aromatic heterocyclic group (provided that both of the any two atoms are not X a (not bonded to a benzene ring substituted with -CH2- or -(CH2)2-) may be bridged by -CH2- or -(CH2)2- (excluding 5-trifluoromethyl-4,5-dihydro-1,2,4-oxadiazol-3-yl group and 4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl group), a cyano group, OR 8a , S.R. 9a , S(O)R 10a , S(O)R 11a , C(O)R 12a , N.R. 13a R 14a , or C(R 30a ) = NOR 31a represents R 5a and R 6a are the same or different, and are group E a a C1-C4 chain hydrocarbon group, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group, each of which may be substituted by one or more substituents selected from the group consisting of a a phenyl group, a 5- or 6-membered aromatic heterocyclic group {the phenyl group and the 5- or 6-membered aromatic heterocyclic group may be selected from the group G a may be substituted with one or more substituents selected from the group consisting of OR 15a , S.R. 16a , S(O)R 17a , S(O)R 18a , N.R. 19a R 20a , C(O)R 21a , C(R 22a ) = NOR 23a , a cyano group, a nitro group, a halogen atom, or a hydrogen atom, or R 5a and R 6a together with the carbon atom to which they are attached, form a C3-C8 alicyclic hydrocarbon or a 3- to 8-membered non-aromatic heterocycle {the C3-C8 alicyclic hydrocarbon and the 3- to 8-membered non-aromatic heterocycle are selected from the group B a may be substituted with one or more substituents selected from the following; 7a and R 31a are the same or different, and are in the group C1 a a C1-C6 chain hydrocarbon group, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group, each of which may be substituted by one or more substituents selected from the group consisting of a or a hydrogen atom, R 8a and R 9a are the same or different, and are members of Group I a a C1-C2 chain hydrocarbon group substituted with one or more substituents selected from the group C1 a and optionally substituted with one or more substituents selected from the group consisting of a (C2-C8 dialkylamino)carbonyl group {the (C2-C8 dialkylamino)carbonyl group is optionally substituted with one or more halogen atoms}, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group are selected from the group consisting of a (C2-C8 dialkylamino)carbonyl group and ... and a (C2-C8 dialkylamino)carbonyl group {the (C2-C8 dialkylamino)carbonyl group is optionally substituted with one or more halogen atoms}, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group selected from the group consisting of a (C2-C8 dialkylamino)carbonyl group and a (C2-C8 dialkylamino)carbonyl group {the (C2-C8 dialkylamino)carbonyl group is optionally substituted with one or more halogen atoms}, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group selected from the group consisting of a (C2-C8 dialkylamino)carbonyl group and a (C2-C8 dialkylamino)carbonyl group a a phenyl group, or a 5- or 6-membered aromatic heterocyclic group {the phenyl group and the 5- or 6-membered aromatic heterocyclic group may be selected from the group G a R may be substituted with one or more substituents selected from the following 10a and R 11a are the same or different, and are in the group C1 a a C1-C6 chain hydrocarbon group, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group, each of which may be substituted by one or more substituents selected from the group consisting of the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group, each of which may be substituted by one or more substituents selected from the group consisting of the C1-C6 chain hydrocarbon group, the C3-C8 alicyclic hydrocarbon group, and the 3- to 8-membered non-aromatic heterocyclic group a a phenyl group, or a 5- or 6-membered aromatic heterocyclic group {which may be substituted with one or more substituents selected from the following}, a phenyl group, or a 5- or 6-membered aromatic heterocyclic group {the phenyl group and the 5- or 6-membered aromatic heterocyclic group are selected from the following group A a R may be substituted with one or more substituents selected from the following 12a is the group C1 a a C3-C6 chain hydrocarbon group, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group, each of which may be substituted by one or more substituents selected from the group consisting of a a phenyl group, or a 5- or 6-membered aromatic heterocyclic group {the phenyl group and the 5- or 6-membered aromatic heterocyclic group may be selected from the group G a R may be substituted with one or more substituents selected from the following 13a represents a C3-C6 chain hydrocarbon group, a (C3-C6 cycloalkyl)carbonyl group, a C1-C6 alkylsulfonyl group (the C3-C6 chain hydrocarbon group, the (C3-C6 cycloalkyl)carbonyl group, and the C1-C6 alkylsulfonyl group are optionally substituted with one or more halogen atoms), a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group (the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group are each selected from group F a and a 5- or 6-membered aromatic heterocyclic group {which may be substituted with one or more substituents selected from the group G a R may be substituted with one or more substituents selected from the following 14a represents a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group, a (C1-C6 alkoxy)carbonyl group, a (C1-C6 alkylamino)carbonyl group, a (C2-C8 dialkylamino)carbonyl group (the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, the (C1-C6 alkoxy)carbonyl group, the (C1-C6 alkylamino)carbonyl group, and the (C2-C8 dialkylamino)carbonyl group are optionally substituted with one or more halogen atoms), a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group (the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group are each selected from group F a a 5- or 6-membered aromatic heterocyclic group {which may be substituted with one or more substituents selected from the group G a or a hydrogen atom, R 15a and R 16a are the same or different, and are group E a a C1-C6 chain hydrocarbon group optionally substituted by one or more substituents selected from the group consisting of a C1-C6 alkylsulfonyl group, a (C1-C6 alkyl)carbonyl group, a (C1-C6 alkoxy)carbonyl group, a (C1-C6 alkylamino)carbonyl group, a (C2-C8 dialkylamino)carbonyl group {the C1-C6 alkylsulfonyl group, the (C1-C6 alkyl)carbonyl group, the (C1-C6 alkoxy)carbonyl group, the (C1-C6 alkylamino)carbonyl group, and the (C2-C8 dialkylamino)carbonyl group are optionally substituted by one or more halogen atoms}, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group are selected from the group consisting of a C1-C6 alkylsulfonyl group, a C1-C6 alkyl)carbonyl group, a (C1-C6 alkoxy)carbonyl group, a (C1-C6 alkylamino)carbonyl group, and a ... a or a hydrogen atom, R 17a and R 18a are the same or different, and are group E a a C1-C6 chain hydrocarbon group optionally substituted by one or more substituents selected from the group consisting of a C1-C6 alkoxy group, a C1-C6 alkylamino group, a C2-C8 dialkylamino group (the C1-C6 alkoxy group, the C1-C6 alkylamino group, and the C2-C8 dialkylamino group are optionally substituted by one or more halogen atoms), a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group (the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group are selected from the group consisting of ... chain hydrocarbon group, a C1-C6 alkoxy group, a C1-C6 alkylamino group, a C2-C8 dialkylamino group (the C1-C6 alkoxy group, the C1-C6 alkylamino group, and the C2-C8 dialkylamino group are optionally substituted by one or more halogen atoms), a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group (the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group are selected from the group consisting of a a phenyl group, a 5- or 6-membered aromatic heterocyclic group {the phenyl group and the 5- or 6-membered aromatic heterocyclic group may be selected from the group G a or an amino group, R 19a and R 20a are the same or different, and are group E a a C1-C6 chain hydrocarbon group optionally substituted by one or more substituents selected from the group consisting of a C1-C6 alkylsulfonyl group, a (C1-C6 alkyl)carbonyl group, a (C1-C6 alkoxy)carbonyl group, a (C1-C6 alkylamino)carbonyl group, a (C2-C8 dialkylamino)carbonyl group {the C1-C6 alkylsulfonyl group, the (C1-C6 alkyl)carbonyl group, the (C1-C6 alkoxy)carbonyl group, the (C1-C6 alkylamino)carbonyl group, and the (C2-C8 dialkylamino)carbonyl group are optionally substituted by one or more halogen atoms}, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group are selected from the group consisting of a C1-C6 alkylsulfonyl group, a C1-C6 alkyl)carbonyl group, a (C1-C6 alkoxy)carbonyl group, a (C1-C6 alkylamino)carbonyl group, and a ... a a phenyl group, a 5- or 6-membered aromatic heterocyclic group {the phenyl group and the 5- or 6-membered aromatic heterocyclic group may be selected from the group G a or a hydrogen atom, R 21a is Group E a a C1-C6 chain hydrocarbon group optionally substituted by one or more substituents selected from the group consisting of a C1-C6 alkoxy group, a C1-C6 alkylamino group, a C2-C8 dialkylamino group (the C1-C6 alkoxy group, the C1-C6 alkylamino group, and the C2-C8 dialkylamino group are optionally substituted by one or more halogen atoms), a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group (the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group are selected from the group consisting of ... chain hydrocarbon group, a C1-C6 alkoxy group, a C1-C6 alkylamino group, a C2-C8 dialkylamino group (the C1-C6 alkoxy group, the C1-C6 alkylamino group, and the C2-C8 dialkylamino group are optionally substituted by one or more halogen atoms), a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group (the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group are selected from the group consisting of a a phenyl group, a 5- or 6-membered aromatic heterocyclic group {the phenyl group and the 5- or 6-membered aromatic heterocyclic group may be selected from the group G a R represents a hydroxy group, an amino group, or a hydrogen atom, and R 22a , R 28a , R 30a , and R 36a are the same or different, and are in the group C1 a R represents a C1-C6 chain hydrocarbon group optionally substituted with one or more substituents selected from the group consisting of: 23a , R 29a , and R 37a are the same or different, and are group E a a C1-C6 chain hydrocarbon group, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group, each of which may be substituted by one or more substituents selected from the group consisting of a a phenyl group, a 5- or 6-membered aromatic heterocyclic group {the phenyl group and the 5- or 6-membered aromatic heterocyclic group may be selected from the group G a or a hydrogen atom, R 25a , R 26a , R 33a , and R 34a are the same or different, and are group E a a C1-C6 chain hydrocarbon group optionally substituted by one or more substituents selected from the group consisting of a C1-C6 alkylsulfonyl group, a (C1-C6 alkyl)carbonyl group, a (C1-C6 alkoxy)carbonyl group, a (C1-C6 alkylamino)carbonyl group, a (C2-C8 dialkylamino)carbonyl group {the C1-C6 alkylsulfonyl group, the (C1-C6 alkyl)carbonyl group, the (C1-C6 alkoxy)carbonyl group, the (C1-C6 alkylamino)carbonyl group, and the (C2-C8 dialkylamino)carbonyl group are optionally substituted by one or more halogen atoms}, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group are selected from the group consisting of a C1-C6 alkylsulfonyl group, a C1-C6 alkyl)carbonyl group, a (C1-C6 alkoxy)carbonyl group, a (C1-C6 alkylamino)carbonyl group, and a ... a a phenyl group, a 5- or 6-membered aromatic heterocyclic group {the phenyl group and the 5- or 6-membered aromatic heterocyclic group may be selected from the group G a or a hydrogen atom, R 24a and R 32a are the same or different, and are group E a a C1-C6 chain hydrocarbon group optionally substituted by one or more substituents selected from the group consisting of a C1-C6 alkylsulfonyl group, a (C1-C6 alkyl)carbonyl group, a (C1-C6 alkoxy)carbonyl group, a (C1-C6 alkylamino)carbonyl group, a (C2-C8 dialkylamino)carbonyl group {the C1-C6 alkylsulfonyl group, the (C1-C6 alkyl)carbonyl group, the (C1-C6 alkoxy)carbonyl group, the (C1-C6 alkylamino)carbonyl group, and the (C2-C8 dialkylamino)carbonyl group are optionally substituted by one or more halogen atoms}, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group are selected from the group consisting of a C1-C6 alkylsulfonyl group, a C1-C6 alkyl)carbonyl group, a (C1-C6 alkoxy)carbonyl group, a (C1-C6 alkylamino)carbonyl group, and a ... a a phenyl group, or a 5- or 6-membered aromatic heterocyclic group {the phenyl group and the 5- or 6-membered aromatic heterocyclic group may be selected from the group G a R may be substituted with one or more substituents selected from the following 27a and R 35a are the same or different, and are in the group C1 a a C1-C6 chain hydrocarbon group, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group, each of which may be substituted by one or more substituents selected from the group consisting of a Group A represents an amino group, a hydroxy group, or a hydrogen atom, and may be substituted with one or more substituents selected from the group consisting of: a C1-C6 chain hydrocarbon group, C1-C6 alkoxy group, C1-C6 alkylamino group, C2-C8 dialkylamino group, (C1-C6 alkyl)carbonyl group, (C1-C6 alkoxy)carbonyl group, (C1-C6 alkylamino)carbonyl group, (C2-C8 dialkylamino)carbonyl group, (C1-C6 alkyl)carbonylamino group, (C1-C6 alkoxy)carbonylamino group {the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, the C1-C6 alkylamino group, the C2-C8 a dialkylamino group, the (C1-C6 alkyl)carbonyl group, the (C1-C6 alkoxy)carbonyl group, the (C1-C6 alkylamino)carbonyl group, the (C2-C8 dialkylamino)carbonyl group, the (C1-C6 alkyl)carbonylamino group, and the (C1-C6 alkoxy)carbonylamino group are optionally substituted with one or more halogen atoms}, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group are selected from group F a and a group consisting of a halogen atom, a cyano group, a nitro group, a hydroxy group, and a sulfanyl group, each of which may be substituted with one or more substituents selected from the group consisting of: a oxo group, thioxo group, C1-C6 chain hydrocarbon group, C1-C6 alkoxy group, C1-C6 alkylamino group, C2-C8 dialkylamino group, (C1-C6 alkyl)carbonyl group, (C1-C6 alkoxy)carbonyl group, (C1-C6 alkylamino)carbonyl group, (C2-C8 dialkylamino)carbonyl group, (C1-C6 alkyl)carbonylamino group, (C1-C6 alkoxy)carbonylamino group {the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, the C1-C6 alkylamino group, the C2-C8 dialkylamino group, the (C1-C6 alkyl)carbonyl group, the (C1-C6 alkoxy)carbonyl group, the (C1-C6 alkylamino)carbonyl group, the (C2-C8 dialkylamino)carbonyl group, the (C1-C6 alkyl)carbonylamino group, and the (C1-C6 alkoxy)carbonylamino group are optionally substituted with one or more halogen atoms}, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group are selected from group F a and a group consisting of a halogen atom, a cyano group, a nitro group, a hydroxy group, and a sulfanyl group, each of which may be substituted with one or more substituents selected from the group consisting of: a a C1-C6 alkoxy group, a C1-C6 alkylamino group, a C2-C8 dialkylamino group, a C1-C6 alkylsulfanyl group, a C1-C6 alkylsulfinyl group, a C1-C6 alkylsulfonyl group {the C1-C6 alkoxy group, the C1-C6 alkylamino group, the C2-C8 dialkylamino group, the C1-C6 alkylsulfanyl group, the C1-C6 alkylsulfinyl group, and the C1-C6 alkylsulfonyl group are optionally substituted with one or more halogen atoms}, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group are selected from group F a and a group consisting of a halogen atom, a cyano group, a nitro group, a hydroxy group, and a sulfanyl group, each of which may be substituted with one or more substituents selected from the group consisting of a halogen atom, a cyano group, a nitro group, a hydroxy group, and a sulfanyl group. a a C1-C6 alkoxy group, a C1-C6 alkylamino group, a C2-C8 dialkylamino group, a C1-C6 alkylsulfanyl group, a C1-C6 alkylsulfinyl group, a C1-C6 alkylsulfonyl group {the C1-C6 alkoxy group, the C1-C6 alkylamino group, the C2-C8 dialkylamino group, the C1-C6 alkylsulfanyl group, the C1-C6 alkylsulfinyl group, and the C1-C6 alkylsulfonyl group are optionally substituted with one or more halogen atoms}, a C3-C8 alicyclic hydrocarbon group {the C3-C8 alicyclic hydrocarbon group is selected from group F a and a group consisting of a halogen atom, a cyano group, a nitro group, a hydroxy group, and a sulfanyl group, each of which may be substituted with one or more substituents selected from the group consisting of: a a C1-C6 alkoxy group, a C1-C6 alkylsulfanyl group, a C1-C6 alkylsulfinyl group, a (C1-C6 alkyl)carbonyl group, a (C1-C6 alkoxy)carbonyl group, a (C1-C6 alkylamino)carbonyl group, a (C2-C8 dialkylamino)carbonyl group {the C1-C6 alkoxy group, the C1-C6 alkylsulfanyl group, the C1-C6 alkylsulfinyl group, the (C1-C6 alkyl)carbonyl group, the (C1-C6 alkoxy)carbonyl group, the (C1-C6 alkylamino)carbonyl group, and the (C2-C8 dialkylamino)carbonyl group are optionally substituted with one or more halogen atoms}, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group are selected from group F a a phenyl group, a 5- or 6-membered aromatic heterocycle {the phenyl group and the 5- or 6-membered aromatic heterocycle are each selected from the group A a and a cyano group. a a C1-C6 alkoxy group, a C1-C6 alkylamino group, a C2-C8 dialkylamino group, a C1-C6 alkylsulfanyl group, a C1-C6 alkylsulfinyl group, a C1-C6 alkylsulfonyl group {the C1-C6 alkoxy group, the C1-C6 alkylamino group, the C2-C8 dialkylamino group, the C1-C6 alkylsulfanyl group, the C1-C6 alkylsulfinyl group, and the C1-C6 alkylsulfonyl group are optionally substituted with one or more halogen atoms}, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group are selected from group F a a phenyl group, a 5- or 6-membered aromatic heterocyclic group {the phenyl group and the 5- or 6-membered aromatic heterocyclic group may be selected from the group G a and a group consisting of a halogen atom, a cyano group, a nitro group, a hydroxy group, and a sulfanyl group, each of which may be substituted with one or more substituents selected from the group consisting of: a Group G: a group consisting of an oxo group, a thioxo group, a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group, a C1-C6 alkylsulfanyl group, a C1-C6 alkylsulfinyl group, a C1-C6 alkylsulfonyl group (the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, the C1-C6 alkylsulfanyl group, the C1-C6 alkylsulfinyl group, and the C1-C6 alkylsulfonyl group are optionally substituted with one or more halogen atoms), a hydroxy group, a sulfanyl group, a halogen atom, and a cyano group. a C1-C6 chain hydrocarbon group, C1-C6 alkoxy group, C1-C6 alkylsulfanyl group, C1-C6 alkylsulfinyl group, C1-C6 alkylsulfonyl group, C1-C6 alkylamino group, C2-C8 dialkylamino group, (C1-C6 alkyl)carbonyl group, (C1-C6 alkoxy)carbonyl group, (C1-C6 alkylamino)carbonyl group, (C2-C8 dialkylamino)carbonyl group, (C1-C6 alkyl)carbonylamino group, (C1-C6 alkoxy)carbonylamino group {the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, the C1-C6 alkylsulfanyl group, the C1- a C6 alkylsulfinyl group, the C1-C6 alkylsulfonyl group, the C1-C6 alkylamino group, the C2-C8 dialkylamino group, the (C1-C6 alkyl)carbonyl group, the (C1-C6 alkoxy)carbonyl group, the (C1-C6 alkylamino)carbonyl group, the (C2-C8 dialkylamino)carbonyl group, the (C1-C6 alkyl)carbonylamino group, and the (C1-C6 alkoxy)carbonylamino group are optionally substituted with one or more halogen atoms}, a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group are selected from group F a Group H1 is a group consisting of an amino group, a nitro group, a cyano group, a hydroxy group, a sulfanyl group, and a halogen atom, and may be substituted with one or more substituents selected from the group consisting of: a a C1-C6 alkylsulfanyl group, a C1-C6 alkylsulfinyl group, a C1-C6 alkylsulfonyl group, a C1-C6 alkylamino group, a C2-C8 dialkylamino group (the C1-C6 alkylsulfanyl group, the C1-C6 alkylsulfinyl group, the C1-C6 alkylsulfonyl group, the C1-C6 alkylamino group, and the C2-C8 dialkylamino group are optionally substituted with one or more halogen atoms), a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group (the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group are selected from Group E a Group H2 is a group consisting of a hydroxy group and a halogen atom, each of which may be substituted with one or more substituents selected from the group consisting of: a a C1-C6 alkylsulfanyl group, a C1-C6 alkylsulfinyl group, a C1-C6 alkylsulfonyl group, a C1-C6 alkylamino group, a C2-C8 dialkylamino group (the C1-C6 alkylsulfanyl group, the C1-C6 alkylsulfinyl group, the C1-C6 alkylsulfonyl group, the C1-C6 alkylamino group, and the C2-C8 dialkylamino group are optionally substituted with one or more halogen atoms), a C3-C8 alicyclic hydrocarbon group, a 3- to 8-membered non-aromatic heterocyclic group (the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group are selected from Group E a and a hydroxy group. a a C1-C6 alkoxy group, a C1-C6 alkylsulfanyl group, a C1-C6 alkylsulfinyl group, a C1-C6 alkylsulfonyl group {the C1-C6 alkoxy group, the C1-C6 alkylsulfanyl group, the C1-C6 alkylsulfinyl group, and the C1-C6 alkylsulfonyl group are optionally substituted with one or more halogen atoms}, a C3-C8 alicyclic hydrocarbon group, and a 3- to 8-membered non-aromatic heterocyclic group {the C3-C8 alicyclic hydrocarbon group and the 3- to 8-membered non-aromatic heterocyclic group are selected from group F a or an N-oxide thereof, or a salt thereof.

3. A composition comprising the compound according to claim 2, its N-oxide or a salt thereof, and an inert carrier.

4. A composition containing one or more components selected from the group consisting of group (a), group (b), group (c) and group (d), and the compound according to claim 2 or its N-oxide or a salt thereof: Group (a): a group consisting of insecticidal active components, acaricidal active components and nematicidal active components; Group (b): fungicidal active components; Group (c): plant growth regulator components; Group (d): repellent components.

5. A method for controlling plant diseases, which comprises applying an effective amount of the compound or N-oxide thereof or a salt thereof as set forth in claim 2, or an effective amount of the composition as set forth in claim 4 to a plant or the soil in which the plant is grown.

6. Use of the compound or N-oxide or salt thereof according to claim 2, or the composition according to claim 4, for controlling plant diseases.

7. A seed or vegetative reproductive organ bearing an effective amount of the compound of claim 2 or its N-oxide or a salt thereof, or an effective amount of the composition of claim 4.

Images